[
  {
    "level": "parent",
    "parentQuestion": "NA",
    "column": "record",
    "description": "record: Record number",
    "valueType": "Values: 5-703",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "admin",
    "rangeMin": 5,
    "rangeMax": 703
  },
  {
    "level": "parent",
    "parentQuestion": "NA",
    "column": "uuid",
    "description": "uuid: Participant identifier",
    "valueType": "Open Text",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "admin"
  },
  {
    "level": "parent",
    "parentQuestion": "NA",
    "column": "date",
    "description": "date: Completion time and date",
    "valueType": "Values: 1722868320-1723755840",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "admin",
    "rangeMin": 1722868320,
    "rangeMax": 1723755840
  },
  {
    "level": "parent",
    "parentQuestion": "NA",
    "column": "S1",
    "description": "S1: Are you, or is any immediate family member, employed by or affiliated with any pharmaceutical or biotechnology company, or working in market research?",
    "valueType": "Values: 1-2",
    "answerOptions": "1=Yes,2=No",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 2,
    "allowedValues": [
      1,
      2
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "Yes"
      },
      {
        "value": 2,
        "label": "No"
      }
    ]
  },
  {
    "level": "parent",
    "parentQuestion": "NA",
    "column": "S2",
    "description": "S2: How old are you?",
    "valueType": "Values: 29-68",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "numeric_range",
    "rangeMin": 29,
    "rangeMax": 68,
    "rangeStep": 1
  },
  {
    "level": "sub",
    "parentQuestion": "S3",
    "column": "S3r1",
    "description": "S3r1: Asthma - Are you the primary caregiver or one of the primary caregivers for someone with one of the following conditions?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Asthma,1=Asthma",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "S3",
    "column": "S3r2",
    "description": "S3r2: Diabetes - Are you the primary caregiver or one of the primary caregivers for someone with one of the following conditions?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Diabetes,1=Diabetes",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "S3",
    "column": "S3r3",
    "description": "S3r3: Dravet Syndrome - Are you the primary caregiver or one of the primary caregivers for someone with one of the following conditions?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Dravet Syndrome,1=Dravet Syndrome",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "S3",
    "column": "S3r4",
    "description": "S3r4: Lennox-Gastaut Syndrome (LGS) - Are you the primary caregiver or one of the primary caregivers for someone with one of the following conditions?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Lennox-Gastaut Syndrome (LGS),1=Lennox-Gastaut Syndrome (LGS)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "S3",
    "column": "S3r5",
    "description": "S3r5: Other medical condition - Are you the primary caregiver or one of the primary caregivers for someone with one of the following conditions?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Other medical condition,1=Other medical condition",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "S3",
    "column": "S3r99",
    "description": "S3r99: None of these - Are you the primary caregiver or one of the primary caregivers for someone with one of the following conditions?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: None of these,1=None of these",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ],
    "dependentOn": "S2"
  },
  {
    "level": "parent",
    "parentQuestion": "NA",
    "column": "hS3",
    "description": "hS3: Hidden question",
    "valueType": "Values: 1-2",
    "answerOptions": "1=Dravet Syndrome,2=Lennox-Gastaut Syndrome (LGS)",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 2,
    "allowedValues": [
      1,
      2
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "Dravet Syndrome"
      },
      {
        "value": 2,
        "label": "Lennox-Gastaut Syndrome (LGS)"
      }
    ]
  },
  {
    "level": "parent",
    "parentQuestion": "NA",
    "column": "S4",
    "description": "S4: How would you describe your role in providing care for this person with [pipe: hS3]?",
    "valueType": "Values: 1-3",
    "answerOptions": "1=I am highly involved in caring for this person, gathering knowledge, and making decisions - I would consider myself a pr,2=I am involved in caring for this person, but someone else is responsible for gathering knowledge and making decisions,3=I am occasionally involved in caring for this person, but other people are more regularly involved in their care",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 3,
    "allowedValues": [
      1,
      2,
      3
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "I am highly involved in caring for this person"
      },
      {
        "value": 2,
        "label": "I am involved in caring for this person"
      },
      {
        "value": 3,
        "label": "I am occasionally involved in caring for this person"
      }
    ]
  },
  {
    "level": "parent",
    "parentQuestion": "NA",
    "column": "S5",
    "description": "S5: Are you paid by a third-party agency, company, or organization to take care of this person with [pipe: hS3]?",
    "valueType": "Values: 1-2",
    "answerOptions": "1=Yes,2=No",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 2,
    "allowedValues": [
      1,
      2
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "Yes"
      },
      {
        "value": 2,
        "label": "No"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "S6",
    "column": "S6r1",
    "description": "S6r1: I participate in decisions on their medical care - Which aspects of care are you actively involved in?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: I participate in decisions on their medical care,1=I participate in decisions on their medical care",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "S6",
    "column": "S6r2",
    "description": "S6r2: I attend the majority of their healthcare provider's appointments - Which aspects of care are you actively involved in?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: I attend the majority of their healthcare provider's appointments,1=I attend the majority of their healthcare provider's appointments",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "S6",
    "column": "S6r3",
    "description": "S6r3: I help with managing personal care such as bathing and dressing - Which aspects of care are you actively involved in?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: I help with managing personal care such as bathing and dressing,1=I help with managing personal care such as bathing and dressing",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "S6",
    "column": "S6r4",
    "description": "S6r4: I help with their day-to-day life such as meals, transportation, and activities - Which aspects of care are you actively involved in?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: I help with their day-to-day life such as meals, transportation, and activities,1=I help with their day-to-day life such as meals, transportation, and activities",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "S6",
    "column": "S6r5",
    "description": "S6r5: I help make antiseizure treatment decisions - Which aspects of care are you actively involved in?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: I help make antiseizure treatment decisions,1=I help make antiseizure treatment decisions",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "S6",
    "column": "S6r6",
    "description": "S6r6: I help them take their medication correctly - Which aspects of care are you actively involved in?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: I help them take their medication correctly,1=I help them take their medication correctly",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "S6",
    "column": "S6r99",
    "description": "S6r99: None of these - Which aspects of care are you actively involved in?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: None of these,1=None of these",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ],
    "dependentOn": "S5"
  },
  {
    "level": "parent",
    "parentQuestion": "NA",
    "column": "S7",
    "description": "S7: Is this person with [pipe: hS3] currently taking antiseizure treatment for [pipe: hS3]?",
    "valueType": "Values: 1-2",
    "answerOptions": "1=Yes,2=No",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 2,
    "allowedValues": [
      1,
      2
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "Yes"
      },
      {
        "value": 2,
        "label": "No"
      }
    ]
  },
  {
    "level": "parent",
    "parentQuestion": "NA",
    "column": "S9",
    "description": "S9: What is the first initial of the first name of the person with [pipe: hS3]?",
    "valueType": "Open Text",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "text_open"
  },
  {
    "level": "parent",
    "parentQuestion": "NA",
    "column": "S10",
    "description": "S10: What is the age of [pipe: S9 upper]?",
    "valueType": "Values: 2-37",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 2,
    "rangeMax": 37,
    "allowedValues": [
      2,
      3,
      4,
      5,
      6,
      7,
      8,
      9,
      10,
      11,
      12,
      13,
      14,
      15,
      16,
      17,
      18,
      19,
      20,
      21,
      22,
      23,
      24,
      25,
      26,
      27,
      28,
      29,
      30,
      31,
      32,
      33,
      34,
      35,
      36,
      37
    ]
  },
  {
    "level": "parent",
    "parentQuestion": "NA",
    "column": "HS10",
    "description": "HS10: Age ranges",
    "valueType": "Values: 1-3",
    "answerOptions": "1=Pediatric,2=Young adult,3=Adult",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 3,
    "allowedValues": [
      1,
      2,
      3
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "Pediatric"
      },
      {
        "value": 2,
        "label": "Young adult"
      },
      {
        "value": 3,
        "label": "Adult"
      }
    ]
  },
  {
    "level": "parent",
    "parentQuestion": "NA",
    "column": "HS10VsS3",
    "description": "HS10VsS3: Hidden question",
    "valueType": "Values: 1-4",
    "answerOptions": "1=DRAVET SYNDROME PEDIATRIC,2=DRAVET SYNDROME ADULT,3=LGS PEDIATRIC,4=LGS ADULT",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 4,
    "allowedValues": [
      1,
      2,
      3,
      4
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "DRAVET SYNDROME PEDIATRIC"
      },
      {
        "value": 2,
        "label": "DRAVET SYNDROME ADULT"
      },
      {
        "value": 3,
        "label": "LGS PEDIATRIC"
      },
      {
        "value": 4,
        "label": "LGS ADULT"
      }
    ]
  },
  {
    "level": "parent",
    "parentQuestion": "NA",
    "column": "S11",
    "description": "S11: What is the gender identity of [pipe: S9 upper]?",
    "valueType": "Values: 1-4",
    "answerOptions": "1=Male,2=Female,3=Other,4=Prefer not to answer",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 4,
    "allowedValues": [
      1,
      2,
      3,
      4
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "Male"
      },
      {
        "value": 2,
        "label": "Female"
      },
      {
        "value": 3,
        "label": "Other"
      },
      {
        "value": 4,
        "label": "Prefer not to answer"
      }
    ]
  },
  {
    "level": "parent",
    "parentQuestion": "NA",
    "column": "END_Screener",
    "description": "END_Screener: This research study is strictly non-promotional. We will be seeking to get your perspectives and feedback, not to promote products. In accordance with market research codes of conduct, any information you disclose will be treated in the stri",
    "valueType": "Values: 1-2",
    "answerOptions": "1=Yes,2=No",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 2,
    "allowedValues": [
      1,
      2
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "Yes"
      },
      {
        "value": 2,
        "label": "No"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A1",
    "column": "A1r1",
    "description": "A1r1: When thinking about prescription antiseizure treatments for [pipe: hS3], what treatments come to mind?",
    "valueType": "Open Text",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "text_open"
  },
  {
    "level": "sub",
    "parentQuestion": "A1",
    "column": "A1r2",
    "description": "A1r2: When thinking about prescription antiseizure treatments for [pipe: hS3], what treatments come to mind?",
    "valueType": "Open Text",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "text_open"
  },
  {
    "level": "sub",
    "parentQuestion": "A1",
    "column": "A1r3",
    "description": "A1r3: When thinking about prescription antiseizure treatments for [pipe: hS3], what treatments come to mind?",
    "valueType": "Open Text",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "text_open"
  },
  {
    "level": "sub",
    "parentQuestion": "A1",
    "column": "A1r4",
    "description": "A1r4: When thinking about prescription antiseizure treatments for [pipe: hS3], what treatments come to mind?",
    "valueType": "Open Text",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "text_open"
  },
  {
    "level": "sub",
    "parentQuestion": "A1",
    "column": "A1r5",
    "description": "A1r5: When thinking about prescription antiseizure treatments for [pipe: hS3], what treatments come to mind?",
    "valueType": "Open Text",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "text_open"
  },
  {
    "level": "sub",
    "parentQuestion": "A1",
    "column": "A1r6",
    "description": "A1r6: When thinking about prescription antiseizure treatments for [pipe: hS3], what treatments come to mind?",
    "valueType": "Open Text",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "text_open"
  },
  {
    "level": "sub",
    "parentQuestion": "A1",
    "column": "A1r7",
    "description": "A1r7: When thinking about prescription antiseizure treatments for [pipe: hS3], what treatments come to mind?",
    "valueType": "Open Text",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "text_open"
  },
  {
    "level": "sub",
    "parentQuestion": "A1",
    "column": "A1r8",
    "description": "A1r8: When thinking about prescription antiseizure treatments for [pipe: hS3], what treatments come to mind?",
    "valueType": "Open Text",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "text_open"
  },
  {
    "level": "sub",
    "parentQuestion": "A1",
    "column": "A1r9",
    "description": "A1r9: When thinking about prescription antiseizure treatments for [pipe: hS3], what treatments come to mind?",
    "valueType": "Open Text",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "text_open"
  },
  {
    "level": "sub",
    "parentQuestion": "A1",
    "column": "A1r10",
    "description": "A1r10: When thinking about prescription antiseizure treatments for [pipe: hS3], what treatments come to mind?",
    "valueType": "Open Text",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "text_open"
  },
  {
    "level": "parent",
    "parentQuestion": "NA",
    "column": "noanswerA1_n1",
    "description": "noanswerA1_n1: When thinking about prescription antiseizure treatments for [pipe: hS3], what treatments come to mind?: I can't think of any - No Answer",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: When thinking about prescription antiseizure treatments for [pipe: hS3], what treatments come to mind?: I can't t,1=When thinking about prescription antiseizure treatments for [pipe: hS3], what treatments come to mind?: I can't think of",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A2",
    "column": "A2r1",
    "description": "A2r1: BANZEL (rufinamide) - Which of the following antiseizure treatments are you aware of that may be an option for [pipe: hS3]?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: BANZEL (rufinamide),1=BANZEL (rufinamide)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A2",
    "column": "A2r2",
    "description": "A2r2: DEPAKOTE (valproate) - Which of the following antiseizure treatments are you aware of that may be an option for [pipe: hS3]?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: DEPAKOTE (valproate),1=DEPAKOTE (valproate)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A2",
    "column": "A2r3",
    "description": "A2r3: DIACOMIT (stiripentol) - Which of the following antiseizure treatments are you aware of that may be an option for [pipe: hS3]?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: DIACOMIT (stiripentol),1=DIACOMIT (stiripentol)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A2",
    "column": "A2r4",
    "description": "A2r4: DIASTAT (diazepam) - Which of the following antiseizure treatments are you aware of that may be an option for [pipe: hS3]?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: DIASTAT (diazepam),1=DIASTAT (diazepam)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A2",
    "column": "A2r5",
    "description": "A2r5: EPIDIOLEX (cannabidiol) - Which of the following antiseizure treatments are you aware of that may be an option for [pipe: hS3]?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: EPIDIOLEX (cannabidiol),1=EPIDIOLEX (cannabidiol)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A2",
    "column": "A2r6",
    "description": "A2r6: FELBATOL (felbamate) - Which of the following antiseizure treatments are you aware of that may be an option for [pipe: hS3]?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: FELBATOL (felbamate),1=FELBATOL (felbamate)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A2",
    "column": "A2r7",
    "description": "A2r7: FINTEPLA (fenfluramine) - Which of the following antiseizure treatments are you aware of that may be an option for [pipe: hS3]?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: FINTEPLA (fenfluramine),1=FINTEPLA (fenfluramine)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A2",
    "column": "A2r8",
    "description": "A2r8: KEPPRA (levetiracetam) - Which of the following antiseizure treatments are you aware of that may be an option for [pipe: hS3]?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: KEPPRA (levetiracetam),1=KEPPRA (levetiracetam)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A2",
    "column": "A2r9",
    "description": "A2r9: KLONOPIN (clonazepam) - Which of the following antiseizure treatments are you aware of that may be an option for [pipe: hS3]?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: KLONOPIN (clonazepam),1=KLONOPIN (clonazepam)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A2",
    "column": "A2r10",
    "description": "A2r10: LAMICTAL (lamotrigine) - Which of the following antiseizure treatments are you aware of that may be an option for [pipe: hS3]?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: LAMICTAL (lamotrigine),1=LAMICTAL (lamotrigine)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A2",
    "column": "A2r11",
    "description": "A2r11: Nasal rescue medications (NAYZILAM, VALTOCO) - Which of the following antiseizure treatments are you aware of that may be an option for [pipe: hS3]?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Nasal rescue medications (NAYZILAM, VALTOCO),1=Nasal rescue medications (NAYZILAM, VALTOCO)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A2",
    "column": "A2r12",
    "description": "A2r12: ONFI (clobazam pill/tablet) - Which of the following antiseizure treatments are you aware of that may be an option for [pipe: hS3]?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: ONFI (clobazam pill/tablet),1=ONFI (clobazam pill/tablet)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A2",
    "column": "A2r13",
    "description": "A2r13: RIVOTRIL (clonazepam) - Which of the following antiseizure treatments are you aware of that may be an option for [pipe: hS3]?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: RIVOTRIL (clonazepam),1=RIVOTRIL (clonazepam)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A2",
    "column": "A2r14",
    "description": "A2r14: TOPAMAX (topiramate) - Which of the following antiseizure treatments are you aware of that may be an option for [pipe: hS3]?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: TOPAMAX (topiramate),1=TOPAMAX (topiramate)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A2",
    "column": "A2r15",
    "description": "A2r15: VALPROIC ACID (valproate) - Which of the following antiseizure treatments are you aware of that may be an option for [pipe: hS3]?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: VALPROIC ACID (valproate),1=VALPROIC ACID (valproate)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A2",
    "column": "A2r16",
    "description": "A2r16: XCOPRI (cenobamate) - Which of the following antiseizure treatments are you aware of that may be an option for [pipe: hS3]?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: XCOPRI (cenobamate),1=XCOPRI (cenobamate)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A2",
    "column": "A2r17",
    "description": "A2r17: ZONEGRAN (zonisamide) - Which of the following antiseizure treatments are you aware of that may be an option for [pipe: hS3]?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: ZONEGRAN (zonisamide),1=ZONEGRAN (zonisamide)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A2",
    "column": "A2r99",
    "description": "A2r99: None of these - Which of the following antiseizure treatments are you aware of that may be an option for [pipe: hS3]?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: None of these,1=None of these",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r1c1",
    "description": "A3r1c1: BANZEL (rufinamide) - Currently taking/using - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What procedures received in past",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: BANZEL (rufinamide),1=BANZEL (rufinamide)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r2c1",
    "description": "A3r2c1: DEPAKOTE (valproate) - Currently taking/using - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What procedures received in past",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: DEPAKOTE (valproate),1=DEPAKOTE (valproate)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r3c1",
    "description": "A3r3c1: DIACOMIT (stiripentol) - Currently taking/using - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What procedures received in pa",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: DIACOMIT (stiripentol),1=DIACOMIT (stiripentol)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r4c1",
    "description": "A3r4c1: DIASTAT (diazepam) - Currently taking/using - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What procedures received in past o",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: DIASTAT (diazepam),1=DIASTAT (diazepam)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r5c1",
    "description": "A3r5c1: EPIDIOLEX (cannabidiol) - Currently taking/using - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What procedures received in p",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: EPIDIOLEX (cannabidiol),1=EPIDIOLEX (cannabidiol)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r6c1",
    "description": "A3r6c1: FELBATOL (felbamate) - Currently taking/using - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What procedures received in past",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: FELBATOL (felbamate),1=FELBATOL (felbamate)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r7c1",
    "description": "A3r7c1: FINTEPLA (fenfluramine) - Currently taking/using - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What procedures received in p",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: FINTEPLA (fenfluramine),1=FINTEPLA (fenfluramine)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r8c1",
    "description": "A3r8c1: KEPPRA (levetiracetam) - Currently taking/using - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What procedures received in pa",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: KEPPRA (levetiracetam),1=KEPPRA (levetiracetam)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r9c1",
    "description": "A3r9c1: KLONOPIN (clonazepam) - Currently taking/using - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What procedures received in pas",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: KLONOPIN (clonazepam),1=KLONOPIN (clonazepam)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r10c1",
    "description": "A3r10c1: LAMICTAL (lamotrigine) - Currently taking/using - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What procedures received in p",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: LAMICTAL (lamotrigine),1=LAMICTAL (lamotrigine)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r11c1",
    "description": "A3r11c1: Nasal rescue medications (NAYZILAM, VALTOCO) - Currently taking/using - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What pr",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Nasal rescue medications (NAYZILAM, VALTOCO),1=Nasal rescue medications (NAYZILAM, VALTOCO)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r12c1",
    "description": "A3r12c1: ONFI (clobazam pill/tablet) - Currently taking/using - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What procedures received",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: ONFI (clobazam pill/tablet),1=ONFI (clobazam pill/tablet)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r13c1",
    "description": "A3r13c1: RIVOTRIL (clonazepam) - Currently taking/using - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What procedures received in pa",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: RIVOTRIL (clonazepam),1=RIVOTRIL (clonazepam)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r14c1",
    "description": "A3r14c1: TOPAMAX (topiramate) - Currently taking/using - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What procedures received in pas",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: TOPAMAX (topiramate),1=TOPAMAX (topiramate)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r15c1",
    "description": "A3r15c1: VALPROIC ACID (valproate) - Currently taking/using - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What procedures received i",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: VALPROIC ACID (valproate),1=VALPROIC ACID (valproate)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r16c1",
    "description": "A3r16c1: XCOPRI (cenobamate) - Currently taking/using - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What procedures received in past",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: XCOPRI (cenobamate),1=XCOPRI (cenobamate)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r17c1",
    "description": "A3r17c1: ZONEGRAN (zonisamide) - Currently taking/using - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What procedures received in pa",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: ZONEGRAN (zonisamide),1=ZONEGRAN (zonisamide)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r18c1",
    "description": "A3r18c1: ATIVAN (lorazepam) - Currently taking/using - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What procedures received in past",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: ATIVAN (lorazepam),1=ATIVAN (lorazepam)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r19c1",
    "description": "A3r19c1: BRIVIACT (brivaracetam) - Currently taking/using - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What procedures received in",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: BRIVIACT (brivaracetam),1=BRIVIACT (brivaracetam)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r20c1",
    "description": "A3r20c1: DILANTIN (phenytoin) - Currently taking/using - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What procedures received in pas",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: DILANTIN (phenytoin),1=DILANTIN (phenytoin)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r21c1",
    "description": "A3r21c1: EPITOL (carbamazepine) - Currently taking/using - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What procedures received in p",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: EPITOL (carbamazepine),1=EPITOL (carbamazepine)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r22c1",
    "description": "A3r22c1: EQUETRO (carbamazepine) - Currently taking/using - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What procedures received in",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: EQUETRO (carbamazepine),1=EQUETRO (carbamazepine)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r23c1",
    "description": "A3r23c1: FYCOMPA (parampanel) - Currently taking/using - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What procedures received in pas",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: FYCOMPA (parampanel),1=FYCOMPA (parampanel)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r24c1",
    "description": "A3r24c1: Ketogenic Diet - Currently taking/using - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What procedures received in past or p",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Ketogenic Diet,1=Ketogenic Diet",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r25c1",
    "description": "A3r25c1: Nasal rescue medications (NAYZILAM, VALTOCO) - Currently taking/using - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What pr",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Nasal rescue medications (NAYZILAM, VALTOCO),1=Nasal rescue medications (NAYZILAM, VALTOCO)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r26c1",
    "description": "A3r26c1: OXTELLAR XR (oxcarbazepine) - Currently taking/using - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What procedures received",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: OXTELLAR XR (oxcarbazepine),1=OXTELLAR XR (oxcarbazepine)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r27c1",
    "description": "A3r27c1: SABRIL (vigabatrin) - Currently taking/using - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What procedures received in past",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: SABRIL (vigabatrin),1=SABRIL (vigabatrin)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r28c1",
    "description": "A3r28c1: SOLFOTON (phenobarbital) - Currently taking/using - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What procedures received in",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: SOLFOTON (phenobarbital),1=SOLFOTON (phenobarbital)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r29c1",
    "description": "A3r29c1: SYMPAZAN (clobazam oral film/strip) - Currently taking/using - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What procedures",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: SYMPAZAN (clobazam oral film/strip),1=SYMPAZAN (clobazam oral film/strip)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r30c1",
    "description": "A3r30c1: TEGRETOL XR (carbamazepine) - Currently taking/using - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What procedures received",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: TEGRETOL XR (carbamazepine),1=TEGRETOL XR (carbamazepine)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r31c1",
    "description": "A3r31c1: TRILEPTAL (oxcarbazepine) - Currently taking/using - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What procedures received i",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: TRILEPTAL (oxcarbazepine),1=TRILEPTAL (oxcarbazepine)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r32c1",
    "description": "A3r32c1: VALIUM (diazepan) - Currently taking/using - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What procedures received in past o",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: VALIUM (diazepan),1=VALIUM (diazepan)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r33c1",
    "description": "A3r33c1: VIMPAT (Lacosamide) - Currently taking/using - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What procedures received in past",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: VIMPAT (Lacosamide),1=VIMPAT (Lacosamide)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r34c1",
    "description": "A3r34c1: Corpus Collosum Surgery - Currently taking/using - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What procedures received in",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Corpus Collosum Surgery,1=Corpus Collosum Surgery",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r35c1",
    "description": "A3r35c1: Vagus Nerve Stimulation (VNS) - Currently taking/using - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What procedures receiv",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Vagus Nerve Stimulation (VNS),1=Vagus Nerve Stimulation (VNS)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r98c1",
    "description": "A3r98c1: Something else (Specify:) - Currently taking/using - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What procedures received i",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Something else (Specify:),1=Something else (Specify:)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r99c1",
    "description": "A3r99c1: None - Currently taking/using - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What procedures received in past or planned in",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: None,1=None",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r1c2",
    "description": "A3r1c2: BANZEL (rufinamide) - Previously used/taken, but not currently - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What procedures",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: BANZEL (rufinamide),1=BANZEL (rufinamide)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r2c2",
    "description": "A3r2c2: DEPAKOTE (valproate) - Previously used/taken, but not currently - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What procedure",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: DEPAKOTE (valproate),1=DEPAKOTE (valproate)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r3c2",
    "description": "A3r3c2: DIACOMIT (stiripentol) - Previously used/taken, but not currently - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What procedu",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: DIACOMIT (stiripentol),1=DIACOMIT (stiripentol)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r4c2",
    "description": "A3r4c2: DIASTAT (diazepam) - Previously used/taken, but not currently - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What procedures",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: DIASTAT (diazepam),1=DIASTAT (diazepam)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r5c2",
    "description": "A3r5c2: EPIDIOLEX (cannabidiol) - Previously used/taken, but not currently - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What proced",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: EPIDIOLEX (cannabidiol),1=EPIDIOLEX (cannabidiol)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r6c2",
    "description": "A3r6c2: FELBATOL (felbamate) - Previously used/taken, but not currently - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What procedure",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: FELBATOL (felbamate),1=FELBATOL (felbamate)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r7c2",
    "description": "A3r7c2: FINTEPLA (fenfluramine) - Previously used/taken, but not currently - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What proced",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: FINTEPLA (fenfluramine),1=FINTEPLA (fenfluramine)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r8c2",
    "description": "A3r8c2: KEPPRA (levetiracetam) - Previously used/taken, but not currently - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What procedu",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: KEPPRA (levetiracetam),1=KEPPRA (levetiracetam)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r9c2",
    "description": "A3r9c2: KLONOPIN (clonazepam) - Previously used/taken, but not currently - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What procedur",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: KLONOPIN (clonazepam),1=KLONOPIN (clonazepam)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r10c2",
    "description": "A3r10c2: LAMICTAL (lamotrigine) - Previously used/taken, but not currently - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What proced",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: LAMICTAL (lamotrigine),1=LAMICTAL (lamotrigine)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r11c2",
    "description": "A3r11c2: Nasal rescue medications (NAYZILAM, VALTOCO) - Previously used/taken, but not currently - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [p",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Nasal rescue medications (NAYZILAM, VALTOCO),1=Nasal rescue medications (NAYZILAM, VALTOCO)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r12c2",
    "description": "A3r12c2: ONFI (clobazam pill/tablet) - Previously used/taken, but not currently - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What p",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: ONFI (clobazam pill/tablet),1=ONFI (clobazam pill/tablet)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r13c2",
    "description": "A3r13c2: RIVOTRIL (clonazepam) - Previously used/taken, but not currently - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What procedu",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: RIVOTRIL (clonazepam),1=RIVOTRIL (clonazepam)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r14c2",
    "description": "A3r14c2: TOPAMAX (topiramate) - Previously used/taken, but not currently - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What procedur",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: TOPAMAX (topiramate),1=TOPAMAX (topiramate)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r15c2",
    "description": "A3r15c2: VALPROIC ACID (valproate) - Previously used/taken, but not currently - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What pro",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: VALPROIC ACID (valproate),1=VALPROIC ACID (valproate)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r16c2",
    "description": "A3r16c2: XCOPRI (cenobamate) - Previously used/taken, but not currently - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What procedure",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: XCOPRI (cenobamate),1=XCOPRI (cenobamate)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r17c2",
    "description": "A3r17c2: ZONEGRAN (zonisamide) - Previously used/taken, but not currently - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What procedu",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: ZONEGRAN (zonisamide),1=ZONEGRAN (zonisamide)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r18c2",
    "description": "A3r18c2: ATIVAN (lorazepam) - Previously used/taken, but not currently - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What procedures",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: ATIVAN (lorazepam),1=ATIVAN (lorazepam)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r19c2",
    "description": "A3r19c2: BRIVIACT (brivaracetam) - Previously used/taken, but not currently - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What proce",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: BRIVIACT (brivaracetam),1=BRIVIACT (brivaracetam)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r20c2",
    "description": "A3r20c2: DILANTIN (phenytoin) - Previously used/taken, but not currently - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What procedur",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: DILANTIN (phenytoin),1=DILANTIN (phenytoin)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r21c2",
    "description": "A3r21c2: EPITOL (carbamazepine) - Previously used/taken, but not currently - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What proced",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: EPITOL (carbamazepine),1=EPITOL (carbamazepine)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r22c2",
    "description": "A3r22c2: EQUETRO (carbamazepine) - Previously used/taken, but not currently - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What proce",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: EQUETRO (carbamazepine),1=EQUETRO (carbamazepine)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r23c2",
    "description": "A3r23c2: FYCOMPA (parampanel) - Previously used/taken, but not currently - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What procedur",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: FYCOMPA (parampanel),1=FYCOMPA (parampanel)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r24c2",
    "description": "A3r24c2: Ketogenic Diet - Previously used/taken, but not currently - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What procedures rec",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Ketogenic Diet,1=Ketogenic Diet",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r25c2",
    "description": "A3r25c2: Nasal rescue medications (NAYZILAM, VALTOCO) - Previously used/taken, but not currently - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [p",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Nasal rescue medications (NAYZILAM, VALTOCO),1=Nasal rescue medications (NAYZILAM, VALTOCO)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r26c2",
    "description": "A3r26c2: OXTELLAR XR (oxcarbazepine) - Previously used/taken, but not currently - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What p",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: OXTELLAR XR (oxcarbazepine),1=OXTELLAR XR (oxcarbazepine)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r27c2",
    "description": "A3r27c2: SABRIL (vigabatrin) - Previously used/taken, but not currently - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What procedure",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: SABRIL (vigabatrin),1=SABRIL (vigabatrin)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r28c2",
    "description": "A3r28c2: SOLFOTON (phenobarbital) - Previously used/taken, but not currently - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What proc",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: SOLFOTON (phenobarbital),1=SOLFOTON (phenobarbital)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r29c2",
    "description": "A3r29c2: SYMPAZAN (clobazam oral film/strip) - Previously used/taken, but not currently - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: SYMPAZAN (clobazam oral film/strip),1=SYMPAZAN (clobazam oral film/strip)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r30c2",
    "description": "A3r30c2: TEGRETOL XR (carbamazepine) - Previously used/taken, but not currently - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What p",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: TEGRETOL XR (carbamazepine),1=TEGRETOL XR (carbamazepine)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r31c2",
    "description": "A3r31c2: TRILEPTAL (oxcarbazepine) - Previously used/taken, but not currently - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What pro",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: TRILEPTAL (oxcarbazepine),1=TRILEPTAL (oxcarbazepine)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r32c2",
    "description": "A3r32c2: VALIUM (diazepan) - Previously used/taken, but not currently - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What procedures",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: VALIUM (diazepan),1=VALIUM (diazepan)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r33c2",
    "description": "A3r33c2: VIMPAT (Lacosamide) - Previously used/taken, but not currently - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What procedure",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: VIMPAT (Lacosamide),1=VIMPAT (Lacosamide)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r34c2",
    "description": "A3r34c2: Corpus Collosum Surgery - Previously used/taken, but not currently - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What proce",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Corpus Collosum Surgery,1=Corpus Collosum Surgery",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r35c2",
    "description": "A3r35c2: Vagus Nerve Stimulation (VNS) - Previously used/taken, but not currently - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Vagus Nerve Stimulation (VNS),1=Vagus Nerve Stimulation (VNS)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r98c2",
    "description": "A3r98c2: Something else (Specify:) - Previously used/taken, but not currently - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What pro",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Something else (Specify:),1=Something else (Specify:)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r99c2",
    "description": "A3r99c2: None - Previously used/taken, but not currently - Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What procedures received in p",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: None,1=None",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A3",
    "column": "A3r98oe",
    "description": "A3r98oe: Which of the following antiseizure treatments/procedures is [pipe: S9 upper] currently taking/using or has previously taken or undergone as treatment for [pipe: hS3]? What procedures received in past or planned in future? - Something else (Specif",
    "valueType": "Open Text",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "text_open"
  },
  {
    "level": "parent",
    "parentQuestion": "NA",
    "column": "HA3",
    "description": "HA3: Number of current prescription antiseizure treatments",
    "valueType": "Values: 1-9",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 9,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8,
      9
    ]
  },
  {
    "level": "parent",
    "parentQuestion": "NA",
    "column": "HA4",
    "description": "HA4: Number of previously taken treatments",
    "valueType": "Values: 0-24",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 0,
    "rangeMax": 24,
    "allowedValues": [
      0,
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8,
      9,
      10,
      11,
      12,
      13,
      14,
      15,
      16,
      17,
      18,
      19,
      20,
      21,
      22,
      23,
      24
    ]
  },
  {
    "level": "parent",
    "parentQuestion": "NA",
    "column": "HA5",
    "description": "HA5: Number of treatments ‘never prescribed’.",
    "valueType": "Values: 1-28",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 28,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8,
      9,
      10,
      11,
      12,
      13,
      14,
      15,
      16,
      17,
      18,
      19,
      20,
      21,
      22,
      23,
      24,
      25,
      26,
      27,
      28
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A4",
    "column": "A4r1",
    "description": "A4r1: Finding antiseizure treatment options that provide seizure control we aim for - Which of the following are the most challenging and/or frustrating aspects of managing [pipe: S9 upper]'s medical care?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Finding antiseizure treatment options that provide seizure control we aim for,1=Finding antiseizure treatment options that provide seizure control we aim for",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A4",
    "column": "A4r2",
    "description": "A4r2: Managing side-effects of antiseizure treatments - Which of the following are the most challenging and/or frustrating aspects of managing [pipe: S9 upper]'s medical care?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Managing side-effects of antiseizure treatments,1=Managing side-effects of antiseizure treatments",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A4",
    "column": "A4r3",
    "description": "A4r3: Trying to find the right antiseizure treatment combination for [pipe: S9 upper] - Which of the following are the most challenging and/or frustrating aspects of managing [pipe: S9 upper]'s medical care?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Trying to find the right antiseizure treatment combination for [pipe: S9 upper],1=Trying to find the right antiseizure treatment combination for [pipe: S9 upper]",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A4",
    "column": "A4r4",
    "description": "A4r4: Being able to afford antiseizure treatments - Which of the following are the most challenging and/or frustrating aspects of managing [pipe: S9 upper]'s medical care?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Being able to afford antiseizure treatments,1=Being able to afford antiseizure treatments",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A4",
    "column": "A4r5",
    "description": "A4r5: Transporting [pipe: S9 upper] to healthcare provider visits, testing, etc. - Which of the following are the most challenging and/or frustrating aspects of managing [pipe: S9 upper]'s medical care?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Transporting [pipe: S9 upper] to healthcare provider visits, testing, etc.,1=Transporting [pipe: S9 upper] to healthcare provider visits, testing, etc.",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A4",
    "column": "A4r6",
    "description": "A4r6: Making and managing appointments for [pipe: S9 upper] - Which of the following are the most challenging and/or frustrating aspects of managing [pipe: S9 upper]'s medical care?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Making and managing appointments for [pipe: S9 upper],1=Making and managing appointments for [pipe: S9 upper]",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A4",
    "column": "A4r7",
    "description": "A4r7: Getting insurance to approve antiseizure treatments - Which of the following are the most challenging and/or frustrating aspects of managing [pipe: S9 upper]'s medical care?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Getting insurance to approve antiseizure treatments,1=Getting insurance to approve antiseizure treatments",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A4",
    "column": "A4r8",
    "description": "A4r8: Uncertainty on how [pipe: S9 upper] will adjust when their healthcare provider recommends an antiseizure treatment change - Which of the following are the most challenging and/or frustrating aspects of managing [pipe: S9 upper]'s medical care?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Uncertainty on how [pipe: S9 upper] will adjust when their healthcare provider recommends an antiseizure treatmen,1=Uncertainty on how [pipe: S9 upper] will adjust when their healthcare provider recommends an antiseizure treatment chang",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A4",
    "column": "A4r9",
    "description": "A4r9: Impact of [pipe: S9 upper] being on too many antiseizure treatments at one time - Which of the following are the most challenging and/or frustrating aspects of managing [pipe: S9 upper]'s medical care?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Impact of [pipe: S9 upper] being on too many antiseizure treatments at one time,1=Impact of [pipe: S9 upper] being on too many antiseizure treatments at one time",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A4",
    "column": "A4r10",
    "description": "A4r10: Getting on same page with [pipe: S9 upper]'s healthcare provider - Which of the following are the most challenging and/or frustrating aspects of managing [pipe: S9 upper]'s medical care?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Getting on same page with [pipe: S9 upper]'s healthcare provider,1=Getting on same page with [pipe: S9 upper]'s healthcare provider",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A4",
    "column": "A4r11",
    "description": "A4r11: Coming to an agreement on antiseizure treatment decisions with [pipe: S9 upper]'s healthcare provider - Which of the following are the most challenging and/or frustrating aspects of managing [pipe: S9 upper]'s medical care?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Coming to an agreement on antiseizure treatment decisions with [pipe: S9 upper]'s healthcare provider,1=Coming to an agreement on antiseizure treatment decisions with [pipe: S9 upper]'s healthcare provider",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A4",
    "column": "A4r12",
    "description": "A4r12: Needing to adjust or change current antiseizure treatment in order to try a new antiseizure treatment - Which of the following are the most challenging and/or frustrating aspects of managing [pipe: S9 upper]'s medical care?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Needing to adjust or change current antiseizure treatment in order to try a new antiseizure treatment,1=Needing to adjust or change current antiseizure treatment in order to try a new antiseizure treatment",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A4",
    "column": "A4r15",
    "description": "A4r15: Finding an HCP we can trust - Which of the following are the most challenging and/or frustrating aspects of managing [pipe: S9 upper]'s medical care?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Finding an HCP we can trust,1=Finding an HCP we can trust",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A4",
    "column": "A4r16",
    "description": "A4r16: Managing the tests required to continue antiseizure treatments, such as blood work, EEGs, ECHOs, etc. - Which of the following are the most challenging and/or frustrating aspects of managing [pipe: S9 upper]'s medical care?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Managing the tests required to continue antiseizure treatments, such as blood work, EEGs, ECHOs, etc.,1=Managing the tests required to continue antiseizure treatments, such as blood work, EEGs, ECHOs, etc.",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A4",
    "column": "A4r17",
    "description": "A4r17: Finding time and managing needs of other family members - Which of the following are the most challenging and/or frustrating aspects of managing [pipe: S9 upper]'s medical care?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Finding time and managing needs of other family members,1=Finding time and managing needs of other family members",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A4",
    "column": "A4r13",
    "description": "A4r13: Other (Specify) - Which of the following are the most challenging and/or frustrating aspects of managing [pipe: S9 upper]'s medical care?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Other (Specify),1=Other (Specify)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A4",
    "column": "A4r14",
    "description": "A4r14: No challenges - Which of the following are the most challenging and/or frustrating aspects of managing [pipe: S9 upper]'s medical care?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: No challenges,1=No challenges",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A4",
    "column": "A4r13oe",
    "description": "A4r13oe: Which of the following are the most challenging and/or frustrating aspects of managing [pipe: S9 upper]'s medical care? - Other (Specify)",
    "valueType": "Open Text",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "text_open"
  },
  {
    "level": "parent",
    "parentQuestion": "NA",
    "column": "A6",
    "description": "A6: Using the scale below, how would you describe the current status of [pipe: S9 upper]?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Does not have their seizures under control at all,2=2,3=3,4=4,5=5,6=6,7=7 Has their seizures completely under control",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Does not have their seizures under control at all"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Has their seizures completely under control"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A9",
    "column": "A9r1",
    "description": "A9r1: I am always researching the latest news and updates in [pipe: hS3], such as new antiseizure treatments - Please indicate the extent by which you agree or disagree with each statement related to caring for [pipe: S9 upper].",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Strongly disagree,2=2,3=3,4=4,5=5,6=6,7=7 Strongly agree",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Strongly disagree"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Strongly agree"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A9",
    "column": "A9r2",
    "description": "A9r2: Even if [pipe: S9 upper]'s seizures were under control, I am willing to add an additional antiseizure treatment if the healthcare provider thinks it could help improve their condition even more - Please indicate the extent by which you agree or disa",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Strongly disagree,2=2,3=3,4=4,5=5,6=6,7=7 Strongly agree",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Strongly disagree"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Strongly agree"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A9",
    "column": "A9r3",
    "description": "A9r3: I proactively share my perspective regarding [pipe: S9 upper]'s antiseizure treatment with their healthcare provider - Please indicate the extent by which you agree or disagree with each statement related to caring for [pipe: S9 upper].",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Strongly disagree,2=2,3=3,4=4,5=5,6=6,7=7 Strongly agree",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Strongly disagree"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Strongly agree"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A9",
    "column": "A9r4",
    "description": "A9r4: I would not be comfortable having [pipe: S9 upper] start an antiseizure treatment with more safety concerns than [pipe: S9 upper]'s current treatment(s), even if the healthcare provider recommended it - Please indicate the extent by which you agree",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Strongly disagree,2=2,3=3,4=4,5=5,6=6,7=7 Strongly agree",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Strongly disagree"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Strongly agree"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A9",
    "column": "A9r5",
    "description": "A9r5: If [pipe: S9 upper]'s healthcare provider recommends an antiseizure treatment, I typically agree with the recommendation - Please indicate the extent by which you agree or disagree with each statement related to caring for [pipe: S9 upper].",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Strongly disagree,2=2,3=3,4=4,5=5,6=6,7=7 Strongly agree",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Strongly disagree"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Strongly agree"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A9",
    "column": "A9r6",
    "description": "A9r6: [pipe: S9 upper]'s healthcare provider welcomes my feedback when discussing antiseizure treatments - Please indicate the extent by which you agree or disagree with each statement related to caring for [pipe: S9 upper].",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Strongly disagree,2=2,3=3,4=4,5=5,6=6,7=7 Strongly agree",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Strongly disagree"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Strongly agree"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A9",
    "column": "A9r7",
    "description": "A9r7: I am active and involved in [pipe: hS3] associations and/or support groups - Please indicate the extent by which you agree or disagree with each statement related to caring for [pipe: S9 upper].",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Strongly disagree,2=2,3=3,4=4,5=5,6=6,7=7 Strongly agree",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Strongly disagree"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Strongly agree"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A9",
    "column": "A9r8",
    "description": "A9r8: I bring up antiseizure treatments I've researched to [pipe: S9 upper]'s healthcare provider for consideration - Please indicate the extent by which you agree or disagree with each statement related to caring for [pipe: S9 upper].",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Strongly disagree,2=2,3=3,4=4,5=5,6=6,7=7 Strongly agree",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Strongly disagree"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Strongly agree"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A9",
    "column": "A9r9",
    "description": "A9r9: I am knowledgeable and have a strong understanding of [pipe: hS3] - Please indicate the extent by which you agree or disagree with each statement related to caring for [pipe: S9 upper].",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Strongly disagree,2=2,3=3,4=4,5=5,6=6,7=7 Strongly agree",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Strongly disagree"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Strongly agree"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A9",
    "column": "A9r10",
    "description": "A9r10: I am confident in [pipe: S9 upper]'s healthcare provider's ability to treat and manage [pipe: hS3] - Please indicate the extent by which you agree or disagree with each statement related to caring for [pipe: S9 upper].",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Strongly disagree,2=2,3=3,4=4,5=5,6=6,7=7 Strongly agree",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Strongly disagree"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Strongly agree"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A9",
    "column": "A9r12",
    "description": "A9r12: [pipe: S9 upper]'s healthcare provider is knowledgeable about [pipe: hS3] treatments - Please indicate the extent by which you agree or disagree with each statement related to caring for [pipe: S9 upper].",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Strongly disagree,2=2,3=3,4=4,5=5,6=6,7=7 Strongly agree",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Strongly disagree"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Strongly agree"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "A9",
    "column": "A9r11",
    "description": "A9r11: I’ve become more involved in [pipe: S9 upper]'s treatment decisions over time - Please indicate the extent by which you agree or disagree with each statement related to caring for [pipe: S9 upper].",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Strongly disagree,2=2,3=3,4=4,5=5,6=6,7=7 Strongly agree",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Strongly disagree"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Strongly agree"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B1a",
    "column": "B1ar1",
    "description": "B1ar1: Agree with recommendation during the same visit and start the process to get [pipe: S9 upper] started on that treatment - When [pipe: S9 upper]'s healthcare provider makes an antiseizure treatment recommendation, what is your typical next step?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Agree with recommendation during the same visit and start the process to get [pipe: S9 upper] started on that tre,1=Agree with recommendation during the same visit and start the process to get [pipe: S9 upper] started on that treatment",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B1a",
    "column": "B1ar2",
    "description": "B1ar2: Wait to make a decision until I do research on the healthcare provider’s recommendation - When [pipe: S9 upper]'s healthcare provider makes an antiseizure treatment recommendation, what is your typical next step?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Wait to make a decision until I do research on the healthcare provider’s recommendation,1=Wait to make a decision until I do research on the healthcare provider’s recommendation",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B1a",
    "column": "B1ar3",
    "description": "B1ar3: Wait to make a decision until I discuss with others in support groups - When [pipe: S9 upper]'s healthcare provider makes an antiseizure treatment recommendation, what is your typical next step?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Wait to make a decision until I discuss with others in support groups,1=Wait to make a decision until I discuss with others in support groups",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B1a",
    "column": "B1ar4",
    "description": "B1ar4: Wait to make a decision until I discuss with other family members - When [pipe: S9 upper]'s healthcare provider makes an antiseizure treatment recommendation, what is your typical next step?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Wait to make a decision until I discuss with other family members,1=Wait to make a decision until I discuss with other family members",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B1a",
    "column": "B1ar5",
    "description": "B1ar5: Wait to make a decision until I discuss with [pipe: S9 upper]’s other healthcare providers - When [pipe: S9 upper]'s healthcare provider makes an antiseizure treatment recommendation, what is your typical next step?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Wait to make a decision until I discuss with [pipe: S9 upper]’s other healthcare providers,1=Wait to make a decision until I discuss with [pipe: S9 upper]’s other healthcare providers",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B1a",
    "column": "B1ar6",
    "description": "B1ar6: Other (Specify): - When [pipe: S9 upper]'s healthcare provider makes an antiseizure treatment recommendation, what is your typical next step?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Other (Specify):,1=Other (Specify):",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B1a",
    "column": "B1ar6oe",
    "description": "B1ar6oe: When [pipe: S9 upper]'s healthcare provider makes an antiseizure treatment recommendation, what is your typical next step? - Other (Specify):",
    "valueType": "Open Text",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "text_open"
  },
  {
    "level": "parent",
    "parentQuestion": "NA",
    "column": "B2a",
    "description": "B2a: How often do you search for information on [pipe: hS3]? This can include researching general news on [pipe: hS3], new and existing antiseizure treatments, etc.",
    "valueType": "Values: 1-6",
    "answerOptions": "1=Multiple times a week,2=About once a week,3=Once every 2-3 weeks,4=Once every month,5=Less than once a month,6=I never engage in research",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 6,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "Multiple times a week"
      },
      {
        "value": 2,
        "label": "About once a week"
      },
      {
        "value": 3,
        "label": "Once every 2-3 weeks"
      },
      {
        "value": 4,
        "label": "Once every month"
      },
      {
        "value": 5,
        "label": "Less than once a month"
      },
      {
        "value": 6,
        "label": "I never engage in research"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B1b",
    "column": "B1br1",
    "description": "B1br1: LGS societies / foundations websites (e.g., The LGS Foundation, Epilepsy Foundation) - Which [pipe: hS3] sites and sources do you use for antiseizure treatment research?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: LGS societies / foundations websites (e.g., The LGS Foundation, Epilepsy Foundation),1=LGS societies / foundations websites (e.g., The LGS Foundation, Epilepsy Foundation)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B1b",
    "column": "B1br2",
    "description": "B1br2: Dravet Syndrome societies / foundations websites (e.g., Dravet Syndrome Foundation, Epilepsy Foundation) - Which [pipe: hS3] sites and sources do you use for antiseizure treatment research?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Dravet Syndrome societies / foundations websites (e.g., Dravet Syndrome Foundation, Epilepsy Foundation),1=Dravet Syndrome societies / foundations websites (e.g., Dravet Syndrome Foundation, Epilepsy Foundation)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B1b",
    "column": "B1br3",
    "description": "B1br3: Epilepsy or neurology societies (Child Neurology Society, Epilepsy Foundation, American Epilepsy Society) - Which [pipe: hS3] sites and sources do you use for antiseizure treatment research?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Epilepsy or neurology societies (Child Neurology Society, Epilepsy Foundation, American Epilepsy Society),1=Epilepsy or neurology societies (Child Neurology Society, Epilepsy Foundation, American Epilepsy Society)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B1b",
    "column": "B1br4",
    "description": "B1br4: Websites and brochures from pharmaceutical companies - Which [pipe: hS3] sites and sources do you use for antiseizure treatment research?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Websites and brochures from pharmaceutical companies,1=Websites and brochures from pharmaceutical companies",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B1b",
    "column": "B1br5",
    "description": "B1br5: Online or in-person support group of other caregivers - Which [pipe: hS3] sites and sources do you use for antiseizure treatment research?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Online or in-person support group of other caregivers,1=Online or in-person support group of other caregivers",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B1b",
    "column": "B1br6",
    "description": "B1br6: Blogs/online health advocates - Which [pipe: hS3] sites and sources do you use for antiseizure treatment research?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Blogs/online health advocates,1=Blogs/online health advocates",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B1b",
    "column": "B1br7",
    "description": "B1br7: Medical Journal, magazine, literature - Which [pipe: hS3] sites and sources do you use for antiseizure treatment research?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Medical Journal, magazine, literature,1=Medical Journal, magazine, literature",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B1b",
    "column": "B1br8",
    "description": "B1br8: Social media - Which [pipe: hS3] sites and sources do you use for antiseizure treatment research?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Social media,1=Social media",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B1b",
    "column": "B1br9",
    "description": "B1br9: Health-specific websites (such as WebMD) - Which [pipe: hS3] sites and sources do you use for antiseizure treatment research?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Health-specific websites (such as WebMD),1=Health-specific websites (such as WebMD)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B1b",
    "column": "B1br10",
    "description": "B1br10: General online searches - Which [pipe: hS3] sites and sources do you use for antiseizure treatment research?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: General online searches,1=General online searches",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B1b",
    "column": "B1br13",
    "description": "B1br13: Shine Forward - Which [pipe: hS3] sites and sources do you use for antiseizure treatment research?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Shine Forward,1=Shine Forward",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B1b",
    "column": "B1br14",
    "description": "B1br14: Fintepla websites or brochures - Which [pipe: hS3] sites and sources do you use for antiseizure treatment research?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Fintepla websites or brochures,1=Fintepla websites or brochures",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B1b",
    "column": "B1br15",
    "description": "B1br15: Epidiolex website or brochures - Which [pipe: hS3] sites and sources do you use for antiseizure treatment research?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Epidiolex website or brochures,1=Epidiolex website or brochures",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B1b",
    "column": "B1br16",
    "description": "B1br16: Diacomit website or brochures - Which [pipe: hS3] sites and sources do you use for antiseizure treatment research?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Diacomit website or brochures,1=Diacomit website or brochures",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B1b",
    "column": "B1br11",
    "description": "B1br11: Other (Specify:) - Which [pipe: hS3] sites and sources do you use for antiseizure treatment research?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Other (Specify:),1=Other (Specify:)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B1b",
    "column": "B1br12",
    "description": "B1br12: I don’t research antiseizure treatments - Which [pipe: hS3] sites and sources do you use for antiseizure treatment research?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: I don’t research antiseizure treatments,1=I don’t research antiseizure treatments",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B1b",
    "column": "B1br11oe",
    "description": "B1br11oe: Which [pipe: hS3] sites and sources do you use for antiseizure treatment research? - Other (Specify:)",
    "valueType": "Open Text",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "text_open"
  },
  {
    "level": "sub",
    "parentQuestion": "B1cnew",
    "column": "B1cnewr1",
    "description": "B1cnewr1: SoundOfProfound.com - You have been randomly selected to provide additional information about a specific antiseizure treatment’s online sources. Which, if any, of the following Fintepla websites have you heard of and/or visited?",
    "valueType": "Values: 1-4",
    "answerOptions": "1=Have Never Heard Of,2=Heard Of, But Never Visited,3=Have Visited, But Over 3 Months Ago,4=Have Visited In The Past 3 Months",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 4,
    "allowedValues": [
      1,
      2,
      3,
      4
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "Have Never Heard Of"
      },
      {
        "value": 2,
        "label": "Heard Of"
      },
      {
        "value": 3,
        "label": "Have Visited"
      },
      {
        "value": 4,
        "label": "Have Visited In The Past 3 Months"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B1cnew",
    "column": "B1cnewr2",
    "description": "B1cnewr2: Fintepla.com - You have been randomly selected to provide additional information about a specific antiseizure treatment’s online sources. Which, if any, of the following Fintepla websites have you heard of and/or visited?",
    "valueType": "Values: 1-4",
    "answerOptions": "1=Have Never Heard Of,2=Heard Of, But Never Visited,3=Have Visited, But Over 3 Months Ago,4=Have Visited In The Past 3 Months",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 4,
    "allowedValues": [
      1,
      2,
      3,
      4
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "Have Never Heard Of"
      },
      {
        "value": 2,
        "label": "Heard Of"
      },
      {
        "value": 3,
        "label": "Have Visited"
      },
      {
        "value": 4,
        "label": "Have Visited In The Past 3 Months"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B1cnew",
    "column": "B1cnewr3",
    "description": "B1cnewr3: Fintepla on Facebook - You have been randomly selected to provide additional information about a specific antiseizure treatment’s online sources. Which, if any, of the following Fintepla websites have you heard of and/or visited?",
    "valueType": "Values: 1-4",
    "answerOptions": "1=Have Never Heard Of,2=Heard Of, But Never Visited,3=Have Visited, But Over 3 Months Ago,4=Have Visited In The Past 3 Months",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 4,
    "allowedValues": [
      1,
      2,
      3,
      4
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "Have Never Heard Of"
      },
      {
        "value": 2,
        "label": "Heard Of"
      },
      {
        "value": 3,
        "label": "Have Visited"
      },
      {
        "value": 4,
        "label": "Have Visited In The Past 3 Months"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B1cnew",
    "column": "B1cnewr4",
    "description": "B1cnewr4: Fintepla on Instagram - You have been randomly selected to provide additional information about a specific antiseizure treatment’s online sources. Which, if any, of the following Fintepla websites have you heard of and/or visited?",
    "valueType": "Values: 1-4",
    "answerOptions": "1=Have Never Heard Of,2=Heard Of, But Never Visited,3=Have Visited, But Over 3 Months Ago,4=Have Visited In The Past 3 Months",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 4,
    "allowedValues": [
      1,
      2,
      3,
      4
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "Have Never Heard Of"
      },
      {
        "value": 2,
        "label": "Heard Of"
      },
      {
        "value": 3,
        "label": "Have Visited"
      },
      {
        "value": 4,
        "label": "Have Visited In The Past 3 Months"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B1cnew",
    "column": "B1cnewr5",
    "description": "B1cnewr5: Youtube.com/c/Fintepla - You have been randomly selected to provide additional information about a specific antiseizure treatment’s online sources. Which, if any, of the following Fintepla websites have you heard of and/or visited?",
    "valueType": "Values: 1-4",
    "answerOptions": "1=Have Never Heard Of,2=Heard Of, But Never Visited,3=Have Visited, But Over 3 Months Ago,4=Have Visited In The Past 3 Months",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 4,
    "allowedValues": [
      1,
      2,
      3,
      4
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "Have Never Heard Of"
      },
      {
        "value": 2,
        "label": "Heard Of"
      },
      {
        "value": 3,
        "label": "Have Visited"
      },
      {
        "value": 4,
        "label": "Have Visited In The Past 3 Months"
      }
    ]
  },
  {
    "level": "parent",
    "parentQuestion": "NA",
    "column": "noanswerB1cnew_n99",
    "description": "noanswerB1cnew_n99: You have been randomly selected to provide additional information about a specific antiseizure treatment’s online sources. Which, if any, of the following Fintepla websites have you heard of and/or visited? : I haven’t heard of any",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: You have been randomly selected to provide additional information about a specific antiseizure treatment’s onli,1=You have been randomly selected to provide additional information about a specific antiseizure treatment’s online sour",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "parent",
    "parentQuestion": "NA",
    "column": "B1c",
    "description": "B1c: Did you attend this year’s [pipe: HidB1cpipe]?",
    "valueType": "Values: 1-2",
    "answerOptions": "1=Yes,2=No",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 2,
    "allowedValues": [
      1,
      2
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "Yes"
      },
      {
        "value": 2,
        "label": "No"
      }
    ]
  },
  {
    "level": "parent",
    "parentQuestion": "NA",
    "column": "B2",
    "description": "B2: Thinking of the time from when [pipe: S9 upper] first started experiencing seizures to today, which of the following best describes your expectations of [pipe: hS3] antiseizure treatments?",
    "valueType": "Values: 1-4",
    "answerOptions": "1=My expectations have always been high,2=My expectations have increased as time has gone on,3=My expectations have lowered as time has gone on,4=My expectations have always been low",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 4,
    "allowedValues": [
      1,
      2,
      3,
      4
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "My expectations have always been high"
      },
      {
        "value": 2,
        "label": "My expectations have increased as time has gone on"
      },
      {
        "value": 3,
        "label": "My expectations have lowered as time has gone on"
      },
      {
        "value": 4,
        "label": "My expectations have always been low"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B3",
    "column": "B3r1",
    "description": "B3r1: BANZEL (rufinamide) - Please rate your level of knowledge and understanding of each of the following [pipe: hS3] antiseizure treatments?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all knowledgeable,2=2,3=3,4=4,5=5,6=6,7=7 Extremely knowledgeable",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all knowledgeable"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely knowledgeable"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B3",
    "column": "B3r2",
    "description": "B3r2: DEPAKOTE (valproate) - Please rate your level of knowledge and understanding of each of the following [pipe: hS3] antiseizure treatments?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all knowledgeable,2=2,3=3,4=4,5=5,6=6,7=7 Extremely knowledgeable",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all knowledgeable"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely knowledgeable"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B3",
    "column": "B3r3",
    "description": "B3r3: DIACOMIT (stiripentol) - Please rate your level of knowledge and understanding of each of the following [pipe: hS3] antiseizure treatments?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all knowledgeable,2=2,3=3,4=4,5=5,6=6,7=7 Extremely knowledgeable",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all knowledgeable"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely knowledgeable"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B3",
    "column": "B3r4",
    "description": "B3r4: DIASTAT (diazepam) - Please rate your level of knowledge and understanding of each of the following [pipe: hS3] antiseizure treatments?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all knowledgeable,2=2,3=3,4=4,5=5,6=6,7=7 Extremely knowledgeable",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all knowledgeable"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely knowledgeable"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B3",
    "column": "B3r5",
    "description": "B3r5: EPIDIOLEX (cannabidiol) - Please rate your level of knowledge and understanding of each of the following [pipe: hS3] antiseizure treatments?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all knowledgeable,2=2,3=3,4=4,5=5,6=6,7=7 Extremely knowledgeable",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all knowledgeable"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely knowledgeable"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B3",
    "column": "B3r6",
    "description": "B3r6: FELBATOL (felbamate) - Please rate your level of knowledge and understanding of each of the following [pipe: hS3] antiseizure treatments?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all knowledgeable,2=2,3=3,4=4,5=5,6=6,7=7 Extremely knowledgeable",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all knowledgeable"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely knowledgeable"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B3",
    "column": "B3r7",
    "description": "B3r7: FINTEPLA (fenfluramine) - Please rate your level of knowledge and understanding of each of the following [pipe: hS3] antiseizure treatments?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all knowledgeable,2=2,3=3,4=4,5=5,6=6,7=7 Extremely knowledgeable",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all knowledgeable"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely knowledgeable"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B3",
    "column": "B3r8",
    "description": "B3r8: KEPPRA (levetiracetam) - Please rate your level of knowledge and understanding of each of the following [pipe: hS3] antiseizure treatments?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all knowledgeable,2=2,3=3,4=4,5=5,6=6,7=7 Extremely knowledgeable",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all knowledgeable"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely knowledgeable"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B3",
    "column": "B3r9",
    "description": "B3r9: KLONOPIN (clonazepam) - Please rate your level of knowledge and understanding of each of the following [pipe: hS3] antiseizure treatments?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all knowledgeable,2=2,3=3,4=4,5=5,6=6,7=7 Extremely knowledgeable",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all knowledgeable"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely knowledgeable"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B3",
    "column": "B3r10",
    "description": "B3r10: LAMICTAL (lamotrigine) - Please rate your level of knowledge and understanding of each of the following [pipe: hS3] antiseizure treatments?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all knowledgeable,2=2,3=3,4=4,5=5,6=6,7=7 Extremely knowledgeable",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all knowledgeable"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely knowledgeable"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B3",
    "column": "B3r11",
    "description": "B3r11: Nasal rescue medications (NAYZILAM, VALTOCO) - Please rate your level of knowledge and understanding of each of the following [pipe: hS3] antiseizure treatments?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all knowledgeable,2=2,3=3,4=4,5=5,6=6,7=7 Extremely knowledgeable",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all knowledgeable"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely knowledgeable"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B3",
    "column": "B3r12",
    "description": "B3r12: ONFI (clobazam pill/tablet) - Please rate your level of knowledge and understanding of each of the following [pipe: hS3] antiseizure treatments?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all knowledgeable,2=2,3=3,4=4,5=5,6=6,7=7 Extremely knowledgeable",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all knowledgeable"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely knowledgeable"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B3",
    "column": "B3r13",
    "description": "B3r13: RIVOTRIL (clonazepam) - Please rate your level of knowledge and understanding of each of the following [pipe: hS3] antiseizure treatments?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all knowledgeable,2=2,3=3,4=4,5=5,6=6,7=7 Extremely knowledgeable",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all knowledgeable"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely knowledgeable"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B3",
    "column": "B3r14",
    "description": "B3r14: TOPAMAX (topiramate) - Please rate your level of knowledge and understanding of each of the following [pipe: hS3] antiseizure treatments?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all knowledgeable,2=2,3=3,4=4,5=5,6=6,7=7 Extremely knowledgeable",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all knowledgeable"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely knowledgeable"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B3",
    "column": "B3r15",
    "description": "B3r15: VALPROIC ACID (valproate) - Please rate your level of knowledge and understanding of each of the following [pipe: hS3] antiseizure treatments?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all knowledgeable,2=2,3=3,4=4,5=5,6=6,7=7 Extremely knowledgeable",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all knowledgeable"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely knowledgeable"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B3",
    "column": "B3r16",
    "description": "B3r16: XCOPRI (cenobamate) - Please rate your level of knowledge and understanding of each of the following [pipe: hS3] antiseizure treatments?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all knowledgeable,2=2,3=3,4=4,5=5,6=6,7=7 Extremely knowledgeable",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all knowledgeable"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely knowledgeable"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B3",
    "column": "B3r17",
    "description": "B3r17: ZONEGRAN (zonisamide) - Please rate your level of knowledge and understanding of each of the following [pipe: hS3] antiseizure treatments?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all knowledgeable,2=2,3=3,4=4,5=5,6=6,7=7 Extremely knowledgeable",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all knowledgeable"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely knowledgeable"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B3",
    "column": "B3r18",
    "description": "B3r18: ATIVAN (lorazepam) - Please rate your level of knowledge and understanding of each of the following [pipe: hS3] antiseizure treatments?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all knowledgeable,2=2,3=3,4=4,5=5,6=6,7=7 Extremely knowledgeable",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all knowledgeable"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely knowledgeable"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B3",
    "column": "B3r19",
    "description": "B3r19: BRIVIACT (brivaracetam) - Please rate your level of knowledge and understanding of each of the following [pipe: hS3] antiseizure treatments?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all knowledgeable,2=2,3=3,4=4,5=5,6=6,7=7 Extremely knowledgeable",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all knowledgeable"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely knowledgeable"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B3",
    "column": "B3r20",
    "description": "B3r20: DILANTIN (phenytoin) - Please rate your level of knowledge and understanding of each of the following [pipe: hS3] antiseizure treatments?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all knowledgeable,2=2,3=3,4=4,5=5,6=6,7=7 Extremely knowledgeable",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all knowledgeable"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely knowledgeable"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B3",
    "column": "B3r21",
    "description": "B3r21: EPITOL (carbamazepine) - Please rate your level of knowledge and understanding of each of the following [pipe: hS3] antiseizure treatments?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all knowledgeable,2=2,3=3,4=4,5=5,6=6,7=7 Extremely knowledgeable",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all knowledgeable"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely knowledgeable"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B3",
    "column": "B3r22",
    "description": "B3r22: EQUETRO (carbamazepine) - Please rate your level of knowledge and understanding of each of the following [pipe: hS3] antiseizure treatments?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all knowledgeable,2=2,3=3,4=4,5=5,6=6,7=7 Extremely knowledgeable",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all knowledgeable"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely knowledgeable"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B3",
    "column": "B3r23",
    "description": "B3r23: FYCOMPA (parampanel) - Please rate your level of knowledge and understanding of each of the following [pipe: hS3] antiseizure treatments?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all knowledgeable,2=2,3=3,4=4,5=5,6=6,7=7 Extremely knowledgeable",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all knowledgeable"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely knowledgeable"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B3",
    "column": "B3r24",
    "description": "B3r24: Ketogenic Diet - Please rate your level of knowledge and understanding of each of the following [pipe: hS3] antiseizure treatments?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all knowledgeable,2=2,3=3,4=4,5=5,6=6,7=7 Extremely knowledgeable",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all knowledgeable"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely knowledgeable"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B3",
    "column": "B3r25",
    "description": "B3r25: Nasal rescue medications (NAYZILAM, VALTOCO) - Please rate your level of knowledge and understanding of each of the following [pipe: hS3] antiseizure treatments?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all knowledgeable,2=2,3=3,4=4,5=5,6=6,7=7 Extremely knowledgeable",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all knowledgeable"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely knowledgeable"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B3",
    "column": "B3r26",
    "description": "B3r26: OXTELLAR XR (oxcarbazepine) - Please rate your level of knowledge and understanding of each of the following [pipe: hS3] antiseizure treatments?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all knowledgeable,2=2,3=3,4=4,5=5,6=6,7=7 Extremely knowledgeable",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all knowledgeable"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely knowledgeable"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B3",
    "column": "B3r27",
    "description": "B3r27: SABRIL (vigabatrin) - Please rate your level of knowledge and understanding of each of the following [pipe: hS3] antiseizure treatments?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all knowledgeable,2=2,3=3,4=4,5=5,6=6,7=7 Extremely knowledgeable",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all knowledgeable"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely knowledgeable"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B3",
    "column": "B3r28",
    "description": "B3r28: SOLFOTON (phenobarbital) - Please rate your level of knowledge and understanding of each of the following [pipe: hS3] antiseizure treatments?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all knowledgeable,2=2,3=3,4=4,5=5,6=6,7=7 Extremely knowledgeable",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all knowledgeable"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely knowledgeable"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B3",
    "column": "B3r29",
    "description": "B3r29: SYMPAZAN (clobazam oral film/strip) - Please rate your level of knowledge and understanding of each of the following [pipe: hS3] antiseizure treatments?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all knowledgeable,2=2,3=3,4=4,5=5,6=6,7=7 Extremely knowledgeable",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all knowledgeable"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely knowledgeable"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B3",
    "column": "B3r30",
    "description": "B3r30: TEGRETOL XR (carbamazepine) - Please rate your level of knowledge and understanding of each of the following [pipe: hS3] antiseizure treatments?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all knowledgeable,2=2,3=3,4=4,5=5,6=6,7=7 Extremely knowledgeable",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all knowledgeable"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely knowledgeable"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B3",
    "column": "B3r31",
    "description": "B3r31: TRILEPTAL (oxcarbazepine) - Please rate your level of knowledge and understanding of each of the following [pipe: hS3] antiseizure treatments?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all knowledgeable,2=2,3=3,4=4,5=5,6=6,7=7 Extremely knowledgeable",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all knowledgeable"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely knowledgeable"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B3",
    "column": "B3r32",
    "description": "B3r32: VALIUM (diazepan) - Please rate your level of knowledge and understanding of each of the following [pipe: hS3] antiseizure treatments?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all knowledgeable,2=2,3=3,4=4,5=5,6=6,7=7 Extremely knowledgeable",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all knowledgeable"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely knowledgeable"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B3",
    "column": "B3r33",
    "description": "B3r33: VIMPAT (Lacosamide) - Please rate your level of knowledge and understanding of each of the following [pipe: hS3] antiseizure treatments?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all knowledgeable,2=2,3=3,4=4,5=5,6=6,7=7 Extremely knowledgeable",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all knowledgeable"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely knowledgeable"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B3c",
    "column": "B3cc1",
    "description": "B3cc1: Fintepla - Where did you first learn about each of the following [pipe: hS3] antiseizure treatments?",
    "valueType": "Values: 1-99",
    "answerOptions": "1=LGS societies / foundations websites (e.g., The LGS Foundation, Epilepsy Foundation),2=Dravet Syndrome societies / foundations websites (e.g., Dravet Syndrome Foundation, Epilepsy Foundation),3=Epilepsy or neurology societies (Child Neurology Society, Epilepsy Foundation, American Epilepsy Society),4=Websites and brochures from pharmaceutical companies,5=Online or in-person support group of other caregivers,6=Blogs/online health advocates,7=Medical Journal, magazine, literature,8=Social media,9=Health-specific websites (such as WebMD),10=General online searches,11=Our healthcare provider informed us,98=Somewhere else (Specify:),99=I don’t remember",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 99,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8,
      9,
      10,
      11,
      98,
      99
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "LGS societies / foundations websites (e.g."
      },
      {
        "value": 2,
        "label": "Dravet Syndrome societies / foundations websites (e.g."
      },
      {
        "value": 3,
        "label": "Epilepsy or neurology societies (Child Neurology Society"
      },
      {
        "value": 4,
        "label": "Websites and brochures from pharmaceutical companies"
      },
      {
        "value": 5,
        "label": "Online or in-person support group of other caregivers"
      },
      {
        "value": 6,
        "label": "Blogs/online health advocates"
      },
      {
        "value": 7,
        "label": "Medical Journal"
      },
      {
        "value": 8,
        "label": "Social media"
      },
      {
        "value": 9,
        "label": "Health-specific websites (such as WebMD)"
      },
      {
        "value": 10,
        "label": "General online searches"
      },
      {
        "value": 11,
        "label": "Our healthcare provider informed us"
      },
      {
        "value": 98,
        "label": "Somewhere else (Specify:)"
      },
      {
        "value": 99,
        "label": "I don’t remember"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B3c",
    "column": "B3cc2",
    "description": "B3cc2: Epidiolex - Where did you first learn about each of the following [pipe: hS3] antiseizure treatments?",
    "valueType": "Values: 1-99",
    "answerOptions": "1=LGS societies / foundations websites (e.g., The LGS Foundation, Epilepsy Foundation),2=Dravet Syndrome societies / foundations websites (e.g., Dravet Syndrome Foundation, Epilepsy Foundation),3=Epilepsy or neurology societies (Child Neurology Society, Epilepsy Foundation, American Epilepsy Society),4=Websites and brochures from pharmaceutical companies,5=Online or in-person support group of other caregivers,6=Blogs/online health advocates,7=Medical Journal, magazine, literature,8=Social media,9=Health-specific websites (such as WebMD),10=General online searches,11=Our healthcare provider informed us,98=Somewhere else (Specify:),99=I don’t remember",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 99,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8,
      9,
      10,
      11,
      98,
      99
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "LGS societies / foundations websites (e.g."
      },
      {
        "value": 2,
        "label": "Dravet Syndrome societies / foundations websites (e.g."
      },
      {
        "value": 3,
        "label": "Epilepsy or neurology societies (Child Neurology Society"
      },
      {
        "value": 4,
        "label": "Websites and brochures from pharmaceutical companies"
      },
      {
        "value": 5,
        "label": "Online or in-person support group of other caregivers"
      },
      {
        "value": 6,
        "label": "Blogs/online health advocates"
      },
      {
        "value": 7,
        "label": "Medical Journal"
      },
      {
        "value": 8,
        "label": "Social media"
      },
      {
        "value": 9,
        "label": "Health-specific websites (such as WebMD)"
      },
      {
        "value": 10,
        "label": "General online searches"
      },
      {
        "value": 11,
        "label": "Our healthcare provider informed us"
      },
      {
        "value": 98,
        "label": "Somewhere else (Specify:)"
      },
      {
        "value": 99,
        "label": "I don’t remember"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B3c",
    "column": "B3cc3",
    "description": "B3cc3: Diacomit - Where did you first learn about each of the following [pipe: hS3] antiseizure treatments?",
    "valueType": "Values: 1-99",
    "answerOptions": "1=LGS societies / foundations websites (e.g., The LGS Foundation, Epilepsy Foundation),2=Dravet Syndrome societies / foundations websites (e.g., Dravet Syndrome Foundation, Epilepsy Foundation),3=Epilepsy or neurology societies (Child Neurology Society, Epilepsy Foundation, American Epilepsy Society),4=Websites and brochures from pharmaceutical companies,5=Online or in-person support group of other caregivers,6=Blogs/online health advocates,7=Medical Journal, magazine, literature,8=Social media,9=Health-specific websites (such as WebMD),10=General online searches,11=Our healthcare provider informed us,98=Somewhere else (Specify:),99=I don’t remember",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 99,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8,
      9,
      10,
      11,
      98,
      99
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "LGS societies / foundations websites (e.g."
      },
      {
        "value": 2,
        "label": "Dravet Syndrome societies / foundations websites (e.g."
      },
      {
        "value": 3,
        "label": "Epilepsy or neurology societies (Child Neurology Society"
      },
      {
        "value": 4,
        "label": "Websites and brochures from pharmaceutical companies"
      },
      {
        "value": 5,
        "label": "Online or in-person support group of other caregivers"
      },
      {
        "value": 6,
        "label": "Blogs/online health advocates"
      },
      {
        "value": 7,
        "label": "Medical Journal"
      },
      {
        "value": 8,
        "label": "Social media"
      },
      {
        "value": 9,
        "label": "Health-specific websites (such as WebMD)"
      },
      {
        "value": 10,
        "label": "General online searches"
      },
      {
        "value": 11,
        "label": "Our healthcare provider informed us"
      },
      {
        "value": 98,
        "label": "Somewhere else (Specify:)"
      },
      {
        "value": 99,
        "label": "I don’t remember"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B3c",
    "column": "B3cr98oe",
    "description": "B3cr98oe: Where did you first learn about each of the following [pipe: hS3] antiseizure treatments? - Somewhere else (Specify:)",
    "valueType": "Open Text",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "text_open"
  },
  {
    "level": "sub",
    "parentQuestion": "B4",
    "column": "B4r1",
    "description": "B4r1: BANZEL (rufinamide) - How satisfied are you/were you with each of these treatments when it comes to managing [pipe: S9 upper]’s [pipe: hS3]?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all satisfied,2=2,3=3,4=4,5=5,6=6,7=7 Extremely Satisfied",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all satisfied"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely Satisfied"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B4",
    "column": "B4r2",
    "description": "B4r2: DEPAKOTE (valproate) - How satisfied are you/were you with each of these treatments when it comes to managing [pipe: S9 upper]’s [pipe: hS3]?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all satisfied,2=2,3=3,4=4,5=5,6=6,7=7 Extremely Satisfied",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all satisfied"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely Satisfied"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B4",
    "column": "B4r3",
    "description": "B4r3: DIACOMIT (stiripentol) - How satisfied are you/were you with each of these treatments when it comes to managing [pipe: S9 upper]’s [pipe: hS3]?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all satisfied,2=2,3=3,4=4,5=5,6=6,7=7 Extremely Satisfied",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all satisfied"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely Satisfied"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B4",
    "column": "B4r4",
    "description": "B4r4: DIASTAT (diazepam) - How satisfied are you/were you with each of these treatments when it comes to managing [pipe: S9 upper]’s [pipe: hS3]?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all satisfied,2=2,3=3,4=4,5=5,6=6,7=7 Extremely Satisfied",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all satisfied"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely Satisfied"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B4",
    "column": "B4r5",
    "description": "B4r5: EPIDIOLEX (cannabidiol) - How satisfied are you/were you with each of these treatments when it comes to managing [pipe: S9 upper]’s [pipe: hS3]?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all satisfied,2=2,3=3,4=4,5=5,6=6,7=7 Extremely Satisfied",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all satisfied"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely Satisfied"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B4",
    "column": "B4r6",
    "description": "B4r6: FELBATOL (felbamate) - How satisfied are you/were you with each of these treatments when it comes to managing [pipe: S9 upper]’s [pipe: hS3]?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all satisfied,2=2,3=3,4=4,5=5,6=6,7=7 Extremely Satisfied",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all satisfied"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely Satisfied"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B4",
    "column": "B4r7",
    "description": "B4r7: FINTEPLA (fenfluramine) - How satisfied are you/were you with each of these treatments when it comes to managing [pipe: S9 upper]’s [pipe: hS3]?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all satisfied,2=2,3=3,4=4,5=5,6=6,7=7 Extremely Satisfied",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all satisfied"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely Satisfied"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B4",
    "column": "B4r8",
    "description": "B4r8: KEPPRA (levetiracetam) - How satisfied are you/were you with each of these treatments when it comes to managing [pipe: S9 upper]’s [pipe: hS3]?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all satisfied,2=2,3=3,4=4,5=5,6=6,7=7 Extremely Satisfied",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all satisfied"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely Satisfied"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B4",
    "column": "B4r9",
    "description": "B4r9: KLONOPIN (clonazepam) - How satisfied are you/were you with each of these treatments when it comes to managing [pipe: S9 upper]’s [pipe: hS3]?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all satisfied,2=2,3=3,4=4,5=5,6=6,7=7 Extremely Satisfied",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all satisfied"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely Satisfied"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B4",
    "column": "B4r10",
    "description": "B4r10: LAMICTAL (lamotrigine) - How satisfied are you/were you with each of these treatments when it comes to managing [pipe: S9 upper]’s [pipe: hS3]?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all satisfied,2=2,3=3,4=4,5=5,6=6,7=7 Extremely Satisfied",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all satisfied"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely Satisfied"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B4",
    "column": "B4r11",
    "description": "B4r11: Nasal rescue medications (NAYZILAM, VALTOCO) - How satisfied are you/were you with each of these treatments when it comes to managing [pipe: S9 upper]’s [pipe: hS3]?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all satisfied,2=2,3=3,4=4,5=5,6=6,7=7 Extremely Satisfied",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all satisfied"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely Satisfied"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B4",
    "column": "B4r12",
    "description": "B4r12: ONFI (clobazam pill/tablet) - How satisfied are you/were you with each of these treatments when it comes to managing [pipe: S9 upper]’s [pipe: hS3]?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all satisfied,2=2,3=3,4=4,5=5,6=6,7=7 Extremely Satisfied",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all satisfied"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely Satisfied"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B4",
    "column": "B4r13",
    "description": "B4r13: RIVOTRIL (clonazepam) - How satisfied are you/were you with each of these treatments when it comes to managing [pipe: S9 upper]’s [pipe: hS3]?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all satisfied,2=2,3=3,4=4,5=5,6=6,7=7 Extremely Satisfied",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all satisfied"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely Satisfied"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B4",
    "column": "B4r14",
    "description": "B4r14: TOPAMAX (topiramate) - How satisfied are you/were you with each of these treatments when it comes to managing [pipe: S9 upper]’s [pipe: hS3]?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all satisfied,2=2,3=3,4=4,5=5,6=6,7=7 Extremely Satisfied",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all satisfied"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely Satisfied"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B4",
    "column": "B4r15",
    "description": "B4r15: VALPROIC ACID (valproate) - How satisfied are you/were you with each of these treatments when it comes to managing [pipe: S9 upper]’s [pipe: hS3]?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all satisfied,2=2,3=3,4=4,5=5,6=6,7=7 Extremely Satisfied",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all satisfied"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely Satisfied"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B4",
    "column": "B4r16",
    "description": "B4r16: XCOPRI (cenobamate) - How satisfied are you/were you with each of these treatments when it comes to managing [pipe: S9 upper]’s [pipe: hS3]?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all satisfied,2=2,3=3,4=4,5=5,6=6,7=7 Extremely Satisfied",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all satisfied"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely Satisfied"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B4",
    "column": "B4r17",
    "description": "B4r17: ZONEGRAN (zonisamide) - How satisfied are you/were you with each of these treatments when it comes to managing [pipe: S9 upper]’s [pipe: hS3]?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all satisfied,2=2,3=3,4=4,5=5,6=6,7=7 Extremely Satisfied",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all satisfied"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely Satisfied"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B4",
    "column": "B4r18",
    "description": "B4r18: ATIVAN (lorazepam) - How satisfied are you/were you with each of these treatments when it comes to managing [pipe: S9 upper]’s [pipe: hS3]?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all satisfied,2=2,3=3,4=4,5=5,6=6,7=7 Extremely Satisfied",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all satisfied"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely Satisfied"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B4",
    "column": "B4r19",
    "description": "B4r19: BRIVIACT (brivaracetam) - How satisfied are you/were you with each of these treatments when it comes to managing [pipe: S9 upper]’s [pipe: hS3]?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all satisfied,2=2,3=3,4=4,5=5,6=6,7=7 Extremely Satisfied",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all satisfied"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely Satisfied"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B4",
    "column": "B4r20",
    "description": "B4r20: DILANTIN (phenytoin) - How satisfied are you/were you with each of these treatments when it comes to managing [pipe: S9 upper]’s [pipe: hS3]?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all satisfied,2=2,3=3,4=4,5=5,6=6,7=7 Extremely Satisfied",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all satisfied"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely Satisfied"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B4",
    "column": "B4r21",
    "description": "B4r21: EPITOL (carbamazepine) - How satisfied are you/were you with each of these treatments when it comes to managing [pipe: S9 upper]’s [pipe: hS3]?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all satisfied,2=2,3=3,4=4,5=5,6=6,7=7 Extremely Satisfied",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all satisfied"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely Satisfied"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B4",
    "column": "B4r22",
    "description": "B4r22: EQUETRO (carbamazepine) - How satisfied are you/were you with each of these treatments when it comes to managing [pipe: S9 upper]’s [pipe: hS3]?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all satisfied,2=2,3=3,4=4,5=5,6=6,7=7 Extremely Satisfied",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all satisfied"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely Satisfied"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B4",
    "column": "B4r23",
    "description": "B4r23: FYCOMPA (parampanel) - How satisfied are you/were you with each of these treatments when it comes to managing [pipe: S9 upper]’s [pipe: hS3]?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all satisfied,2=2,3=3,4=4,5=5,6=6,7=7 Extremely Satisfied",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all satisfied"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely Satisfied"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B4",
    "column": "B4r24",
    "description": "B4r24: Ketogenic Diet - How satisfied are you/were you with each of these treatments when it comes to managing [pipe: S9 upper]’s [pipe: hS3]?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all satisfied,2=2,3=3,4=4,5=5,6=6,7=7 Extremely Satisfied",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all satisfied"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely Satisfied"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B4",
    "column": "B4r25",
    "description": "B4r25: Nasal rescue medications (NAYZILAM, VALTOCO) - How satisfied are you/were you with each of these treatments when it comes to managing [pipe: S9 upper]’s [pipe: hS3]?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all satisfied,2=2,3=3,4=4,5=5,6=6,7=7 Extremely Satisfied",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all satisfied"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely Satisfied"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B4",
    "column": "B4r26",
    "description": "B4r26: OXTELLAR XR (oxcarbazepine) - How satisfied are you/were you with each of these treatments when it comes to managing [pipe: S9 upper]’s [pipe: hS3]?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all satisfied,2=2,3=3,4=4,5=5,6=6,7=7 Extremely Satisfied",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all satisfied"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely Satisfied"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B4",
    "column": "B4r27",
    "description": "B4r27: SABRIL (vigabatrin) - How satisfied are you/were you with each of these treatments when it comes to managing [pipe: S9 upper]’s [pipe: hS3]?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all satisfied,2=2,3=3,4=4,5=5,6=6,7=7 Extremely Satisfied",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all satisfied"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely Satisfied"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B4",
    "column": "B4r28",
    "description": "B4r28: SOLFOTON (phenobarbital) - How satisfied are you/were you with each of these treatments when it comes to managing [pipe: S9 upper]’s [pipe: hS3]?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all satisfied,2=2,3=3,4=4,5=5,6=6,7=7 Extremely Satisfied",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all satisfied"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely Satisfied"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B4",
    "column": "B4r29",
    "description": "B4r29: SYMPAZAN (clobazam oral film/strip) - How satisfied are you/were you with each of these treatments when it comes to managing [pipe: S9 upper]’s [pipe: hS3]?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all satisfied,2=2,3=3,4=4,5=5,6=6,7=7 Extremely Satisfied",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all satisfied"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely Satisfied"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B4",
    "column": "B4r30",
    "description": "B4r30: TEGRETOL XR (carbamazepine) - How satisfied are you/were you with each of these treatments when it comes to managing [pipe: S9 upper]’s [pipe: hS3]?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all satisfied,2=2,3=3,4=4,5=5,6=6,7=7 Extremely Satisfied",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all satisfied"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely Satisfied"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B4",
    "column": "B4r31",
    "description": "B4r31: TRILEPTAL (oxcarbazepine) - How satisfied are you/were you with each of these treatments when it comes to managing [pipe: S9 upper]’s [pipe: hS3]?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all satisfied,2=2,3=3,4=4,5=5,6=6,7=7 Extremely Satisfied",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all satisfied"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely Satisfied"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B4",
    "column": "B4r32",
    "description": "B4r32: VALIUM (diazepan) - How satisfied are you/were you with each of these treatments when it comes to managing [pipe: S9 upper]’s [pipe: hS3]?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all satisfied,2=2,3=3,4=4,5=5,6=6,7=7 Extremely Satisfied",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all satisfied"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely Satisfied"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B4",
    "column": "B4r33",
    "description": "B4r33: VIMPAT (Lacosamide) - How satisfied are you/were you with each of these treatments when it comes to managing [pipe: S9 upper]’s [pipe: hS3]?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all satisfied,2=2,3=3,4=4,5=5,6=6,7=7 Extremely Satisfied",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all satisfied"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely Satisfied"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B4",
    "column": "B4r98",
    "description": "B4r98: $ {A3.r98.open} - How satisfied are you/were you with each of these treatments when it comes to managing [pipe: S9 upper]’s [pipe: hS3]?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all satisfied,2=2,3=3,4=4,5=5,6=6,7=7 Extremely Satisfied",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all satisfied"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely Satisfied"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B6a",
    "column": "B6ar1",
    "description": "B6ar1: Reducing seizure frequency - How important are each of the following attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper]?",
    "valueType": "Values: 1-99",
    "answerOptions": "1=1 Not at all Important,2=2,3=3,4=4,5=5,6=6,7=7 Extremely important,99=Not applicable",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 99,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      99
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all Important"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely important"
      },
      {
        "value": 99,
        "label": "Not applicable"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B6a",
    "column": "B6ar2",
    "description": "B6ar2: Reducing seizure severity - How important are each of the following attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper]?",
    "valueType": "Values: 1-99",
    "answerOptions": "1=1 Not at all Important,2=2,3=3,4=4,5=5,6=6,7=7 Extremely important,99=Not applicable",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 99,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      99
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all Important"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely important"
      },
      {
        "value": 99,
        "label": "Not applicable"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B6a",
    "column": "B6ar3",
    "description": "B6ar3: Reducing need for rescue medication - How important are each of the following attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper]?",
    "valueType": "Values: 1-99",
    "answerOptions": "1=1 Not at all Important,2=2,3=3,4=4,5=5,6=6,7=7 Extremely important,99=Not applicable",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 99,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      99
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all Important"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely important"
      },
      {
        "value": 99,
        "label": "Not applicable"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B6a",
    "column": "B6ar4",
    "description": "B6ar4: Manageable side effects - How important are each of the following attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper]?",
    "valueType": "Values: 1-99",
    "answerOptions": "1=1 Not at all Important,2=2,3=3,4=4,5=5,6=6,7=7 Extremely important,99=Not applicable",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 99,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      99
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all Important"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely important"
      },
      {
        "value": 99,
        "label": "Not applicable"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B6a",
    "column": "B6ar5",
    "description": "B6ar5: Improves behavior - How important are each of the following attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper]?",
    "valueType": "Values: 1-99",
    "answerOptions": "1=1 Not at all Important,2=2,3=3,4=4,5=5,6=6,7=7 Extremely important,99=Not applicable",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 99,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      99
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all Important"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely important"
      },
      {
        "value": 99,
        "label": "Not applicable"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B6a",
    "column": "B6ar6",
    "description": "B6ar6: Improves cognition - How important are each of the following attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper]?",
    "valueType": "Values: 1-99",
    "answerOptions": "1=1 Not at all Important,2=2,3=3,4=4,5=5,6=6,7=7 Extremely important,99=Not applicable",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 99,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      99
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all Important"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely important"
      },
      {
        "value": 99,
        "label": "Not applicable"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B6a",
    "column": "B6ar7",
    "description": "B6ar7: Leads to fewer hospital/Emergency Room visits - How important are each of the following attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper]?",
    "valueType": "Values: 1-99",
    "answerOptions": "1=1 Not at all Important,2=2,3=3,4=4,5=5,6=6,7=7 Extremely important,99=Not applicable",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 99,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      99
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all Important"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely important"
      },
      {
        "value": 99,
        "label": "Not applicable"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B6a",
    "column": "B6ar8",
    "description": "B6ar8: Healthcare provider recommends it - How important are each of the following attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper]?",
    "valueType": "Values: 1-99",
    "answerOptions": "1=1 Not at all Important,2=2,3=3,4=4,5=5,6=6,7=7 Extremely important,99=Not applicable",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 99,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      99
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all Important"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely important"
      },
      {
        "value": 99,
        "label": "Not applicable"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B6a",
    "column": "B6ar9",
    "description": "B6ar9: Covered by insurance with affordable out-of-pocket cost - How important are each of the following attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper]?",
    "valueType": "Values: 1-99",
    "answerOptions": "1=1 Not at all Important,2=2,3=3,4=4,5=5,6=6,7=7 Extremely important,99=Not applicable",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 99,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      99
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all Important"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely important"
      },
      {
        "value": 99,
        "label": "Not applicable"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B6a",
    "column": "B6ar10",
    "description": "B6ar10: Easy to understand details of antiseizure treatment when the healthcare provider explains it - How important are each of the following attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper]?",
    "valueType": "Values: 1-99",
    "answerOptions": "1=1 Not at all Important,2=2,3=3,4=4,5=5,6=6,7=7 Extremely important,99=Not applicable",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 99,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      99
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all Important"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely important"
      },
      {
        "value": 99,
        "label": "Not applicable"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B6a",
    "column": "B6ar11",
    "description": "B6ar11: Availability of support programs, such as access to a nurse hotline that can answer my questions - How important are each of the following attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper]?",
    "valueType": "Values: 1-99",
    "answerOptions": "1=1 Not at all Important,2=2,3=3,4=4,5=5,6=6,7=7 Extremely important,99=Not applicable",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 99,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      99
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all Important"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely important"
      },
      {
        "value": 99,
        "label": "Not applicable"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B6a",
    "column": "B6ar12",
    "description": "B6ar12: No cardiovascular safety concerns - How important are each of the following attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper]?",
    "valueType": "Values: 1-99",
    "answerOptions": "1=1 Not at all Important,2=2,3=3,4=4,5=5,6=6,7=7 Extremely important,99=Not applicable",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 99,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      99
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all Important"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely important"
      },
      {
        "value": 99,
        "label": "Not applicable"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B6a",
    "column": "B6ar13",
    "description": "B6ar13: Know others have had success with this treatment - How important are each of the following attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper]?",
    "valueType": "Values: 1-99",
    "answerOptions": "1=1 Not at all Important,2=2,3=3,4=4,5=5,6=6,7=7 Extremely important,99=Not applicable",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 99,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      99
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all Important"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely important"
      },
      {
        "value": 99,
        "label": "Not applicable"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B6a",
    "column": "B6ar14",
    "description": "B6ar14: Easy to comply with antiseizure treatment requirements/monitoring - How important are each of the following attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper]?",
    "valueType": "Values: 1-99",
    "answerOptions": "1=1 Not at all Important,2=2,3=3,4=4,5=5,6=6,7=7 Extremely important,99=Not applicable",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 99,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      99
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all Important"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely important"
      },
      {
        "value": 99,
        "label": "Not applicable"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B6a",
    "column": "B6ar15",
    "description": "B6ar15: Limited potential for abuse - How important are each of the following attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper]?",
    "valueType": "Values: 1-99",
    "answerOptions": "1=1 Not at all Important,2=2,3=3,4=4,5=5,6=6,7=7 Extremely important,99=Not applicable",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 99,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      99
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all Important"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely important"
      },
      {
        "value": 99,
        "label": "Not applicable"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B6a",
    "column": "B6ar16",
    "description": "B6ar16: Ability to add without having to adjust current treatments - How important are each of the following attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper]?",
    "valueType": "Values: 1-99",
    "answerOptions": "1=1 Not at all Important,2=2,3=3,4=4,5=5,6=6,7=7 Extremely important,99=Not applicable",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 99,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      99
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all Important"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely important"
      },
      {
        "value": 99,
        "label": "Not applicable"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B6a",
    "column": "B6ar17",
    "description": "B6ar17: Liquid formulation that can be used with feeding tubes - How important are each of the following attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper]?",
    "valueType": "Values: 1-99",
    "answerOptions": "1=1 Not at all Important,2=2,3=3,4=4,5=5,6=6,7=7 Extremely important,99=Not applicable",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 99,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      99
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all Important"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely important"
      },
      {
        "value": 99,
        "label": "Not applicable"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B6a",
    "column": "B6ar18",
    "description": "B6ar18: A mechanism of action that is different from an antiseizure medication we tried before - How important are each of the following attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper]?",
    "valueType": "Values: 1-99",
    "answerOptions": "1=1 Not at all Important,2=2,3=3,4=4,5=5,6=6,7=7 Extremely important,99=Not applicable",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 99,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      99
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all Important"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely important"
      },
      {
        "value": 99,
        "label": "Not applicable"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B6a",
    "column": "B6ar19",
    "description": "B6ar19: Time it takes to find out the medication is working - How important are each of the following attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper]?",
    "valueType": "Values: 1-99",
    "answerOptions": "1=1 Not at all Important,2=2,3=3,4=4,5=5,6=6,7=7 Extremely important,99=Not applicable",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 99,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      99
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all Important"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely important"
      },
      {
        "value": 99,
        "label": "Not applicable"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B6a",
    "column": "B6ar20",
    "description": "B6ar20: An antiseizure medication with minimal interactions with other current medications used - How important are each of the following attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper]?",
    "valueType": "Values: 1-99",
    "answerOptions": "1=1 Not at all Important,2=2,3=3,4=4,5=5,6=6,7=7 Extremely important,99=Not applicable",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 99,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      99
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all Important"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely important"
      },
      {
        "value": 99,
        "label": "Not applicable"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B6b",
    "column": "B6br1",
    "description": "B6br1: Reducing seizure frequency - Please rank the most important attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper] where 1 is the most important, 2 is the second most important, etc. [pipe: Text_B6b]",
    "valueType": "Values: 1-5",
    "answerOptions": "1=1st Important,2=2nd Important,3=3rd Important,4=4th Important,5=5th Important",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1st Important"
      },
      {
        "value": 2,
        "label": "2nd Important"
      },
      {
        "value": 3,
        "label": "3rd Important"
      },
      {
        "value": 4,
        "label": "4th Important"
      },
      {
        "value": 5,
        "label": "5th Important"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B6b",
    "column": "B6br2",
    "description": "B6br2: Reducing seizure severity - Please rank the most important attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper] where 1 is the most important, 2 is the second most important, etc. [pipe: Text_B6b]",
    "valueType": "Values: 1-5",
    "answerOptions": "1=1st Important,2=2nd Important,3=3rd Important,4=4th Important,5=5th Important",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1st Important"
      },
      {
        "value": 2,
        "label": "2nd Important"
      },
      {
        "value": 3,
        "label": "3rd Important"
      },
      {
        "value": 4,
        "label": "4th Important"
      },
      {
        "value": 5,
        "label": "5th Important"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B6b",
    "column": "B6br3",
    "description": "B6br3: Reducing need for rescue medication - Please rank the most important attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper] where 1 is the most important, 2 is the second most important, etc. [pipe: Text_B6b]",
    "valueType": "Values: 1-5",
    "answerOptions": "1=1st Important,2=2nd Important,3=3rd Important,4=4th Important,5=5th Important",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1st Important"
      },
      {
        "value": 2,
        "label": "2nd Important"
      },
      {
        "value": 3,
        "label": "3rd Important"
      },
      {
        "value": 4,
        "label": "4th Important"
      },
      {
        "value": 5,
        "label": "5th Important"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B6b",
    "column": "B6br4",
    "description": "B6br4: Manageable side effects - Please rank the most important attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper] where 1 is the most important, 2 is the second most important, etc. [pipe: Text_B6b]",
    "valueType": "Values: 1-5",
    "answerOptions": "1=1st Important,2=2nd Important,3=3rd Important,4=4th Important,5=5th Important",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1st Important"
      },
      {
        "value": 2,
        "label": "2nd Important"
      },
      {
        "value": 3,
        "label": "3rd Important"
      },
      {
        "value": 4,
        "label": "4th Important"
      },
      {
        "value": 5,
        "label": "5th Important"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B6b",
    "column": "B6br5",
    "description": "B6br5: Improves behavior - Please rank the most important attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper] where 1 is the most important, 2 is the second most important, etc. [pipe: Text_B6b]",
    "valueType": "Values: 1-5",
    "answerOptions": "1=1st Important,2=2nd Important,3=3rd Important,4=4th Important,5=5th Important",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1st Important"
      },
      {
        "value": 2,
        "label": "2nd Important"
      },
      {
        "value": 3,
        "label": "3rd Important"
      },
      {
        "value": 4,
        "label": "4th Important"
      },
      {
        "value": 5,
        "label": "5th Important"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B6b",
    "column": "B6br6",
    "description": "B6br6: Improves cognition - Please rank the most important attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper] where 1 is the most important, 2 is the second most important, etc. [pipe: Text_B6b]",
    "valueType": "Values: 1-5",
    "answerOptions": "1=1st Important,2=2nd Important,3=3rd Important,4=4th Important,5=5th Important",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1st Important"
      },
      {
        "value": 2,
        "label": "2nd Important"
      },
      {
        "value": 3,
        "label": "3rd Important"
      },
      {
        "value": 4,
        "label": "4th Important"
      },
      {
        "value": 5,
        "label": "5th Important"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B6b",
    "column": "B6br7",
    "description": "B6br7: Leads to fewer hospital/Emergency Room visits - Please rank the most important attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper] where 1 is the most important, 2 is the second most important, etc. [pipe: Text_B6b]",
    "valueType": "Values: 1-5",
    "answerOptions": "1=1st Important,2=2nd Important,3=3rd Important,4=4th Important,5=5th Important",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1st Important"
      },
      {
        "value": 2,
        "label": "2nd Important"
      },
      {
        "value": 3,
        "label": "3rd Important"
      },
      {
        "value": 4,
        "label": "4th Important"
      },
      {
        "value": 5,
        "label": "5th Important"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B6b",
    "column": "B6br8",
    "description": "B6br8: Healthcare provider recommends it - Please rank the most important attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper] where 1 is the most important, 2 is the second most important, etc. [pipe: Text_B6b]",
    "valueType": "Values: 1-5",
    "answerOptions": "1=1st Important,2=2nd Important,3=3rd Important,4=4th Important,5=5th Important",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1st Important"
      },
      {
        "value": 2,
        "label": "2nd Important"
      },
      {
        "value": 3,
        "label": "3rd Important"
      },
      {
        "value": 4,
        "label": "4th Important"
      },
      {
        "value": 5,
        "label": "5th Important"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B6b",
    "column": "B6br9",
    "description": "B6br9: Covered by insurance with affordable out-of-pocket cost - Please rank the most important attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper] where 1 is the most important, 2 is the second most important, etc. [pipe:",
    "valueType": "Values: 1-5",
    "answerOptions": "1=1st Important,2=2nd Important,3=3rd Important,4=4th Important,5=5th Important",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1st Important"
      },
      {
        "value": 2,
        "label": "2nd Important"
      },
      {
        "value": 3,
        "label": "3rd Important"
      },
      {
        "value": 4,
        "label": "4th Important"
      },
      {
        "value": 5,
        "label": "5th Important"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B6b",
    "column": "B6br10",
    "description": "B6br10: Easy to understand details of antiseizure treatment when the healthcare provider explains it - Please rank the most important attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper] where 1 is the most important, 2 is t",
    "valueType": "Values: 1-5",
    "answerOptions": "1=1st Important,2=2nd Important,3=3rd Important,4=4th Important,5=5th Important",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1st Important"
      },
      {
        "value": 2,
        "label": "2nd Important"
      },
      {
        "value": 3,
        "label": "3rd Important"
      },
      {
        "value": 4,
        "label": "4th Important"
      },
      {
        "value": 5,
        "label": "5th Important"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B6b",
    "column": "B6br11",
    "description": "B6br11: Availability of support programs, such as access to a nurse hotline that can answer my questions - Please rank the most important attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper] where 1 is the most important, 2",
    "valueType": "Values: 1-5",
    "answerOptions": "1=1st Important,2=2nd Important,3=3rd Important,4=4th Important,5=5th Important",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1st Important"
      },
      {
        "value": 2,
        "label": "2nd Important"
      },
      {
        "value": 3,
        "label": "3rd Important"
      },
      {
        "value": 4,
        "label": "4th Important"
      },
      {
        "value": 5,
        "label": "5th Important"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B6b",
    "column": "B6br12",
    "description": "B6br12: No cardiovascular safety concerns - Please rank the most important attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper] where 1 is the most important, 2 is the second most important, etc. [pipe: Text_B6b]",
    "valueType": "Values: 1-5",
    "answerOptions": "1=1st Important,2=2nd Important,3=3rd Important,4=4th Important,5=5th Important",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1st Important"
      },
      {
        "value": 2,
        "label": "2nd Important"
      },
      {
        "value": 3,
        "label": "3rd Important"
      },
      {
        "value": 4,
        "label": "4th Important"
      },
      {
        "value": 5,
        "label": "5th Important"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B6b",
    "column": "B6br13",
    "description": "B6br13: Know others have had success with this treatment - Please rank the most important attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper] where 1 is the most important, 2 is the second most important, etc. [pipe: Text_B",
    "valueType": "Values: 1-5",
    "answerOptions": "1=1st Important,2=2nd Important,3=3rd Important,4=4th Important,5=5th Important",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1st Important"
      },
      {
        "value": 2,
        "label": "2nd Important"
      },
      {
        "value": 3,
        "label": "3rd Important"
      },
      {
        "value": 4,
        "label": "4th Important"
      },
      {
        "value": 5,
        "label": "5th Important"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B6b",
    "column": "B6br14",
    "description": "B6br14: Easy to comply with antiseizure treatment requirements/monitoring - Please rank the most important attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper] where 1 is the most important, 2 is the second most important, e",
    "valueType": "Values: 1-5",
    "answerOptions": "1=1st Important,2=2nd Important,3=3rd Important,4=4th Important,5=5th Important",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1st Important"
      },
      {
        "value": 2,
        "label": "2nd Important"
      },
      {
        "value": 3,
        "label": "3rd Important"
      },
      {
        "value": 4,
        "label": "4th Important"
      },
      {
        "value": 5,
        "label": "5th Important"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B6b",
    "column": "B6br15",
    "description": "B6br15: Limited potential for abuse - Please rank the most important attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper] where 1 is the most important, 2 is the second most important, etc. [pipe: Text_B6b]",
    "valueType": "Values: 1-5",
    "answerOptions": "1=1st Important,2=2nd Important,3=3rd Important,4=4th Important,5=5th Important",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1st Important"
      },
      {
        "value": 2,
        "label": "2nd Important"
      },
      {
        "value": 3,
        "label": "3rd Important"
      },
      {
        "value": 4,
        "label": "4th Important"
      },
      {
        "value": 5,
        "label": "5th Important"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B6b",
    "column": "B6br16",
    "description": "B6br16: Ability to add without having to adjust current treatments - Please rank the most important attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper] where 1 is the most important, 2 is the second most important, etc. [pi",
    "valueType": "Values: 1-5",
    "answerOptions": "1=1st Important,2=2nd Important,3=3rd Important,4=4th Important,5=5th Important",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1st Important"
      },
      {
        "value": 2,
        "label": "2nd Important"
      },
      {
        "value": 3,
        "label": "3rd Important"
      },
      {
        "value": 4,
        "label": "4th Important"
      },
      {
        "value": 5,
        "label": "5th Important"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B6b",
    "column": "B6br17",
    "description": "B6br17: Liquid formulation that can be used with feeding tubes - Please rank the most important attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper] where 1 is the most important, 2 is the second most important, etc. [pipe:",
    "valueType": "Values: 1-5",
    "answerOptions": "1=1st Important,2=2nd Important,3=3rd Important,4=4th Important,5=5th Important",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1st Important"
      },
      {
        "value": 2,
        "label": "2nd Important"
      },
      {
        "value": 3,
        "label": "3rd Important"
      },
      {
        "value": 4,
        "label": "4th Important"
      },
      {
        "value": 5,
        "label": "5th Important"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B6b",
    "column": "B6br18",
    "description": "B6br18: A mechanism of action that is different from an antiseizure medication we tried before - Please rank the most important attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper] where 1 is the most important, 2 is the sec",
    "valueType": "Values: 1-5",
    "answerOptions": "1=1st Important,2=2nd Important,3=3rd Important,4=4th Important,5=5th Important",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1st Important"
      },
      {
        "value": 2,
        "label": "2nd Important"
      },
      {
        "value": 3,
        "label": "3rd Important"
      },
      {
        "value": 4,
        "label": "4th Important"
      },
      {
        "value": 5,
        "label": "5th Important"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B6b",
    "column": "B6br19",
    "description": "B6br19: Time it takes to find out the medication is working - Please rank the most important attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper] where 1 is the most important, 2 is the second most important, etc. [pipe: Tex",
    "valueType": "Values: 1-5",
    "answerOptions": "1=1st Important,2=2nd Important,3=3rd Important,4=4th Important,5=5th Important",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1st Important"
      },
      {
        "value": 2,
        "label": "2nd Important"
      },
      {
        "value": 3,
        "label": "3rd Important"
      },
      {
        "value": 4,
        "label": "4th Important"
      },
      {
        "value": 5,
        "label": "5th Important"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B6b",
    "column": "B6br20",
    "description": "B6br20: An antiseizure medication with minimal interactions with other current medications used - Please rank the most important attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper] where 1 is the most important, 2 is the se",
    "valueType": "Values: 1-5",
    "answerOptions": "1=1st Important,2=2nd Important,3=3rd Important,4=4th Important,5=5th Important",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1st Important"
      },
      {
        "value": 2,
        "label": "2nd Important"
      },
      {
        "value": 3,
        "label": "3rd Important"
      },
      {
        "value": 4,
        "label": "4th Important"
      },
      {
        "value": 5,
        "label": "5th Important"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B6ba",
    "column": "B6bar1",
    "description": "B6bar1: Reducing seizure frequency - Please rank the most important attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper] where 1 is the most important, 2 is the second most important, etc. [pipe: Text_B6b]",
    "valueType": "Values: 1-5",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B6ba",
    "column": "B6bar2",
    "description": "B6bar2: Reducing seizure severity - Please rank the most important attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper] where 1 is the most important, 2 is the second most important, etc. [pipe: Text_B6b]",
    "valueType": "Values: 1-5",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B6ba",
    "column": "B6bar3",
    "description": "B6bar3: Reducing need for rescue medication - Please rank the most important attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper] where 1 is the most important, 2 is the second most important, etc. [pipe: Text_B6b]",
    "valueType": "Values: 1-5",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B6ba",
    "column": "B6bar4",
    "description": "B6bar4: Manageable side effects - Please rank the most important attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper] where 1 is the most important, 2 is the second most important, etc. [pipe: Text_B6b]",
    "valueType": "Values: 1-5",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B6ba",
    "column": "B6bar5",
    "description": "B6bar5: Improves behavior - Please rank the most important attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper] where 1 is the most important, 2 is the second most important, etc. [pipe: Text_B6b]",
    "valueType": "Values: 1-5",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B6ba",
    "column": "B6bar6",
    "description": "B6bar6: Improves cognition - Please rank the most important attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper] where 1 is the most important, 2 is the second most important, etc. [pipe: Text_B6b]",
    "valueType": "Values: 1-5",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B6ba",
    "column": "B6bar7",
    "description": "B6bar7: Leads to fewer hospital/Emergency Room visits - Please rank the most important attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper] where 1 is the most important, 2 is the second most important, etc. [pipe: Text_B6b]",
    "valueType": "Values: 1-5",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B6ba",
    "column": "B6bar8",
    "description": "B6bar8: Healthcare provider recommends it - Please rank the most important attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper] where 1 is the most important, 2 is the second most important, etc. [pipe: Text_B6b]",
    "valueType": "Values: 2-5",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 2,
    "rangeMax": 5,
    "allowedValues": [
      2,
      3,
      4,
      5
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B6ba",
    "column": "B6bar9",
    "description": "B6bar9: Covered by insurance with affordable out-of-pocket cost - Please rank the most important attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper] where 1 is the most important, 2 is the second most important, etc. [pipe:",
    "valueType": "Values: 1-5",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B6ba",
    "column": "B6bar10",
    "description": "B6bar10: Easy to understand details of antiseizure treatment when the healthcare provider explains it - Please rank the most important attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper] where 1 is the most important, 2 is",
    "valueType": "Values: 2-2",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 2,
    "rangeMax": 2,
    "allowedValues": [
      2
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B6ba",
    "column": "B6bar11",
    "description": "B6bar11: Availability of support programs, such as access to a nurse hotline that can answer my questions - Please rank the most important attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper] where 1 is the most important, 2",
    "valueType": "Values: 5-5",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 5,
    "rangeMax": 5,
    "allowedValues": [
      5
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B6ba",
    "column": "B6bar12",
    "description": "B6bar12: No cardiovascular safety concerns - Please rank the most important attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper] where 1 is the most important, 2 is the second most important, etc. [pipe: Text_B6b]",
    "valueType": "Values: 1-5",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B6ba",
    "column": "B6bar13",
    "description": "B6bar13: Know others have had success with this treatment - Please rank the most important attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper] where 1 is the most important, 2 is the second most important, etc. [pipe: Text_",
    "valueType": "Values: 1-5",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B6ba",
    "column": "B6bar14",
    "description": "B6bar14: Easy to comply with antiseizure treatment requirements/monitoring - Please rank the most important attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper] where 1 is the most important, 2 is the second most important,",
    "valueType": "Values: 4-5",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 4,
    "rangeMax": 5,
    "allowedValues": [
      4,
      5
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B6ba",
    "column": "B6bar15",
    "description": "B6bar15: Limited potential for abuse - Please rank the most important attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper] where 1 is the most important, 2 is the second most important, etc. [pipe: Text_B6b]",
    "valueType": "Values: [object Object]-[object Object]",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "numeric_range",
    "rangeMin": {},
    "rangeMax": {},
    "rangeStep": 1
  },
  {
    "level": "sub",
    "parentQuestion": "B6ba",
    "column": "B6bar16",
    "description": "B6bar16: Ability to add without having to adjust current treatments - Please rank the most important attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper] where 1 is the most important, 2 is the second most important, etc. [p",
    "valueType": "Values: 1-5",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B6ba",
    "column": "B6bar17",
    "description": "B6bar17: Liquid formulation that can be used with feeding tubes - Please rank the most important attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper] where 1 is the most important, 2 is the second most important, etc. [pipe:",
    "valueType": "Values: 1-5",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B6ba",
    "column": "B6bar18",
    "description": "B6bar18: A mechanism of action that is different from an antiseizure medication we tried before - Please rank the most important attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper] where 1 is the most important, 2 is the se",
    "valueType": "Values: 2-5",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 2,
    "rangeMax": 5,
    "allowedValues": [
      2,
      3,
      4,
      5
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B6ba",
    "column": "B6bar19",
    "description": "B6bar19: Time it takes to find out the medication is working - Please rank the most important attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper] where 1 is the most important, 2 is the second most important, etc. [pipe: Te",
    "valueType": "Values: 2-5",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 2,
    "rangeMax": 5,
    "allowedValues": [
      2,
      3,
      4,
      5
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B6ba",
    "column": "B6bar20",
    "description": "B6bar20: An antiseizure medication with minimal interactions with other current medications used - Please rank the most important attributes/factors when making antiseizure treatment decisions for [pipe: S9 upper] where 1 is the most important, 2 is the s",
    "valueType": "Values: 1-5",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "B7",
    "column": "B7r1",
    "description": "B7r1: Adventurous - Please indicate how much more you agree with one statement vs. the other when it comes to what success looks like for [pipe: hS3] antiseizure treatments.",
    "valueType": "Values: 1-6",
    "answerOptions": "1=Agree much more - Statement A,2=Agree somewhat more - Statement A,3=Agree slightly more - Statement A,4=Agree slightly more - Statement B,5=Agree somewhat more - Statement B,6=Agree much more - Statement B",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 6,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "Agree much more - Statement A"
      },
      {
        "value": 2,
        "label": "Agree somewhat more - Statement A"
      },
      {
        "value": 3,
        "label": "Agree slightly more - Statement A"
      },
      {
        "value": 4,
        "label": "Agree slightly more - Statement B"
      },
      {
        "value": 5,
        "label": "Agree somewhat more - Statement B"
      },
      {
        "value": 6,
        "label": "Agree much more - Statement B"
      }
    ]
  },
  {
    "level": "parent",
    "parentQuestion": "NA",
    "column": "Treatment_1",
    "description": "Treatment_1: Hidden question",
    "valueType": "Values: 1-34",
    "answerOptions": "1=BANZEL (rufinamide),2=DEPAKOTE (valproate),3=DIACOMIT (stiripentol),4=DIASTAT (diazepam),5=EPIDIOLEX (cannabidiol),6=FELBATOL (felbamate),7=FINTEPLA (fenfluramine),8=KEPPRA (levetiracetam),9=KLONOPIN (clonazepam),10=LAMICTAL (lamotrigine),11=Nasal rescue medications (NAYZILAM, VALTOCO),12=ONFI (clobazam pill/tablet),13=RIVOTRIL (clonazepam),14=TOPAMAX (topiramate),15=VALPROIC ACID (valproate),16=XCOPRI (cenobamate),17=ZONEGRAN (zonisamide),18=ATIVAN (lorazepam),19=BRIVIACT (brivaracetam),20=DILANTIN (phenytoin),21=EPITOL (carbamazepine),22=EQUETRO (carbamazepine),23=FYCOMPA (parampanel),24=Ketogenic Diet,25=Nasal rescue medications (NAYZILAM, VALTOCO),26=OXTELLAR XR (oxcarbazepine),27=SABRIL (vigabatrin),28=SOLFOTON (phenobarbital),29=SYMPAZAN (clobazam oral film/strip),30=TEGRETOL XR (carbamazepine),31=TRILEPTAL (oxcarbazepine),32=VALIUM (diazepan),33=VIMPAT (Lacosamide),34=$ {A3.r98.open}",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 34,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8,
      9,
      10,
      11,
      12,
      13,
      14,
      15,
      16,
      17,
      18,
      19,
      20,
      21,
      22,
      23,
      24,
      25,
      26,
      27,
      28,
      29,
      30,
      31,
      32,
      33,
      34
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "BANZEL (rufinamide)"
      },
      {
        "value": 2,
        "label": "DEPAKOTE (valproate)"
      },
      {
        "value": 3,
        "label": "DIACOMIT (stiripentol)"
      },
      {
        "value": 4,
        "label": "DIASTAT (diazepam)"
      },
      {
        "value": 5,
        "label": "EPIDIOLEX (cannabidiol)"
      },
      {
        "value": 6,
        "label": "FELBATOL (felbamate)"
      },
      {
        "value": 7,
        "label": "FINTEPLA (fenfluramine)"
      },
      {
        "value": 8,
        "label": "KEPPRA (levetiracetam)"
      },
      {
        "value": 9,
        "label": "KLONOPIN (clonazepam)"
      },
      {
        "value": 10,
        "label": "LAMICTAL (lamotrigine)"
      },
      {
        "value": 11,
        "label": "Nasal rescue medications (NAYZILAM"
      },
      {
        "value": 12,
        "label": "ONFI (clobazam pill/tablet)"
      },
      {
        "value": 13,
        "label": "RIVOTRIL (clonazepam)"
      },
      {
        "value": 14,
        "label": "TOPAMAX (topiramate)"
      },
      {
        "value": 15,
        "label": "VALPROIC ACID (valproate)"
      },
      {
        "value": 16,
        "label": "XCOPRI (cenobamate)"
      },
      {
        "value": 17,
        "label": "ZONEGRAN (zonisamide)"
      },
      {
        "value": 18,
        "label": "ATIVAN (lorazepam)"
      },
      {
        "value": 19,
        "label": "BRIVIACT (brivaracetam)"
      },
      {
        "value": 20,
        "label": "DILANTIN (phenytoin)"
      },
      {
        "value": 21,
        "label": "EPITOL (carbamazepine)"
      },
      {
        "value": 22,
        "label": "EQUETRO (carbamazepine)"
      },
      {
        "value": 23,
        "label": "FYCOMPA (parampanel)"
      },
      {
        "value": 24,
        "label": "Ketogenic Diet"
      },
      {
        "value": 25,
        "label": "Nasal rescue medications (NAYZILAM"
      },
      {
        "value": 26,
        "label": "OXTELLAR XR (oxcarbazepine)"
      },
      {
        "value": 27,
        "label": "SABRIL (vigabatrin)"
      },
      {
        "value": 28,
        "label": "SOLFOTON (phenobarbital)"
      },
      {
        "value": 29,
        "label": "SYMPAZAN (clobazam oral film/strip)"
      },
      {
        "value": 30,
        "label": "TEGRETOL XR (carbamazepine)"
      },
      {
        "value": 31,
        "label": "TRILEPTAL (oxcarbazepine)"
      },
      {
        "value": 32,
        "label": "VALIUM (diazepan)"
      },
      {
        "value": 33,
        "label": "VIMPAT (Lacosamide)"
      },
      {
        "value": 34,
        "label": "$ {A3.r98.open}"
      }
    ]
  },
  {
    "level": "parent",
    "parentQuestion": "NA",
    "column": "Treatment_2",
    "description": "Treatment_2: Hidden question",
    "valueType": "Values: 1-34",
    "answerOptions": "1=BANZEL (rufinamide),2=DEPAKOTE (valproate),3=DIACOMIT (stiripentol),4=DIASTAT (diazepam),5=EPIDIOLEX (cannabidiol),6=FELBATOL (felbamate),7=FINTEPLA (fenfluramine),8=KEPPRA (levetiracetam),9=KLONOPIN (clonazepam),10=LAMICTAL (lamotrigine),11=Nasal rescue medications (NAYZILAM, VALTOCO),12=ONFI (clobazam pill/tablet),13=RIVOTRIL (clonazepam),14=TOPAMAX (topiramate),15=VALPROIC ACID (valproate),16=XCOPRI (cenobamate),17=ZONEGRAN (zonisamide),18=ATIVAN (lorazepam),19=BRIVIACT (brivaracetam),20=DILANTIN (phenytoin),21=EPITOL (carbamazepine),22=EQUETRO (carbamazepine),23=FYCOMPA (parampanel),24=Ketogenic Diet,25=Nasal rescue medications (NAYZILAM, VALTOCO),26=OXTELLAR XR (oxcarbazepine),27=SABRIL (vigabatrin),28=SOLFOTON (phenobarbital),29=SYMPAZAN (clobazam oral film/strip),30=TEGRETOL XR (carbamazepine),31=TRILEPTAL (oxcarbazepine),32=VALIUM (diazepan),33=VIMPAT (Lacosamide),34=$ {A3.r98.open}",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 34,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8,
      9,
      10,
      11,
      12,
      13,
      14,
      15,
      16,
      17,
      18,
      19,
      20,
      21,
      22,
      23,
      24,
      25,
      26,
      27,
      28,
      29,
      30,
      31,
      32,
      33,
      34
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "BANZEL (rufinamide)"
      },
      {
        "value": 2,
        "label": "DEPAKOTE (valproate)"
      },
      {
        "value": 3,
        "label": "DIACOMIT (stiripentol)"
      },
      {
        "value": 4,
        "label": "DIASTAT (diazepam)"
      },
      {
        "value": 5,
        "label": "EPIDIOLEX (cannabidiol)"
      },
      {
        "value": 6,
        "label": "FELBATOL (felbamate)"
      },
      {
        "value": 7,
        "label": "FINTEPLA (fenfluramine)"
      },
      {
        "value": 8,
        "label": "KEPPRA (levetiracetam)"
      },
      {
        "value": 9,
        "label": "KLONOPIN (clonazepam)"
      },
      {
        "value": 10,
        "label": "LAMICTAL (lamotrigine)"
      },
      {
        "value": 11,
        "label": "Nasal rescue medications (NAYZILAM"
      },
      {
        "value": 12,
        "label": "ONFI (clobazam pill/tablet)"
      },
      {
        "value": 13,
        "label": "RIVOTRIL (clonazepam)"
      },
      {
        "value": 14,
        "label": "TOPAMAX (topiramate)"
      },
      {
        "value": 15,
        "label": "VALPROIC ACID (valproate)"
      },
      {
        "value": 16,
        "label": "XCOPRI (cenobamate)"
      },
      {
        "value": 17,
        "label": "ZONEGRAN (zonisamide)"
      },
      {
        "value": 18,
        "label": "ATIVAN (lorazepam)"
      },
      {
        "value": 19,
        "label": "BRIVIACT (brivaracetam)"
      },
      {
        "value": 20,
        "label": "DILANTIN (phenytoin)"
      },
      {
        "value": 21,
        "label": "EPITOL (carbamazepine)"
      },
      {
        "value": 22,
        "label": "EQUETRO (carbamazepine)"
      },
      {
        "value": 23,
        "label": "FYCOMPA (parampanel)"
      },
      {
        "value": 24,
        "label": "Ketogenic Diet"
      },
      {
        "value": 25,
        "label": "Nasal rescue medications (NAYZILAM"
      },
      {
        "value": 26,
        "label": "OXTELLAR XR (oxcarbazepine)"
      },
      {
        "value": 27,
        "label": "SABRIL (vigabatrin)"
      },
      {
        "value": 28,
        "label": "SOLFOTON (phenobarbital)"
      },
      {
        "value": 29,
        "label": "SYMPAZAN (clobazam oral film/strip)"
      },
      {
        "value": 30,
        "label": "TEGRETOL XR (carbamazepine)"
      },
      {
        "value": 31,
        "label": "TRILEPTAL (oxcarbazepine)"
      },
      {
        "value": 32,
        "label": "VALIUM (diazepan)"
      },
      {
        "value": 33,
        "label": "VIMPAT (Lacosamide)"
      },
      {
        "value": 34,
        "label": "$ {A3.r98.open}"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1_1",
    "column": "C1_1r1",
    "description": "C1_1r1: Reducing seizure frequency - To the best of your knowledge, please rate the performance of on each of the attributes below. Please base your ratings on your personal experience with the product, as well as anything you may have seen or heard about",
    "valueType": "Values: 1-8",
    "answerOptions": "1=1 Performs extremely poorly,2=2,3=3,4=4,5=5,6=6,7=7 Performs extremely well,8=Don't know",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 8,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Performs extremely poorly"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Performs extremely well"
      },
      {
        "value": 8,
        "label": "Don't know"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1_1",
    "column": "C1_1r2",
    "description": "C1_1r2: Reducing seizure severity - To the best of your knowledge, please rate the performance of on each of the attributes below. Please base your ratings on your personal experience with the product, as well as anything you may have seen or heard about",
    "valueType": "Values: 1-8",
    "answerOptions": "1=1 Performs extremely poorly,2=2,3=3,4=4,5=5,6=6,7=7 Performs extremely well,8=Don't know",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 8,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Performs extremely poorly"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Performs extremely well"
      },
      {
        "value": 8,
        "label": "Don't know"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1_1",
    "column": "C1_1r3",
    "description": "C1_1r3: Reducing need for rescue medication - To the best of your knowledge, please rate the performance of on each of the attributes below. Please base your ratings on your personal experience with the product, as well as anything you may have seen or he",
    "valueType": "Values: 1-8",
    "answerOptions": "1=1 Performs extremely poorly,2=2,3=3,4=4,5=5,6=6,7=7 Performs extremely well,8=Don't know",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 8,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Performs extremely poorly"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Performs extremely well"
      },
      {
        "value": 8,
        "label": "Don't know"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1_1",
    "column": "C1_1r4",
    "description": "C1_1r4: Manageable side effects - To the best of your knowledge, please rate the performance of on each of the attributes below. Please base your ratings on your personal experience with the product, as well as anything you may have seen or heard about it",
    "valueType": "Values: 1-8",
    "answerOptions": "1=1 Performs extremely poorly,2=2,3=3,4=4,5=5,6=6,7=7 Performs extremely well,8=Don't know",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 8,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Performs extremely poorly"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Performs extremely well"
      },
      {
        "value": 8,
        "label": "Don't know"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1_1",
    "column": "C1_1r5",
    "description": "C1_1r5: Improves behavior - To the best of your knowledge, please rate the performance of on each of the attributes below. Please base your ratings on your personal experience with the product, as well as anything you may have seen or heard about it.",
    "valueType": "Values: 1-8",
    "answerOptions": "1=1 Performs extremely poorly,2=2,3=3,4=4,5=5,6=6,7=7 Performs extremely well,8=Don't know",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 8,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Performs extremely poorly"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Performs extremely well"
      },
      {
        "value": 8,
        "label": "Don't know"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1_1",
    "column": "C1_1r6",
    "description": "C1_1r6: Improves cognition - To the best of your knowledge, please rate the performance of on each of the attributes below. Please base your ratings on your personal experience with the product, as well as anything you may have seen or heard about it.",
    "valueType": "Values: 1-8",
    "answerOptions": "1=1 Performs extremely poorly,2=2,3=3,4=4,5=5,6=6,7=7 Performs extremely well,8=Don't know",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 8,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Performs extremely poorly"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Performs extremely well"
      },
      {
        "value": 8,
        "label": "Don't know"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1_1",
    "column": "C1_1r7",
    "description": "C1_1r7: Leads to fewer hospital/Emergency Room visits - To the best of your knowledge, please rate the performance of on each of the attributes below. Please base your ratings on your personal experience with the product, as well as anything you may have",
    "valueType": "Values: 1-8",
    "answerOptions": "1=1 Performs extremely poorly,2=2,3=3,4=4,5=5,6=6,7=7 Performs extremely well,8=Don't know",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 8,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Performs extremely poorly"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Performs extremely well"
      },
      {
        "value": 8,
        "label": "Don't know"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1_1",
    "column": "C1_1r8",
    "description": "C1_1r8: Healthcare provider recommends it - To the best of your knowledge, please rate the performance of on each of the attributes below. Please base your ratings on your personal experience with the product, as well as anything you may have seen or hear",
    "valueType": "Values: 1-8",
    "answerOptions": "1=1 Performs extremely poorly,2=2,3=3,4=4,5=5,6=6,7=7 Performs extremely well,8=Don't know",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 8,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Performs extremely poorly"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Performs extremely well"
      },
      {
        "value": 8,
        "label": "Don't know"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1_1",
    "column": "C1_1r9",
    "description": "C1_1r9: Covered by insurance with affordable out-of-pocket cost - To the best of your knowledge, please rate the performance of on each of the attributes below. Please base your ratings on your personal experience with the product, as well as anything you",
    "valueType": "Values: 1-8",
    "answerOptions": "1=1 Performs extremely poorly,2=2,3=3,4=4,5=5,6=6,7=7 Performs extremely well,8=Don't know",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 8,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Performs extremely poorly"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Performs extremely well"
      },
      {
        "value": 8,
        "label": "Don't know"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1_1",
    "column": "C1_1r10",
    "description": "C1_1r10: Easy to understand details of antiseizure treatment when the healthcare provider explains it - To the best of your knowledge, please rate the performance of on each of the attributes below. Please base your ratings on your personal experience wit",
    "valueType": "Values: 1-8",
    "answerOptions": "1=1 Performs extremely poorly,2=2,3=3,4=4,5=5,6=6,7=7 Performs extremely well,8=Don't know",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 8,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Performs extremely poorly"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Performs extremely well"
      },
      {
        "value": 8,
        "label": "Don't know"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1_1",
    "column": "C1_1r11",
    "description": "C1_1r11: Availability of support programs, such as access to a nurse hotline that can answer my questions - To the best of your knowledge, please rate the performance of on each of the attributes below. Please base your ratings on your personal experience",
    "valueType": "Values: 1-8",
    "answerOptions": "1=1 Performs extremely poorly,2=2,3=3,4=4,5=5,6=6,7=7 Performs extremely well,8=Don't know",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 8,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Performs extremely poorly"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Performs extremely well"
      },
      {
        "value": 8,
        "label": "Don't know"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1_1",
    "column": "C1_1r12",
    "description": "C1_1r12: No cardiovascular safety concerns - To the best of your knowledge, please rate the performance of on each of the attributes below. Please base your ratings on your personal experience with the product, as well as anything you may have seen or hea",
    "valueType": "Values: 1-8",
    "answerOptions": "1=1 Performs extremely poorly,2=2,3=3,4=4,5=5,6=6,7=7 Performs extremely well,8=Don't know",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 8,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Performs extremely poorly"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Performs extremely well"
      },
      {
        "value": 8,
        "label": "Don't know"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1_1",
    "column": "C1_1r13",
    "description": "C1_1r13: Know others have had success with this treatment - To the best of your knowledge, please rate the performance of on each of the attributes below. Please base your ratings on your personal experience with the product, as well as anything you may h",
    "valueType": "Values: 1-8",
    "answerOptions": "1=1 Performs extremely poorly,2=2,3=3,4=4,5=5,6=6,7=7 Performs extremely well,8=Don't know",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 8,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Performs extremely poorly"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Performs extremely well"
      },
      {
        "value": 8,
        "label": "Don't know"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1_1",
    "column": "C1_1r14",
    "description": "C1_1r14: Easy to comply with antiseizure treatment requirements/monitoring - To the best of your knowledge, please rate the performance of on each of the attributes below. Please base your ratings on your personal experience with the product, as well as a",
    "valueType": "Values: 1-8",
    "answerOptions": "1=1 Performs extremely poorly,2=2,3=3,4=4,5=5,6=6,7=7 Performs extremely well,8=Don't know",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 8,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Performs extremely poorly"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Performs extremely well"
      },
      {
        "value": 8,
        "label": "Don't know"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1_1",
    "column": "C1_1r15",
    "description": "C1_1r15: Limited potential for abuse - To the best of your knowledge, please rate the performance of on each of the attributes below. Please base your ratings on your personal experience with the product, as well as anything you may have seen or heard abo",
    "valueType": "Values: 1-8",
    "answerOptions": "1=1 Performs extremely poorly,2=2,3=3,4=4,5=5,6=6,7=7 Performs extremely well,8=Don't know",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 8,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Performs extremely poorly"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Performs extremely well"
      },
      {
        "value": 8,
        "label": "Don't know"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1_1",
    "column": "C1_1r16",
    "description": "C1_1r16: Ability to add without having to adjust current treatments - To the best of your knowledge, please rate the performance of on each of the attributes below. Please base your ratings on your personal experience with the product, as well as anything",
    "valueType": "Values: 1-8",
    "answerOptions": "1=1 Performs extremely poorly,2=2,3=3,4=4,5=5,6=6,7=7 Performs extremely well,8=Don't know",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 8,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Performs extremely poorly"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Performs extremely well"
      },
      {
        "value": 8,
        "label": "Don't know"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1_1",
    "column": "C1_1r17",
    "description": "C1_1r17: Liquid formulation that can be used with feeding tubes - To the best of your knowledge, please rate the performance of on each of the attributes below. Please base your ratings on your personal experience with the product, as well as anything you",
    "valueType": "Values: 1-8",
    "answerOptions": "1=1 Performs extremely poorly,2=2,3=3,4=4,5=5,6=6,7=7 Performs extremely well,8=Don't know",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 8,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Performs extremely poorly"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Performs extremely well"
      },
      {
        "value": 8,
        "label": "Don't know"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1_1",
    "column": "C1_1r18",
    "description": "C1_1r18: A mechanism of action that is different from an antiseizure medication we tried before - To the best of your knowledge, please rate the performance of on each of the attributes below. Please base your ratings on your personal experience with the",
    "valueType": "Values: 1-8",
    "answerOptions": "1=1 Performs extremely poorly,2=2,3=3,4=4,5=5,6=6,7=7 Performs extremely well,8=Don't know",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 8,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Performs extremely poorly"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Performs extremely well"
      },
      {
        "value": 8,
        "label": "Don't know"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1_1",
    "column": "C1_1r19",
    "description": "C1_1r19: Time it takes to find out the medication is working - To the best of your knowledge, please rate the performance of on each of the attributes below. Please base your ratings on your personal experience with the product, as well as anything you ma",
    "valueType": "Values: 1-8",
    "answerOptions": "1=1 Performs extremely poorly,2=2,3=3,4=4,5=5,6=6,7=7 Performs extremely well,8=Don't know",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 8,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Performs extremely poorly"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Performs extremely well"
      },
      {
        "value": 8,
        "label": "Don't know"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1_1",
    "column": "C1_1r20",
    "description": "C1_1r20: An antiseizure medication with minimal interactions with other current medications used - To the best of your knowledge, please rate the performance of on each of the attributes below. Please base your ratings on your personal experience with the",
    "valueType": "Values: 1-8",
    "answerOptions": "1=1 Performs extremely poorly,2=2,3=3,4=4,5=5,6=6,7=7 Performs extremely well,8=Don't know",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 8,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Performs extremely poorly"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Performs extremely well"
      },
      {
        "value": 8,
        "label": "Don't know"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C2_1",
    "column": "C2_1r1c1",
    "description": "C2_1r1c1: Not confident that it will help improve seizure control - Concerns I currently have - What concerns, if any, do you have with as a treatment for [pipe: S9 upper]? What concerns did you used to have about , but no longer do?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Not confident that it will help improve seizure control,1=Not confident that it will help improve seizure control",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C2_1",
    "column": "C2_1r2c1",
    "description": "C2_1r2c1: Undesirable side effects - Concerns I currently have - What concerns, if any, do you have with as a treatment for [pipe: S9 upper]? What concerns did you used to have about , but no longer do?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Undesirable side effects,1=Undesirable side effects",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C2_1",
    "column": "C2_1r3c1",
    "description": "C2_1r3c1: Doesn’t seem safe enough for my loved one - Concerns I currently have - What concerns, if any, do you have with as a treatment for [pipe: S9 upper]? What concerns did you used to have about , but no longer do?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Doesn’t seem safe enough for my loved one,1=Doesn’t seem safe enough for my loved one",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C2_1",
    "column": "C2_1r4c1",
    "description": "C2_1r4c1: Have heard others have not had good experiences with this treatment - Concerns I currently have - What concerns, if any, do you have with as a treatment for [pipe: S9 upper]? What concerns did you used to have about , but no longer do?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Have heard others have not had good experiences with this treatment,1=Have heard others have not had good experiences with this treatment",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C2_1",
    "column": "C2_1r5c1",
    "description": "C2_1r5c1: Has not been on market for long enough - Concerns I currently have - What concerns, if any, do you have with as a treatment for [pipe: S9 upper]? What concerns did you used to have about , but no longer do?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Has not been on market for long enough,1=Has not been on market for long enough",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C2_1",
    "column": "C2_1r6c1",
    "description": "C2_1r6c1: Not satisfied with how well it works - Concerns I currently have - What concerns, if any, do you have with as a treatment for [pipe: S9 upper]? What concerns did you used to have about , but no longer do?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Not satisfied with how well it works,1=Not satisfied with how well it works",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C2_1",
    "column": "C2_1r7c1",
    "description": "C2_1r7c1: Healthcare provider did not seem confident when discussing it - Concerns I currently have - What concerns, if any, do you have with as a treatment for [pipe: S9 upper]? What concerns did you used to have about , but no longer do?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Healthcare provider did not seem confident when discussing it,1=Healthcare provider did not seem confident when discussing it",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C2_1",
    "column": "C2_1r8c1",
    "description": "C2_1r8c1: Is not covered by insurance / high costs - Concerns I currently have - What concerns, if any, do you have with as a treatment for [pipe: S9 upper]? What concerns did you used to have about , but no longer do?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Is not covered by insurance / high costs,1=Is not covered by insurance / high costs",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C2_1",
    "column": "C2_1r9c1",
    "description": "C2_1r9c1: Seems difficult to comply with treatment monitoring and requirements - Concerns I currently have - What concerns, if any, do you have with as a treatment for [pipe: S9 upper]? What concerns did you used to have about , but no longer do?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Seems difficult to comply with treatment monitoring and requirements,1=Seems difficult to comply with treatment monitoring and requirements",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C2_1",
    "column": "C2_1r10c1",
    "description": "C2_1r10c1: The safety risks do not seem worth the benefit - Concerns I currently have - What concerns, if any, do you have with as a treatment for [pipe: S9 upper]? What concerns did you used to have about , but no longer do?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: The safety risks do not seem worth the benefit,1=The safety risks do not seem worth the benefit",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C2_1",
    "column": "C2_1r11c1",
    "description": "C2_1r11c1: Had never heard of it when healthcare provider mentioned it - Concerns I currently have - What concerns, if any, do you have with as a treatment for [pipe: S9 upper]? What concerns did you used to have about , but no longer do?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Had never heard of it when healthcare provider mentioned it,1=Had never heard of it when healthcare provider mentioned it",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C2_1",
    "column": "C2_1r12c1",
    "description": "C2_1r12c1: What I learned during my research was below my expectations - Concerns I currently have - What concerns, if any, do you have with as a treatment for [pipe: S9 upper]? What concerns did you used to have about , but no longer do?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: What I learned during my research was below my expectations,1=What I learned during my research was below my expectations",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C2_1",
    "column": "C2_1r15c1",
    "description": "C2_1r15c1: My healthcare provider is not knowledgeable about this treatment - Concerns I currently have - What concerns, if any, do you have with as a treatment for [pipe: S9 upper]? What concerns did you used to have about , but no longer do?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: My healthcare provider is not knowledgeable about this treatment,1=My healthcare provider is not knowledgeable about this treatment",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C2_1",
    "column": "C2_1r13c1",
    "description": "C2_1r13c1: Other (Specify) - Concerns I currently have - What concerns, if any, do you have with as a treatment for [pipe: S9 upper]? What concerns did you used to have about , but no longer do?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Other (Specify),1=Other (Specify)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C2_1",
    "column": "C2_1r14c1",
    "description": "C2_1r14c1: None - Concerns I currently have - What concerns, if any, do you have with as a treatment for [pipe: S9 upper]? What concerns did you used to have about , but no longer do?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: None,1=None",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C2_1",
    "column": "C2_1r1c2",
    "description": "C2_1r1c2: Not confident that it will help improve seizure control - Concerns I used to have, but no longer - What concerns, if any, do you have with as a treatment for [pipe: S9 upper]? What concerns did you used to have about , but no longer do?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Not confident that it will help improve seizure control,1=Not confident that it will help improve seizure control",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C2_1",
    "column": "C2_1r2c2",
    "description": "C2_1r2c2: Undesirable side effects - Concerns I used to have, but no longer - What concerns, if any, do you have with as a treatment for [pipe: S9 upper]? What concerns did you used to have about , but no longer do?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Undesirable side effects,1=Undesirable side effects",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C2_1",
    "column": "C2_1r3c2",
    "description": "C2_1r3c2: Doesn’t seem safe enough for my loved one - Concerns I used to have, but no longer - What concerns, if any, do you have with as a treatment for [pipe: S9 upper]? What concerns did you used to have about , but no longer do?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Doesn’t seem safe enough for my loved one,1=Doesn’t seem safe enough for my loved one",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C2_1",
    "column": "C2_1r4c2",
    "description": "C2_1r4c2: Have heard others have not had good experiences with this treatment - Concerns I used to have, but no longer - What concerns, if any, do you have with as a treatment for [pipe: S9 upper]? What concerns did you used to have about , but no longer",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Have heard others have not had good experiences with this treatment,1=Have heard others have not had good experiences with this treatment",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C2_1",
    "column": "C2_1r5c2",
    "description": "C2_1r5c2: Has not been on market for long enough - Concerns I used to have, but no longer - What concerns, if any, do you have with as a treatment for [pipe: S9 upper]? What concerns did you used to have about , but no longer do?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Has not been on market for long enough,1=Has not been on market for long enough",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C2_1",
    "column": "C2_1r6c2",
    "description": "C2_1r6c2: Not satisfied with how well it works - Concerns I used to have, but no longer - What concerns, if any, do you have with as a treatment for [pipe: S9 upper]? What concerns did you used to have about , but no longer do?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Not satisfied with how well it works,1=Not satisfied with how well it works",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C2_1",
    "column": "C2_1r7c2",
    "description": "C2_1r7c2: Healthcare provider did not seem confident when discussing it - Concerns I used to have, but no longer - What concerns, if any, do you have with as a treatment for [pipe: S9 upper]? What concerns did you used to have about , but no longer do?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Healthcare provider did not seem confident when discussing it,1=Healthcare provider did not seem confident when discussing it",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C2_1",
    "column": "C2_1r8c2",
    "description": "C2_1r8c2: Is not covered by insurance / high costs - Concerns I used to have, but no longer - What concerns, if any, do you have with as a treatment for [pipe: S9 upper]? What concerns did you used to have about , but no longer do?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Is not covered by insurance / high costs,1=Is not covered by insurance / high costs",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C2_1",
    "column": "C2_1r9c2",
    "description": "C2_1r9c2: Seems difficult to comply with treatment monitoring and requirements - Concerns I used to have, but no longer - What concerns, if any, do you have with as a treatment for [pipe: S9 upper]? What concerns did you used to have about , but no longer",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Seems difficult to comply with treatment monitoring and requirements,1=Seems difficult to comply with treatment monitoring and requirements",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C2_1",
    "column": "C2_1r10c2",
    "description": "C2_1r10c2: The safety risks do not seem worth the benefit - Concerns I used to have, but no longer - What concerns, if any, do you have with as a treatment for [pipe: S9 upper]? What concerns did you used to have about , but no longer do?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: The safety risks do not seem worth the benefit,1=The safety risks do not seem worth the benefit",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C2_1",
    "column": "C2_1r11c2",
    "description": "C2_1r11c2: Had never heard of it when healthcare provider mentioned it - Concerns I used to have, but no longer - What concerns, if any, do you have with as a treatment for [pipe: S9 upper]? What concerns did you used to have about , but no longer do?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Had never heard of it when healthcare provider mentioned it,1=Had never heard of it when healthcare provider mentioned it",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C2_1",
    "column": "C2_1r12c2",
    "description": "C2_1r12c2: What I learned during my research was below my expectations - Concerns I used to have, but no longer - What concerns, if any, do you have with as a treatment for [pipe: S9 upper]? What concerns did you used to have about , but no longer do?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: What I learned during my research was below my expectations,1=What I learned during my research was below my expectations",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C2_1",
    "column": "C2_1r15c2",
    "description": "C2_1r15c2: My healthcare provider is not knowledgeable about this treatment - Concerns I used to have, but no longer - What concerns, if any, do you have with as a treatment for [pipe: S9 upper]? What concerns did you used to have about , but no longer do",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: My healthcare provider is not knowledgeable about this treatment,1=My healthcare provider is not knowledgeable about this treatment",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C2_1",
    "column": "C2_1r13c2",
    "description": "C2_1r13c2: Other (Specify) - Concerns I used to have, but no longer - What concerns, if any, do you have with as a treatment for [pipe: S9 upper]? What concerns did you used to have about , but no longer do?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Other (Specify),1=Other (Specify)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C2_1",
    "column": "C2_1r14c2",
    "description": "C2_1r14c2: None - Concerns I used to have, but no longer - What concerns, if any, do you have with as a treatment for [pipe: S9 upper]? What concerns did you used to have about , but no longer do?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: None,1=None",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C2_1",
    "column": "C2_1r13oe",
    "description": "C2_1r13oe: What concerns, if any, do you have with as a treatment for [pipe: S9 upper]? What concerns did you used to have about , but no longer do? - Other (Specify)",
    "valueType": "Open Text",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "text_open"
  },
  {
    "level": "sub",
    "parentQuestion": "C1a_1",
    "column": "C1a_1r1",
    "description": "C1a_1r1: Annoyed - Which of the following emotions, if any, best reflect how you feel about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Annoyed,1=Annoyed",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1a_1",
    "column": "C1a_1r2",
    "description": "C1a_1r2: Frustrated - Which of the following emotions, if any, best reflect how you feel about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Frustrated,1=Frustrated",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1a_1",
    "column": "C1a_1r3",
    "description": "C1a_1r3: Critical - Which of the following emotions, if any, best reflect how you feel about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Critical,1=Critical",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1a_1",
    "column": "C1a_1r4",
    "description": "C1a_1r4: Worried - Which of the following emotions, if any, best reflect how you feel about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Worried,1=Worried",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1a_1",
    "column": "C1a_1r5",
    "description": "C1a_1r5: Challenged - Which of the following emotions, if any, best reflect how you feel about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Challenged,1=Challenged",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1a_1",
    "column": "C1a_1r6",
    "description": "C1a_1r6: Defeated - Which of the following emotions, if any, best reflect how you feel about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Defeated,1=Defeated",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1a_1",
    "column": "C1a_1r7",
    "description": "C1a_1r7: Depressed - Which of the following emotions, if any, best reflect how you feel about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Depressed,1=Depressed",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1a_1",
    "column": "C1a_1r8",
    "description": "C1a_1r8: Guilty - Which of the following emotions, if any, best reflect how you feel about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Guilty,1=Guilty",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1a_1",
    "column": "C1a_1r9",
    "description": "C1a_1r9: Tired - Which of the following emotions, if any, best reflect how you feel about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Tired,1=Tired",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1a_1",
    "column": "C1a_1r10",
    "description": "C1a_1r10: Confused - Which of the following emotions, if any, best reflect how you feel about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Confused,1=Confused",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1a_1",
    "column": "C1a_1r11",
    "description": "C1a_1r11: Anxious - Which of the following emotions, if any, best reflect how you feel about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Anxious,1=Anxious",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1a_1",
    "column": "C1a_1r12",
    "description": "C1a_1r12: Hopeless - Which of the following emotions, if any, best reflect how you feel about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Hopeless,1=Hopeless",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1a_1",
    "column": "C1a_1r13",
    "description": "C1a_1r13: Insecure - Which of the following emotions, if any, best reflect how you feel about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Insecure,1=Insecure",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1a_1",
    "column": "C1a_1r14",
    "description": "C1a_1r14: Hopeful - Which of the following emotions, if any, best reflect how you feel about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Hopeful,1=Hopeful",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1a_1",
    "column": "C1a_1r15",
    "description": "C1a_1r15: Content - Which of the following emotions, if any, best reflect how you feel about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Content,1=Content",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1a_1",
    "column": "C1a_1r16",
    "description": "C1a_1r16: Relieved - Which of the following emotions, if any, best reflect how you feel about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Relieved,1=Relieved",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1a_1",
    "column": "C1a_1r17",
    "description": "C1a_1r17: Trusting - Which of the following emotions, if any, best reflect how you feel about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Trusting,1=Trusting",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1a_1",
    "column": "C1a_1r18",
    "description": "C1a_1r18: Helpful - Which of the following emotions, if any, best reflect how you feel about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Helpful,1=Helpful",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1a_1",
    "column": "C1a_1r19",
    "description": "C1a_1r19: In control - Which of the following emotions, if any, best reflect how you feel about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: In control,1=In control",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1a_1",
    "column": "C1a_1r20",
    "description": "C1a_1r20: Empowered - Which of the following emotions, if any, best reflect how you feel about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Empowered,1=Empowered",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1a_1",
    "column": "C1a_1r21",
    "description": "C1a_1r21: Confident - Which of the following emotions, if any, best reflect how you feel about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Confident,1=Confident",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1a_1",
    "column": "C1a_1r22",
    "description": "C1a_1r22: Happy - Which of the following emotions, if any, best reflect how you feel about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Happy,1=Happy",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "parent",
    "parentQuestion": "NA",
    "column": "C9_1",
    "description": "C9_1: How informed was [pipe: S9 upper]’s healthcare provider when it came to prescribing as a [pipe: hS3] treatment?",
    "valueType": "Values: 1-99",
    "answerOptions": "1=1 Not at all informed,2=2,3=3,4=4 Somewhat informed,5=5,6=6,7=7 Extremely informed,99=I never discussed $ {Treatment_1.selected.text} with [pipe: S9 upper]’s healthcare provider",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 99,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      99
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all informed"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4 Somewhat informed"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely informed"
      },
      {
        "value": 99,
        "label": "I never discussed $ {Treatment_1.selected.text} with [pipe: S9 upper]’s healthcare provider"
      }
    ]
  },
  {
    "level": "parent",
    "parentQuestion": "NA",
    "column": "C10_1",
    "description": "C10_1: What was the overall tone of [pipe: S9 upper]’s healthcare provider when discussing as a [pipe: hS3] treatment with you?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Extremely Negative,2=2,3=3,4=4 Neutral,5=5,6=6,7=7 Extremely Positive",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Extremely Negative"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4 Neutral"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely Positive"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1_2",
    "column": "C1_2r1",
    "description": "C1_2r1: Reducing seizure frequency - To the best of your knowledge, please rate the performance of on each of the attributes below. Please base your ratings on your personal experience with the product, as well as anything you may have seen or heard about",
    "valueType": "Values: 1-8",
    "answerOptions": "1=1 Performs extremely poorly,2=2,3=3,4=4,5=5,6=6,7=7 Performs extremely well,8=Don't know",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 8,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Performs extremely poorly"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Performs extremely well"
      },
      {
        "value": 8,
        "label": "Don't know"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1_2",
    "column": "C1_2r2",
    "description": "C1_2r2: Reducing seizure severity - To the best of your knowledge, please rate the performance of on each of the attributes below. Please base your ratings on your personal experience with the product, as well as anything you may have seen or heard about",
    "valueType": "Values: 1-8",
    "answerOptions": "1=1 Performs extremely poorly,2=2,3=3,4=4,5=5,6=6,7=7 Performs extremely well,8=Don't know",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 8,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Performs extremely poorly"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Performs extremely well"
      },
      {
        "value": 8,
        "label": "Don't know"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1_2",
    "column": "C1_2r3",
    "description": "C1_2r3: Reducing need for rescue medication - To the best of your knowledge, please rate the performance of on each of the attributes below. Please base your ratings on your personal experience with the product, as well as anything you may have seen or he",
    "valueType": "Values: 1-8",
    "answerOptions": "1=1 Performs extremely poorly,2=2,3=3,4=4,5=5,6=6,7=7 Performs extremely well,8=Don't know",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 8,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Performs extremely poorly"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Performs extremely well"
      },
      {
        "value": 8,
        "label": "Don't know"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1_2",
    "column": "C1_2r4",
    "description": "C1_2r4: Manageable side effects - To the best of your knowledge, please rate the performance of on each of the attributes below. Please base your ratings on your personal experience with the product, as well as anything you may have seen or heard about it",
    "valueType": "Values: 1-8",
    "answerOptions": "1=1 Performs extremely poorly,2=2,3=3,4=4,5=5,6=6,7=7 Performs extremely well,8=Don't know",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 8,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Performs extremely poorly"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Performs extremely well"
      },
      {
        "value": 8,
        "label": "Don't know"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1_2",
    "column": "C1_2r5",
    "description": "C1_2r5: Improves behavior - To the best of your knowledge, please rate the performance of on each of the attributes below. Please base your ratings on your personal experience with the product, as well as anything you may have seen or heard about it.",
    "valueType": "Values: 1-8",
    "answerOptions": "1=1 Performs extremely poorly,2=2,3=3,4=4,5=5,6=6,7=7 Performs extremely well,8=Don't know",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 8,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Performs extremely poorly"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Performs extremely well"
      },
      {
        "value": 8,
        "label": "Don't know"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1_2",
    "column": "C1_2r6",
    "description": "C1_2r6: Improves cognition - To the best of your knowledge, please rate the performance of on each of the attributes below. Please base your ratings on your personal experience with the product, as well as anything you may have seen or heard about it.",
    "valueType": "Values: 1-8",
    "answerOptions": "1=1 Performs extremely poorly,2=2,3=3,4=4,5=5,6=6,7=7 Performs extremely well,8=Don't know",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 8,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Performs extremely poorly"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Performs extremely well"
      },
      {
        "value": 8,
        "label": "Don't know"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1_2",
    "column": "C1_2r7",
    "description": "C1_2r7: Leads to fewer hospital/Emergency Room visits - To the best of your knowledge, please rate the performance of on each of the attributes below. Please base your ratings on your personal experience with the product, as well as anything you may have",
    "valueType": "Values: 1-8",
    "answerOptions": "1=1 Performs extremely poorly,2=2,3=3,4=4,5=5,6=6,7=7 Performs extremely well,8=Don't know",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 8,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Performs extremely poorly"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Performs extremely well"
      },
      {
        "value": 8,
        "label": "Don't know"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1_2",
    "column": "C1_2r8",
    "description": "C1_2r8: Healthcare provider recommends it - To the best of your knowledge, please rate the performance of on each of the attributes below. Please base your ratings on your personal experience with the product, as well as anything you may have seen or hear",
    "valueType": "Values: 1-8",
    "answerOptions": "1=1 Performs extremely poorly,2=2,3=3,4=4,5=5,6=6,7=7 Performs extremely well,8=Don't know",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 8,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Performs extremely poorly"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Performs extremely well"
      },
      {
        "value": 8,
        "label": "Don't know"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1_2",
    "column": "C1_2r9",
    "description": "C1_2r9: Covered by insurance with affordable out-of-pocket cost - To the best of your knowledge, please rate the performance of on each of the attributes below. Please base your ratings on your personal experience with the product, as well as anything you",
    "valueType": "Values: 1-8",
    "answerOptions": "1=1 Performs extremely poorly,2=2,3=3,4=4,5=5,6=6,7=7 Performs extremely well,8=Don't know",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 8,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Performs extremely poorly"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Performs extremely well"
      },
      {
        "value": 8,
        "label": "Don't know"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1_2",
    "column": "C1_2r10",
    "description": "C1_2r10: Easy to understand details of antiseizure treatment when the healthcare provider explains it - To the best of your knowledge, please rate the performance of on each of the attributes below. Please base your ratings on your personal experience wit",
    "valueType": "Values: 1-8",
    "answerOptions": "1=1 Performs extremely poorly,2=2,3=3,4=4,5=5,6=6,7=7 Performs extremely well,8=Don't know",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 8,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Performs extremely poorly"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Performs extremely well"
      },
      {
        "value": 8,
        "label": "Don't know"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1_2",
    "column": "C1_2r11",
    "description": "C1_2r11: Availability of support programs, such as access to a nurse hotline that can answer my questions - To the best of your knowledge, please rate the performance of on each of the attributes below. Please base your ratings on your personal experience",
    "valueType": "Values: 1-8",
    "answerOptions": "1=1 Performs extremely poorly,2=2,3=3,4=4,5=5,6=6,7=7 Performs extremely well,8=Don't know",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 8,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Performs extremely poorly"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Performs extremely well"
      },
      {
        "value": 8,
        "label": "Don't know"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1_2",
    "column": "C1_2r12",
    "description": "C1_2r12: No cardiovascular safety concerns - To the best of your knowledge, please rate the performance of on each of the attributes below. Please base your ratings on your personal experience with the product, as well as anything you may have seen or hea",
    "valueType": "Values: 1-8",
    "answerOptions": "1=1 Performs extremely poorly,2=2,3=3,4=4,5=5,6=6,7=7 Performs extremely well,8=Don't know",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 8,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Performs extremely poorly"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Performs extremely well"
      },
      {
        "value": 8,
        "label": "Don't know"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1_2",
    "column": "C1_2r13",
    "description": "C1_2r13: Know others have had success with this treatment - To the best of your knowledge, please rate the performance of on each of the attributes below. Please base your ratings on your personal experience with the product, as well as anything you may h",
    "valueType": "Values: 1-8",
    "answerOptions": "1=1 Performs extremely poorly,2=2,3=3,4=4,5=5,6=6,7=7 Performs extremely well,8=Don't know",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 8,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Performs extremely poorly"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Performs extremely well"
      },
      {
        "value": 8,
        "label": "Don't know"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1_2",
    "column": "C1_2r14",
    "description": "C1_2r14: Easy to comply with antiseizure treatment requirements/monitoring - To the best of your knowledge, please rate the performance of on each of the attributes below. Please base your ratings on your personal experience with the product, as well as a",
    "valueType": "Values: 1-8",
    "answerOptions": "1=1 Performs extremely poorly,2=2,3=3,4=4,5=5,6=6,7=7 Performs extremely well,8=Don't know",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 8,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Performs extremely poorly"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Performs extremely well"
      },
      {
        "value": 8,
        "label": "Don't know"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1_2",
    "column": "C1_2r15",
    "description": "C1_2r15: Limited potential for abuse - To the best of your knowledge, please rate the performance of on each of the attributes below. Please base your ratings on your personal experience with the product, as well as anything you may have seen or heard abo",
    "valueType": "Values: 1-8",
    "answerOptions": "1=1 Performs extremely poorly,2=2,3=3,4=4,5=5,6=6,7=7 Performs extremely well,8=Don't know",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 8,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Performs extremely poorly"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Performs extremely well"
      },
      {
        "value": 8,
        "label": "Don't know"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1_2",
    "column": "C1_2r16",
    "description": "C1_2r16: Ability to add without having to adjust current treatments - To the best of your knowledge, please rate the performance of on each of the attributes below. Please base your ratings on your personal experience with the product, as well as anything",
    "valueType": "Values: 1-8",
    "answerOptions": "1=1 Performs extremely poorly,2=2,3=3,4=4,5=5,6=6,7=7 Performs extremely well,8=Don't know",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 8,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Performs extremely poorly"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Performs extremely well"
      },
      {
        "value": 8,
        "label": "Don't know"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1_2",
    "column": "C1_2r17",
    "description": "C1_2r17: Liquid formulation that can be used with feeding tubes - To the best of your knowledge, please rate the performance of on each of the attributes below. Please base your ratings on your personal experience with the product, as well as anything you",
    "valueType": "Values: 1-8",
    "answerOptions": "1=1 Performs extremely poorly,2=2,3=3,4=4,5=5,6=6,7=7 Performs extremely well,8=Don't know",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 8,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Performs extremely poorly"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Performs extremely well"
      },
      {
        "value": 8,
        "label": "Don't know"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1_2",
    "column": "C1_2r18",
    "description": "C1_2r18: A mechanism of action that is different from an antiseizure medication we tried before - To the best of your knowledge, please rate the performance of on each of the attributes below. Please base your ratings on your personal experience with the",
    "valueType": "Values: 1-8",
    "answerOptions": "1=1 Performs extremely poorly,2=2,3=3,4=4,5=5,6=6,7=7 Performs extremely well,8=Don't know",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 8,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Performs extremely poorly"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Performs extremely well"
      },
      {
        "value": 8,
        "label": "Don't know"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1_2",
    "column": "C1_2r19",
    "description": "C1_2r19: Time it takes to find out the medication is working - To the best of your knowledge, please rate the performance of on each of the attributes below. Please base your ratings on your personal experience with the product, as well as anything you ma",
    "valueType": "Values: 1-8",
    "answerOptions": "1=1 Performs extremely poorly,2=2,3=3,4=4,5=5,6=6,7=7 Performs extremely well,8=Don't know",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 8,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Performs extremely poorly"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Performs extremely well"
      },
      {
        "value": 8,
        "label": "Don't know"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1_2",
    "column": "C1_2r20",
    "description": "C1_2r20: An antiseizure medication with minimal interactions with other current medications used - To the best of your knowledge, please rate the performance of on each of the attributes below. Please base your ratings on your personal experience with the",
    "valueType": "Values: 1-8",
    "answerOptions": "1=1 Performs extremely poorly,2=2,3=3,4=4,5=5,6=6,7=7 Performs extremely well,8=Don't know",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 8,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Performs extremely poorly"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Performs extremely well"
      },
      {
        "value": 8,
        "label": "Don't know"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C2_2",
    "column": "C2_2r1c1",
    "description": "C2_2r1c1: Not confident that it will help improve seizure control - Concerns I currently have - What concerns, if any, do you have with as a treatment for [pipe: S9 upper]? What concerns did you used to have about , but no longer do?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Not confident that it will help improve seizure control,1=Not confident that it will help improve seizure control",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C2_2",
    "column": "C2_2r2c1",
    "description": "C2_2r2c1: Undesirable side effects - Concerns I currently have - What concerns, if any, do you have with as a treatment for [pipe: S9 upper]? What concerns did you used to have about , but no longer do?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Undesirable side effects,1=Undesirable side effects",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C2_2",
    "column": "C2_2r3c1",
    "description": "C2_2r3c1: Doesn’t seem safe enough for my loved one - Concerns I currently have - What concerns, if any, do you have with as a treatment for [pipe: S9 upper]? What concerns did you used to have about , but no longer do?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Doesn’t seem safe enough for my loved one,1=Doesn’t seem safe enough for my loved one",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C2_2",
    "column": "C2_2r4c1",
    "description": "C2_2r4c1: Have heard others have not had good experiences with this treatment - Concerns I currently have - What concerns, if any, do you have with as a treatment for [pipe: S9 upper]? What concerns did you used to have about , but no longer do?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Have heard others have not had good experiences with this treatment,1=Have heard others have not had good experiences with this treatment",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C2_2",
    "column": "C2_2r5c1",
    "description": "C2_2r5c1: Has not been on market for long enough - Concerns I currently have - What concerns, if any, do you have with as a treatment for [pipe: S9 upper]? What concerns did you used to have about , but no longer do?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Has not been on market for long enough,1=Has not been on market for long enough",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C2_2",
    "column": "C2_2r6c1",
    "description": "C2_2r6c1: Not satisfied with how well it works - Concerns I currently have - What concerns, if any, do you have with as a treatment for [pipe: S9 upper]? What concerns did you used to have about , but no longer do?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Not satisfied with how well it works,1=Not satisfied with how well it works",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C2_2",
    "column": "C2_2r7c1",
    "description": "C2_2r7c1: Healthcare provider did not seem confident when discussing it - Concerns I currently have - What concerns, if any, do you have with as a treatment for [pipe: S9 upper]? What concerns did you used to have about , but no longer do?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Healthcare provider did not seem confident when discussing it,1=Healthcare provider did not seem confident when discussing it",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C2_2",
    "column": "C2_2r8c1",
    "description": "C2_2r8c1: Is not covered by insurance / high costs - Concerns I currently have - What concerns, if any, do you have with as a treatment for [pipe: S9 upper]? What concerns did you used to have about , but no longer do?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Is not covered by insurance / high costs,1=Is not covered by insurance / high costs",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C2_2",
    "column": "C2_2r9c1",
    "description": "C2_2r9c1: Seems difficult to comply with treatment monitoring and requirements - Concerns I currently have - What concerns, if any, do you have with as a treatment for [pipe: S9 upper]? What concerns did you used to have about , but no longer do?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Seems difficult to comply with treatment monitoring and requirements,1=Seems difficult to comply with treatment monitoring and requirements",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C2_2",
    "column": "C2_2r10c1",
    "description": "C2_2r10c1: The safety risks do not seem worth the benefit - Concerns I currently have - What concerns, if any, do you have with as a treatment for [pipe: S9 upper]? What concerns did you used to have about , but no longer do?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: The safety risks do not seem worth the benefit,1=The safety risks do not seem worth the benefit",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C2_2",
    "column": "C2_2r11c1",
    "description": "C2_2r11c1: Had never heard of it when healthcare provider mentioned it - Concerns I currently have - What concerns, if any, do you have with as a treatment for [pipe: S9 upper]? What concerns did you used to have about , but no longer do?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Had never heard of it when healthcare provider mentioned it,1=Had never heard of it when healthcare provider mentioned it",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C2_2",
    "column": "C2_2r12c1",
    "description": "C2_2r12c1: What I learned during my research was below my expectations - Concerns I currently have - What concerns, if any, do you have with as a treatment for [pipe: S9 upper]? What concerns did you used to have about , but no longer do?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: What I learned during my research was below my expectations,1=What I learned during my research was below my expectations",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C2_2",
    "column": "C2_2r15c1",
    "description": "C2_2r15c1: My healthcare provider is not knowledgeable about this treatment - Concerns I currently have - What concerns, if any, do you have with as a treatment for [pipe: S9 upper]? What concerns did you used to have about , but no longer do?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: My healthcare provider is not knowledgeable about this treatment,1=My healthcare provider is not knowledgeable about this treatment",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C2_2",
    "column": "C2_2r13c1",
    "description": "C2_2r13c1: Other (Specify) - Concerns I currently have - What concerns, if any, do you have with as a treatment for [pipe: S9 upper]? What concerns did you used to have about , but no longer do?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Other (Specify),1=Other (Specify)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C2_2",
    "column": "C2_2r14c1",
    "description": "C2_2r14c1: None - Concerns I currently have - What concerns, if any, do you have with as a treatment for [pipe: S9 upper]? What concerns did you used to have about , but no longer do?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: None,1=None",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C2_2",
    "column": "C2_2r1c2",
    "description": "C2_2r1c2: Not confident that it will help improve seizure control - Concerns I used to have, but no longer - What concerns, if any, do you have with as a treatment for [pipe: S9 upper]? What concerns did you used to have about , but no longer do?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Not confident that it will help improve seizure control,1=Not confident that it will help improve seizure control",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C2_2",
    "column": "C2_2r2c2",
    "description": "C2_2r2c2: Undesirable side effects - Concerns I used to have, but no longer - What concerns, if any, do you have with as a treatment for [pipe: S9 upper]? What concerns did you used to have about , but no longer do?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Undesirable side effects,1=Undesirable side effects",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C2_2",
    "column": "C2_2r3c2",
    "description": "C2_2r3c2: Doesn’t seem safe enough for my loved one - Concerns I used to have, but no longer - What concerns, if any, do you have with as a treatment for [pipe: S9 upper]? What concerns did you used to have about , but no longer do?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Doesn’t seem safe enough for my loved one,1=Doesn’t seem safe enough for my loved one",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C2_2",
    "column": "C2_2r4c2",
    "description": "C2_2r4c2: Have heard others have not had good experiences with this treatment - Concerns I used to have, but no longer - What concerns, if any, do you have with as a treatment for [pipe: S9 upper]? What concerns did you used to have about , but no longer",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Have heard others have not had good experiences with this treatment,1=Have heard others have not had good experiences with this treatment",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C2_2",
    "column": "C2_2r5c2",
    "description": "C2_2r5c2: Has not been on market for long enough - Concerns I used to have, but no longer - What concerns, if any, do you have with as a treatment for [pipe: S9 upper]? What concerns did you used to have about , but no longer do?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Has not been on market for long enough,1=Has not been on market for long enough",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C2_2",
    "column": "C2_2r6c2",
    "description": "C2_2r6c2: Not satisfied with how well it works - Concerns I used to have, but no longer - What concerns, if any, do you have with as a treatment for [pipe: S9 upper]? What concerns did you used to have about , but no longer do?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Not satisfied with how well it works,1=Not satisfied with how well it works",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C2_2",
    "column": "C2_2r7c2",
    "description": "C2_2r7c2: Healthcare provider did not seem confident when discussing it - Concerns I used to have, but no longer - What concerns, if any, do you have with as a treatment for [pipe: S9 upper]? What concerns did you used to have about , but no longer do?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Healthcare provider did not seem confident when discussing it,1=Healthcare provider did not seem confident when discussing it",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C2_2",
    "column": "C2_2r8c2",
    "description": "C2_2r8c2: Is not covered by insurance / high costs - Concerns I used to have, but no longer - What concerns, if any, do you have with as a treatment for [pipe: S9 upper]? What concerns did you used to have about , but no longer do?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Is not covered by insurance / high costs,1=Is not covered by insurance / high costs",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C2_2",
    "column": "C2_2r9c2",
    "description": "C2_2r9c2: Seems difficult to comply with treatment monitoring and requirements - Concerns I used to have, but no longer - What concerns, if any, do you have with as a treatment for [pipe: S9 upper]? What concerns did you used to have about , but no longer",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Seems difficult to comply with treatment monitoring and requirements,1=Seems difficult to comply with treatment monitoring and requirements",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C2_2",
    "column": "C2_2r10c2",
    "description": "C2_2r10c2: The safety risks do not seem worth the benefit - Concerns I used to have, but no longer - What concerns, if any, do you have with as a treatment for [pipe: S9 upper]? What concerns did you used to have about , but no longer do?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: The safety risks do not seem worth the benefit,1=The safety risks do not seem worth the benefit",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C2_2",
    "column": "C2_2r11c2",
    "description": "C2_2r11c2: Had never heard of it when healthcare provider mentioned it - Concerns I used to have, but no longer - What concerns, if any, do you have with as a treatment for [pipe: S9 upper]? What concerns did you used to have about , but no longer do?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Had never heard of it when healthcare provider mentioned it,1=Had never heard of it when healthcare provider mentioned it",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C2_2",
    "column": "C2_2r12c2",
    "description": "C2_2r12c2: What I learned during my research was below my expectations - Concerns I used to have, but no longer - What concerns, if any, do you have with as a treatment for [pipe: S9 upper]? What concerns did you used to have about , but no longer do?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: What I learned during my research was below my expectations,1=What I learned during my research was below my expectations",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C2_2",
    "column": "C2_2r15c2",
    "description": "C2_2r15c2: My healthcare provider is not knowledgeable about this treatment - Concerns I used to have, but no longer - What concerns, if any, do you have with as a treatment for [pipe: S9 upper]? What concerns did you used to have about , but no longer do",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: My healthcare provider is not knowledgeable about this treatment,1=My healthcare provider is not knowledgeable about this treatment",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C2_2",
    "column": "C2_2r13c2",
    "description": "C2_2r13c2: Other (Specify) - Concerns I used to have, but no longer - What concerns, if any, do you have with as a treatment for [pipe: S9 upper]? What concerns did you used to have about , but no longer do?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Other (Specify),1=Other (Specify)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C2_2",
    "column": "C2_2r14c2",
    "description": "C2_2r14c2: None - Concerns I used to have, but no longer - What concerns, if any, do you have with as a treatment for [pipe: S9 upper]? What concerns did you used to have about , but no longer do?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: None,1=None",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C2_2",
    "column": "C2_2r13oe",
    "description": "C2_2r13oe: What concerns, if any, do you have with as a treatment for [pipe: S9 upper]? What concerns did you used to have about , but no longer do? - Other (Specify)",
    "valueType": "Open Text",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "text_open"
  },
  {
    "level": "sub",
    "parentQuestion": "C1a_2",
    "column": "C1a_2r1",
    "description": "C1a_2r1: Annoyed - Which of the following emotions, if any, best reflect how you feel about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Annoyed,1=Annoyed",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1a_2",
    "column": "C1a_2r2",
    "description": "C1a_2r2: Frustrated - Which of the following emotions, if any, best reflect how you feel about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Frustrated,1=Frustrated",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1a_2",
    "column": "C1a_2r3",
    "description": "C1a_2r3: Critical - Which of the following emotions, if any, best reflect how you feel about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Critical,1=Critical",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1a_2",
    "column": "C1a_2r4",
    "description": "C1a_2r4: Worried - Which of the following emotions, if any, best reflect how you feel about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Worried,1=Worried",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1a_2",
    "column": "C1a_2r5",
    "description": "C1a_2r5: Challenged - Which of the following emotions, if any, best reflect how you feel about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Challenged,1=Challenged",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1a_2",
    "column": "C1a_2r6",
    "description": "C1a_2r6: Defeated - Which of the following emotions, if any, best reflect how you feel about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Defeated,1=Defeated",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1a_2",
    "column": "C1a_2r7",
    "description": "C1a_2r7: Depressed - Which of the following emotions, if any, best reflect how you feel about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Depressed,1=Depressed",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1a_2",
    "column": "C1a_2r8",
    "description": "C1a_2r8: Guilty - Which of the following emotions, if any, best reflect how you feel about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Guilty,1=Guilty",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1a_2",
    "column": "C1a_2r9",
    "description": "C1a_2r9: Tired - Which of the following emotions, if any, best reflect how you feel about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Tired,1=Tired",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1a_2",
    "column": "C1a_2r10",
    "description": "C1a_2r10: Confused - Which of the following emotions, if any, best reflect how you feel about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Confused,1=Confused",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1a_2",
    "column": "C1a_2r11",
    "description": "C1a_2r11: Anxious - Which of the following emotions, if any, best reflect how you feel about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Anxious,1=Anxious",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1a_2",
    "column": "C1a_2r12",
    "description": "C1a_2r12: Hopeless - Which of the following emotions, if any, best reflect how you feel about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Hopeless,1=Hopeless",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1a_2",
    "column": "C1a_2r13",
    "description": "C1a_2r13: Insecure - Which of the following emotions, if any, best reflect how you feel about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Insecure,1=Insecure",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1a_2",
    "column": "C1a_2r14",
    "description": "C1a_2r14: Hopeful - Which of the following emotions, if any, best reflect how you feel about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Hopeful,1=Hopeful",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1a_2",
    "column": "C1a_2r15",
    "description": "C1a_2r15: Content - Which of the following emotions, if any, best reflect how you feel about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Content,1=Content",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1a_2",
    "column": "C1a_2r16",
    "description": "C1a_2r16: Relieved - Which of the following emotions, if any, best reflect how you feel about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Relieved,1=Relieved",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1a_2",
    "column": "C1a_2r17",
    "description": "C1a_2r17: Trusting - Which of the following emotions, if any, best reflect how you feel about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Trusting,1=Trusting",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1a_2",
    "column": "C1a_2r18",
    "description": "C1a_2r18: Helpful - Which of the following emotions, if any, best reflect how you feel about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Helpful,1=Helpful",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1a_2",
    "column": "C1a_2r19",
    "description": "C1a_2r19: In control - Which of the following emotions, if any, best reflect how you feel about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: In control,1=In control",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1a_2",
    "column": "C1a_2r20",
    "description": "C1a_2r20: Empowered - Which of the following emotions, if any, best reflect how you feel about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Empowered,1=Empowered",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1a_2",
    "column": "C1a_2r21",
    "description": "C1a_2r21: Confident - Which of the following emotions, if any, best reflect how you feel about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Confident,1=Confident",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C1a_2",
    "column": "C1a_2r22",
    "description": "C1a_2r22: Happy - Which of the following emotions, if any, best reflect how you feel about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Happy,1=Happy",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "parent",
    "parentQuestion": "NA",
    "column": "C9_2",
    "description": "C9_2: How informed was [pipe: S9 upper]’s healthcare provider when it came to prescribing as a [pipe: hS3] treatment?",
    "valueType": "Values: 1-99",
    "answerOptions": "1=1 Not at all informed,2=2,3=3,4=4 Somewhat informed,5=5,6=6,7=7 Extremely informed,99=I never discussed $ {Treatment_2.selected.text} with [pipe: S9 upper]’s healthcare provider",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 99,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      99
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all informed"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4 Somewhat informed"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely informed"
      },
      {
        "value": 99,
        "label": "I never discussed $ {Treatment_2.selected.text} with [pipe: S9 upper]’s healthcare provider"
      }
    ]
  },
  {
    "level": "parent",
    "parentQuestion": "NA",
    "column": "C10_2",
    "description": "C10_2: What was the overall tone of [pipe: S9 upper]’s healthcare provider when discussing as a [pipe: hS3] treatment with you?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Extremely Negative,2=2,3=3,4=4 Neutral,5=5,6=6,7=7 Extremely Positive",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Extremely Negative"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4 Neutral"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely Positive"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C4",
    "column": "C4r1",
    "description": "C4r1: In a 14-week clinical study, Fintepla reduced monthy seizures by 79%. This is compared with only 16% for loved one taking placebo. - Which, if any, of the following messages have you heard about Fintepla?",
    "valueType": "Values: 1-3",
    "answerOptions": "1=Heard from my Healthcare Provider,2=Have heard, but not from my Healthcare Provider,3=Have not heard",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 3,
    "allowedValues": [
      1,
      2,
      3
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "Heard from my Healthcare Provider"
      },
      {
        "value": 2,
        "label": "Have heard"
      },
      {
        "value": 3,
        "label": "Have not heard"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C4",
    "column": "C4r2",
    "description": "C4r2: Throughout a 36-month, long-term, open-label extension study, most patients maintained the seizure reduction they experienced in the clinical studies. - Which, if any, of the following messages have you heard about Fintepla?",
    "valueType": "Values: 1-3",
    "answerOptions": "1=Heard from my Healthcare Provider,2=Have heard, but not from my Healthcare Provider,3=Have not heard",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 3,
    "allowedValues": [
      1,
      2,
      3
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "Heard from my Healthcare Provider"
      },
      {
        "value": 2,
        "label": "Have heard"
      },
      {
        "value": 3,
        "label": "Have not heard"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C4",
    "column": "C4r3",
    "description": "C4r3: In Dravet Syndrome, in clinical studies 50% of patients on FINTEPLA had seizure-free streaks lasting at least 21 days. - Which, if any, of the following messages have you heard about Fintepla?",
    "valueType": "Values: 1-3",
    "answerOptions": "1=Heard from my Healthcare Provider,2=Have heard, but not from my Healthcare Provider,3=Have not heard",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 3,
    "allowedValues": [
      1,
      2,
      3
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "Heard from my Healthcare Provider"
      },
      {
        "value": 2,
        "label": "Have heard"
      },
      {
        "value": 3,
        "label": "Have not heard"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C4",
    "column": "C4r4",
    "description": "C4r4: Patients with LGS had significant and maintained seizure reduction across seizure types commonly experienced in LGS. - Which, if any, of the following messages have you heard about Fintepla?",
    "valueType": "Values: 1-3",
    "answerOptions": "1=Heard from my Healthcare Provider,2=Have heard, but not from my Healthcare Provider,3=Have not heard",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 3,
    "allowedValues": [
      1,
      2,
      3
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "Heard from my Healthcare Provider"
      },
      {
        "value": 2,
        "label": "Have heard"
      },
      {
        "value": 3,
        "label": "Have not heard"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C4",
    "column": "C4r5",
    "description": "C4r5: Clinical studies show patients experience a reduction in drop seizures across a variety of seizure types (e.g. Generalized tonic-clonic seizures, Tonic seizures, Atonic seizures, Tonic-atonic seizures). - Which, if any, of the following messages hav",
    "valueType": "Values: 1-3",
    "answerOptions": "1=Heard from my Healthcare Provider,2=Have heard, but not from my Healthcare Provider,3=Have not heard",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 3,
    "allowedValues": [
      1,
      2,
      3
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "Heard from my Healthcare Provider"
      },
      {
        "value": 2,
        "label": "Have heard"
      },
      {
        "value": 3,
        "label": "Have not heard"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C4",
    "column": "C4r6",
    "description": "C4r6: FINTEPLA fits into your loved one's current antiseizure treatment plan. You don't need to adjust the dose of other antiseizure medications. Add FINTEPLA without potential disruptions or compromising progress with current ASM treatments. - Which, if",
    "valueType": "Values: 1-3",
    "answerOptions": "1=Heard from my Healthcare Provider,2=Have heard, but not from my Healthcare Provider,3=Have not heard",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 3,
    "allowedValues": [
      1,
      2,
      3
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "Heard from my Healthcare Provider"
      },
      {
        "value": 2,
        "label": "Have heard"
      },
      {
        "value": 3,
        "label": "Have not heard"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C4",
    "column": "C4r7",
    "description": "C4r7: None of the 603 patients who took FINTEPLA during the clinical studies developed problems with their heart valves that caused valvular heart disease or high blood pressure in the arteries of the lungs, including patients treated for up to 3 years. -",
    "valueType": "Values: 1-3",
    "answerOptions": "1=Heard from my Healthcare Provider,2=Have heard, but not from my Healthcare Provider,3=Have not heard",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 3,
    "allowedValues": [
      1,
      2,
      3
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "Heard from my Healthcare Provider"
      },
      {
        "value": 2,
        "label": "Have heard"
      },
      {
        "value": 3,
        "label": "Have not heard"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C4",
    "column": "C4r8",
    "description": "C4r8: The FINTEPLA Risk Evaluation and Mitigation Strategy (REMS program is a drug safety program that the US Food and Drug Administration (FDA) requires for certain medicines with serious safety concerns. Drug companies and healthcare providers must take",
    "valueType": "Values: 1-3",
    "answerOptions": "1=Heard from my Healthcare Provider,2=Have heard, but not from my Healthcare Provider,3=Have not heard",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 3,
    "allowedValues": [
      1,
      2,
      3
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "Heard from my Healthcare Provider"
      },
      {
        "value": 2,
        "label": "Have heard"
      },
      {
        "value": 3,
        "label": "Have not heard"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C4",
    "column": "C4r9",
    "description": "C4r9: FINTEPLA is available only through the FINTEPLA REMS due to the risk of problems with valves in the heart (valvular heart disease) and high blood pressure in the arteries of the lungs (pulmonary arterial hypertension). In the past, some adults who t",
    "valueType": "Values: 1-3",
    "answerOptions": "1=Heard from my Healthcare Provider,2=Have heard, but not from my Healthcare Provider,3=Have not heard",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 3,
    "allowedValues": [
      1,
      2,
      3
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "Heard from my Healthcare Provider"
      },
      {
        "value": 2,
        "label": "Have heard"
      },
      {
        "value": 3,
        "label": "Have not heard"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C4",
    "column": "C4r10",
    "description": "C4r10: FINTEPLA Risk Evaluation and Mitigation Strategy (REMS) was created with your loved one’s safety in mind. It requires that they have heart checkups (echocardiograms) once before starting treatment with FINTEPLA, again every 6 months during treatm",
    "valueType": "Values: 1-3",
    "answerOptions": "1=Heard from my Healthcare Provider,2=Have heard, but not from my Healthcare Provider,3=Have not heard",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 3,
    "allowedValues": [
      1,
      2,
      3
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "Heard from my Healthcare Provider"
      },
      {
        "value": 2,
        "label": "Have heard"
      },
      {
        "value": 3,
        "label": "Have not heard"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C4",
    "column": "C4r11",
    "description": "C4r11: If you're considering FINTEPLA for your loved one, chat anytime with Faye, a virtual assistant trained by FINTEPLA experts who's always available on FINTEPLA.com to answer your questions. - Which, if any, of the following messages have you heard ab",
    "valueType": "Values: 1-3",
    "answerOptions": "1=Heard from my Healthcare Provider,2=Have heard, but not from my Healthcare Provider,3=Have not heard",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 3,
    "allowedValues": [
      1,
      2,
      3
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "Heard from my Healthcare Provider"
      },
      {
        "value": 2,
        "label": "Have heard"
      },
      {
        "value": 3,
        "label": "Have not heard"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C4",
    "column": "C4r12",
    "description": "C4r12: If you're considering FINTEPLA for your loved one, you can call and talk to a FINTEPLA Clinical Nurse Educator who are nurses and experts in [pipe: hS3], REMS, Echocardiograms, etc. - Which, if any, of the following messages have you heard about Fi",
    "valueType": "Values: 1-3",
    "answerOptions": "1=Heard from my Healthcare Provider,2=Have heard, but not from my Healthcare Provider,3=Have not heard",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 3,
    "allowedValues": [
      1,
      2,
      3
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "Heard from my Healthcare Provider"
      },
      {
        "value": 2,
        "label": "Have heard"
      },
      {
        "value": 3,
        "label": "Have not heard"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C4",
    "column": "C4r13",
    "description": "C4r13: If your loved one is already taking FINTEPLA, get to know your dedicated Care Coordinator, a nurse who has expertise on [pipe: hS3] and FINTEPLA. They will be specifically assigned to provide your family with one-on-one support throughout treatment",
    "valueType": "Values: 1-3",
    "answerOptions": "1=Heard from my Healthcare Provider,2=Have heard, but not from my Healthcare Provider,3=Have not heard",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 3,
    "allowedValues": [
      1,
      2,
      3
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "Heard from my Healthcare Provider"
      },
      {
        "value": 2,
        "label": "Have heard"
      },
      {
        "value": 3,
        "label": "Have not heard"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C4",
    "column": "C4r14",
    "description": "C4r14: Information on Fintepla's ONWARD program, which offers dedicated one-on-one support and resources to help your family, such as the ONWARD Copay Assistance program, where eligible families can pay as little as $0 copays for FINTEPLA and other associ",
    "valueType": "Values: 1-3",
    "answerOptions": "1=Heard from my Healthcare Provider,2=Have heard, but not from my Healthcare Provider,3=Have not heard",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 3,
    "allowedValues": [
      1,
      2,
      3
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "Heard from my Healthcare Provider"
      },
      {
        "value": 2,
        "label": "Have heard"
      },
      {
        "value": 3,
        "label": "Have not heard"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C4",
    "column": "C4r15",
    "description": "C4r15: If your loved is already on FINTEPLA, you can use the ONWARD Mobile App by down loading it in your phone. One convenient place to chat with your coordinator, track progress on medication shipments, and receive echocardiogram reminders. - Which, if",
    "valueType": "Values: 1-3",
    "answerOptions": "1=Heard from my Healthcare Provider,2=Have heard, but not from my Healthcare Provider,3=Have not heard",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 3,
    "allowedValues": [
      1,
      2,
      3
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "Heard from my Healthcare Provider"
      },
      {
        "value": 2,
        "label": "Have heard"
      },
      {
        "value": 3,
        "label": "Have not heard"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C4",
    "column": "C4r16",
    "description": "C4r16: For patients with Dravet syndrome, FINTEPLA offers profound seizure reduction - Which, if any, of the following messages have you heard about Fintepla?",
    "valueType": "Values: 1-3",
    "answerOptions": "1=Heard from my Healthcare Provider,2=Have heard, but not from my Healthcare Provider,3=Have not heard",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 3,
    "allowedValues": [
      1,
      2,
      3
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "Heard from my Healthcare Provider"
      },
      {
        "value": 2,
        "label": "Have heard"
      },
      {
        "value": 3,
        "label": "Have not heard"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C4",
    "column": "C4r17",
    "description": "C4r17: Throughout the 15-month, long-term, open-label extension study, most patients maintained the seizure reduction they experienced in the clinical study. - Which, if any, of the following messages have you heard about Fintepla?",
    "valueType": "Values: 1-3",
    "answerOptions": "1=Heard from my Healthcare Provider,2=Have heard, but not from my Healthcare Provider,3=Have not heard",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 3,
    "allowedValues": [
      1,
      2,
      3
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "Heard from my Healthcare Provider"
      },
      {
        "value": 2,
        "label": "Have heard"
      },
      {
        "value": 3,
        "label": "Have not heard"
      }
    ]
  },
  {
    "level": "parent",
    "parentQuestion": "NA",
    "column": "C4_time",
    "description": "C4_time: Hidden for Conjoint",
    "valueType": "Values: 0-974.39",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "admin",
    "rangeMin": 0,
    "rangeMax": 974.39
  },
  {
    "level": "sub",
    "parentQuestion": "NA",
    "column": "C13r1c1",
    "description": "C13r1c1: Last 6 Months - Considering Fintepla for my loved one - Please select the following actions, if any, you’ve taken in the last 6 months and/or plan to take in the next 6 months.",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Last 6 Months,1=Last 6 Months",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "NA",
    "column": "C13r1c2",
    "description": "C13r1c2: Next 6 Months - Considering Fintepla for my loved one - Please select the following actions, if any, you’ve taken in the last 6 months and/or plan to take in the next 6 months.",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Next 6 Months,1=Next 6 Months",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "NA",
    "column": "C13r1c3",
    "description": "C13r1c3: Neither - Considering Fintepla for my loved one - Please select the following actions, if any, you’ve taken in the last 6 months and/or plan to take in the next 6 months.",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Neither,1=Neither",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "NA",
    "column": "C13r2c1",
    "description": "C13r2c1: Last 6 Months - Rethinking my loved one’s antiseizure medication(s) - Please select the following actions, if any, you’ve taken in the last 6 months and/or plan to take in the next 6 months.",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Last 6 Months,1=Last 6 Months",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "NA",
    "column": "C13r2c2",
    "description": "C13r2c2: Next 6 Months - Rethinking my loved one’s antiseizure medication(s) - Please select the following actions, if any, you’ve taken in the last 6 months and/or plan to take in the next 6 months.",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Next 6 Months,1=Next 6 Months",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "NA",
    "column": "C13r2c3",
    "description": "C13r2c3: Neither - Rethinking my loved one’s antiseizure medication(s) - Please select the following actions, if any, you’ve taken in the last 6 months and/or plan to take in the next 6 months.",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Neither,1=Neither",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "NA",
    "column": "C13r3c1",
    "description": "C13r3c1: Last 6 Months - Asking my loved one’s doctor about Fintepla - Please select the following actions, if any, you’ve taken in the last 6 months and/or plan to take in the next 6 months.",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Last 6 Months,1=Last 6 Months",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "NA",
    "column": "C13r3c2",
    "description": "C13r3c2: Next 6 Months - Asking my loved one’s doctor about Fintepla - Please select the following actions, if any, you’ve taken in the last 6 months and/or plan to take in the next 6 months.",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Next 6 Months,1=Next 6 Months",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "NA",
    "column": "C13r3c3",
    "description": "C13r3c3: Neither - Asking my loved one’s doctor about Fintepla - Please select the following actions, if any, you’ve taken in the last 6 months and/or plan to take in the next 6 months.",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Neither,1=Neither",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "NA",
    "column": "C13r4c1",
    "description": "C13r4c1: Last 6 Months - Learning more about Fintepla - Please select the following actions, if any, you’ve taken in the last 6 months and/or plan to take in the next 6 months.",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Last 6 Months,1=Last 6 Months",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "NA",
    "column": "C13r4c2",
    "description": "C13r4c2: Next 6 Months - Learning more about Fintepla - Please select the following actions, if any, you’ve taken in the last 6 months and/or plan to take in the next 6 months.",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Next 6 Months,1=Next 6 Months",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "NA",
    "column": "C13r4c3",
    "description": "C13r4c3: Neither - Learning more about Fintepla - Please select the following actions, if any, you’ve taken in the last 6 months and/or plan to take in the next 6 months.",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Neither,1=Neither",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "NA",
    "column": "C13r5c1",
    "description": "C13r5c1: Last 6 Months - Sharing [pipe: S9 upper]’s story with others - Please select the following actions, if any, you’ve taken in the last 6 months and/or plan to take in the next 6 months.",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Last 6 Months,1=Last 6 Months",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "NA",
    "column": "C13r5c2",
    "description": "C13r5c2: Next 6 Months - Sharing [pipe: S9 upper]’s story with others - Please select the following actions, if any, you’ve taken in the last 6 months and/or plan to take in the next 6 months.",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Next 6 Months,1=Next 6 Months",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "NA",
    "column": "C13r5c3",
    "description": "C13r5c3: Neither - Sharing [pipe: S9 upper]’s story with others - Please select the following actions, if any, you’ve taken in the last 6 months and/or plan to take in the next 6 months.",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Neither,1=Neither",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C11b",
    "column": "C11br1",
    "description": "C11br1: Request this treatment from my [pipe: S9 upper]’s healthcare provider - Assuming [pipe: S9 upper] needed a antiseizure treatment change, how likely would you be to do each of the following when it comes to FINTEPLA?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all likely,2=2,3=3,4=4,5=5,6=6,7=7 Extremely likely",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all likely"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely likely"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C11b",
    "column": "C11br2",
    "description": "C11br2: Discuss this treatment with healthcare provider to get HCP perspective - Assuming [pipe: S9 upper] needed a antiseizure treatment change, how likely would you be to do each of the following when it comes to FINTEPLA?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all likely,2=2,3=3,4=4,5=5,6=6,7=7 Extremely likely",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all likely"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely likely"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C11b",
    "column": "C11br3",
    "description": "C11br3: Accept a recommendation for this treatment from [pipe: S9 upper]’s healthcare provider - Assuming [pipe: S9 upper] needed a antiseizure treatment change, how likely would you be to do each of the following when it comes to FINTEPLA?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all likely,2=2,3=3,4=4,5=5,6=6,7=7 Extremely likely",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all likely"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely likely"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C11b",
    "column": "C11br4",
    "description": "C11br4: Research more information about FINTEPLA - Assuming [pipe: S9 upper] needed a antiseizure treatment change, how likely would you be to do each of the following when it comes to FINTEPLA?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all likely,2=2,3=3,4=4,5=5,6=6,7=7 Extremely likely",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all likely"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely likely"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C5a",
    "column": "C5ar1",
    "description": "C5ar1: The FINTEPLA Risk Evaluation and Mitigation Strategy (REMS) program, which requires  echocardiograms before starting treatment and then once every 6 months during treatment - Which of the following have you ever discussed with [pipe: S9 upper]’s",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: The FINTEPLA Risk Evaluation and Mitigation Strategy (REMS) program, which requires  echocardiograms before star,1=The FINTEPLA Risk Evaluation and Mitigation Strategy (REMS) program, which requires  echocardiograms before starting tr",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C5a",
    "column": "C5ar2",
    "description": "C5ar2: FINTEPLA’s efficacy profile - Which of the following have you ever discussed with [pipe: S9 upper]’s healthcare provider when it comes to FINTEPLA?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: FINTEPLA’s efficacy profile,1=FINTEPLA’s efficacy profile",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C5a",
    "column": "C5ar3",
    "description": "C5ar3: FINTEPLA’s safety profile  - Which of the following have you ever discussed with [pipe: S9 upper]’s healthcare provider when it comes to FINTEPLA?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: FINTEPLA’s safety profile ,1=FINTEPLA’s safety profile ",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C5a",
    "column": "C5ar4",
    "description": "C5ar4: Haven’t discussed any of these with [pipe: S9 upper]’s healthcare provider - Which of the following have you ever discussed with [pipe: S9 upper]’s healthcare provider when it comes to FINTEPLA?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Haven’t discussed any of these with [pipe: S9 upper]’s healthcare provider,1=Haven’t discussed any of these with [pipe: S9 upper]’s healthcare provider",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C6",
    "column": "C6r1",
    "description": "C6r1: The FINTEPLA REMS program - When discussing FINTEPLA with [pipe: S9 upper]’s healthcare provider, how well were each of the following explained to you?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not well at all,2=2,3=3,4=4 Somewhat well,5=5,6=6,7=7 Extremely well",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not well at all"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4 Somewhat well"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely well"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C6",
    "column": "C6r2",
    "description": "C6r2: FINTEPLA’s efficacy profile - When discussing FINTEPLA with [pipe: S9 upper]’s healthcare provider, how well were each of the following explained to you?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not well at all,2=2,3=3,4=4 Somewhat well,5=5,6=6,7=7 Extremely well",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not well at all"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4 Somewhat well"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely well"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C6",
    "column": "C6r3",
    "description": "C6r3: FINTEPLA’s safety profile - When discussing FINTEPLA with [pipe: S9 upper]’s healthcare provider, how well were each of the following explained to you?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not well at all,2=2,3=3,4=4 Somewhat well,5=5,6=6,7=7 Extremely well",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not well at all"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4 Somewhat well"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely well"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C5",
    "column": "C5r1",
    "description": "C5r1: The FINTEPLA REMS program is beneficial because it will help keep [pipe: S9 upper] safe - In the previous question, you said you heard about the FINTEPLA Risk Evaluation and Mitigation Strategy (REMS) from [pipe: S9 upper]’s healthcare provider. ",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Does not describe the sentiment well at all,2=2,3=3,4=4 Somewhat describes the sentiment,5=5,6=6,7=7 Describes the sentiment extremely well",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Does not describe the sentiment well at all"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4 Somewhat describes the sentiment"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Describes the sentiment extremely well"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C5",
    "column": "C5r2",
    "description": "C5r2: The logistics of the FINTEPLA REMS program, such as ECHO scheduling, is a concern for considering FINTEPLA - In the previous question, you said you heard about the FINTEPLA Risk Evaluation and Mitigation Strategy (REMS) from [pipe: S9 upper]’s hea",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Does not describe the sentiment well at all,2=2,3=3,4=4 Somewhat describes the sentiment,5=5,6=6,7=7 Describes the sentiment extremely well",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Does not describe the sentiment well at all"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4 Somewhat describes the sentiment"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Describes the sentiment extremely well"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C5",
    "column": "C5r3",
    "description": "C5r3: The FINTEPLA REMS program being required due to safety concerns is a concern for considering FINTEPLA  - In the previous question, you said you heard about the FINTEPLA Risk Evaluation and Mitigation Strategy (REMS) from [pipe: S9 upper]’s health",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Does not describe the sentiment well at all,2=2,3=3,4=4 Somewhat describes the sentiment,5=5,6=6,7=7 Describes the sentiment extremely well",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Does not describe the sentiment well at all"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4 Somewhat describes the sentiment"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Describes the sentiment extremely well"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C7",
    "column": "C7r1",
    "description": "C7r1: The FINTEPLA REMS program is beneficial because it will help keep [pipe: S9 upper] safe - Now, how well do the following statements align with how you feel about FINTEPLA’s REMS program?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Does not describe my sentiment well at all,2=2,3=3,4=4 Somewhat describes my sentiment,5=5,6=6,7=7 Describes my sentiment extremely well",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Does not describe my sentiment well at all"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4 Somewhat describes my sentiment"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Describes my sentiment extremely well"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C7",
    "column": "C7r2",
    "description": "C7r2: The logistics of the FINTEPLA REMS program, such as ECHO scheduling, is a reason to not have [pipe: S9 upper] take FINTEPLA - Now, how well do the following statements align with how you feel about FINTEPLA’s REMS program?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Does not describe my sentiment well at all,2=2,3=3,4=4 Somewhat describes my sentiment,5=5,6=6,7=7 Describes my sentiment extremely well",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Does not describe my sentiment well at all"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4 Somewhat describes my sentiment"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Describes my sentiment extremely well"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "C7",
    "column": "C7r3",
    "description": "C7r3: The FINTEPLA REMS program being required due to safety concerns is a reason to not have [pipe: S9 upper] take FINTEPLA - Now, how well do the following statements align with how you feel about FINTEPLA’s REMS program?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Does not describe my sentiment well at all,2=2,3=3,4=4 Somewhat describes my sentiment,5=5,6=6,7=7 Describes my sentiment extremely well",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Does not describe my sentiment well at all"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4 Somewhat describes my sentiment"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Describes my sentiment extremely well"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "NA",
    "column": "C8",
    "description": "C8: After talking with [pipe: S9 upper]’s healthcare provider about FINTEPLA, how did your perceptions toward FINTEPLA change?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Extremely Worsened  My Perceptions,2=2,3=3,4=4 No Change in Perceptions,5=5,6=6,7=7 Extremely Improved My Perceptions",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Extremely Worsened  My Perceptions"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4 No Change in Perceptions"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely Improved My Perceptions"
      }
    ]
  },
  {
    "level": "parent",
    "parentQuestion": "NA",
    "column": "E1",
    "description": "E1: How familiar were you with the information shared about FINTEPLA (fenfluramine), before reading it just now?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all familiar,2=2,3=3,4=4,5=5,6=6,7=7 Extremely Familiar",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all familiar"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely Familiar"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E2",
    "column": "E2r1",
    "description": "E2r1: Overall - After reading the profile, how does FINTEPLA (fenfluramine) compare to your previous perceptions of FINTELA (fenfluramine) in the following areas?",
    "valueType": "Values: 1-8",
    "answerOptions": "1=1 Much Worse,2=2,3=3,4=4 About the Same,5=5,6=6,7=7 Much Better,8=Did Not Have Any Prior Knowledge Of This",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 8,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Much Worse"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4 About the Same"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Much Better"
      },
      {
        "value": 8,
        "label": "Did Not Have Any Prior Knowledge Of This"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E2",
    "column": "E2r2",
    "description": "E2r2: Effectiveness - After reading the profile, how does FINTEPLA (fenfluramine) compare to your previous perceptions of FINTELA (fenfluramine) in the following areas?",
    "valueType": "Values: 1-8",
    "answerOptions": "1=1 Much Worse,2=2,3=3,4=4 About the Same,5=5,6=6,7=7 Much Better,8=Did Not Have Any Prior Knowledge Of This",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 8,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Much Worse"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4 About the Same"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Much Better"
      },
      {
        "value": 8,
        "label": "Did Not Have Any Prior Knowledge Of This"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E2",
    "column": "E2r3",
    "description": "E2r3: Administration - After reading the profile, how does FINTEPLA (fenfluramine) compare to your previous perceptions of FINTELA (fenfluramine) in the following areas?",
    "valueType": "Values: 1-8",
    "answerOptions": "1=1 Much Worse,2=2,3=3,4=4 About the Same,5=5,6=6,7=7 Much Better,8=Did Not Have Any Prior Knowledge Of This",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 8,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Much Worse"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4 About the Same"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Much Better"
      },
      {
        "value": 8,
        "label": "Did Not Have Any Prior Knowledge Of This"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E2",
    "column": "E2r4",
    "description": "E2r4: Side-Effects - After reading the profile, how does FINTEPLA (fenfluramine) compare to your previous perceptions of FINTELA (fenfluramine) in the following areas?",
    "valueType": "Values: 1-8",
    "answerOptions": "1=1 Much Worse,2=2,3=3,4=4 About the Same,5=5,6=6,7=7 Much Better,8=Did Not Have Any Prior Knowledge Of This",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 8,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Much Worse"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4 About the Same"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Much Better"
      },
      {
        "value": 8,
        "label": "Did Not Have Any Prior Knowledge Of This"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E2",
    "column": "E2r5",
    "description": "E2r5: FINTEPLA REMS Program/monitoring Requirements - After reading the profile, how does FINTEPLA (fenfluramine) compare to your previous perceptions of FINTELA (fenfluramine) in the following areas?",
    "valueType": "Values: 1-8",
    "answerOptions": "1=1 Much Worse,2=2,3=3,4=4 About the Same,5=5,6=6,7=7 Much Better,8=Did Not Have Any Prior Knowledge Of This",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 8,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Much Worse"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4 About the Same"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Much Better"
      },
      {
        "value": 8,
        "label": "Did Not Have Any Prior Knowledge Of This"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E2",
    "column": "E2r6",
    "description": "E2r6: Cardiovascular Safety Risk - After reading the profile, how does FINTEPLA (fenfluramine) compare to your previous perceptions of FINTELA (fenfluramine) in the following areas?",
    "valueType": "Values: 1-8",
    "answerOptions": "1=1 Much Worse,2=2,3=3,4=4 About the Same,5=5,6=6,7=7 Much Better,8=Did Not Have Any Prior Knowledge Of This",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 8,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Much Worse"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4 About the Same"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Much Better"
      },
      {
        "value": 8,
        "label": "Did Not Have Any Prior Knowledge Of This"
      }
    ]
  },
  {
    "level": "parent",
    "parentQuestion": "NA",
    "column": "E4c",
    "description": "E4c: How similar does the information on FINTEPLA (fenfluramine) in the profile compare to what [pipe: S9 upper]’s healthcare provider told you about FINTEPLA (fenfluramine)?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 The profile is much less favorable,2=2,3=3,4=4 The profile is similar to what was described,5=5,6=6,7=7 The profile is much more favorable",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 The profile is much less favorable"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4 The profile is similar to what was described"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 The profile is much more favorable"
      }
    ]
  },
  {
    "level": "parent",
    "parentQuestion": "NA",
    "column": "E3",
    "description": "E3: Based on the profile, what are your overall impressions of FINTEPLA (fenfluramine)?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Extremely unfavorable,2=2,3=3,4=4,5=5,6=6,7=7 Extremely favorable",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Extremely unfavorable"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely favorable"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E4",
    "column": "E4r1",
    "description": "E4r1: Request this treatment from my [pipe: S9 upper]’s healthcare provider - Assuming [pipe: S9 upper] needed an antiseizure treatment change, how likely would you be to do each of the following now that you’ve read the profile of FINTEPLA (fenfluram",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all likely,2=2,3=3,4=4,5=5,6=6,7=7 Extremely likely",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all likely"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely likely"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E4",
    "column": "E4r2",
    "description": "E4r2: Discuss this treatment with healthcare provider to get HCP perspective - Assuming [pipe: S9 upper] needed an antiseizure treatment change, how likely would you be to do each of the following now that you’ve read the profile of FINTEPLA (fenflurami",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all likely,2=2,3=3,4=4,5=5,6=6,7=7 Extremely likely",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all likely"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely likely"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E4",
    "column": "E4r3",
    "description": "E4r3: Accept a recommendation for this treatment from [pipe: S9 upper]’s healthcare provider - Assuming [pipe: S9 upper] needed an antiseizure treatment change, how likely would you be to do each of the following now that you’ve read the profile of FI",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all likely,2=2,3=3,4=4,5=5,6=6,7=7 Extremely likely",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all likely"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely likely"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E4",
    "column": "E4r4",
    "description": "E4r4: Research more information about FINTEPLA (fenfluramine) after the visit - Assuming [pipe: S9 upper] needed an antiseizure treatment change, how likely would you be to do each of the following now that you’ve read the profile of FINTEPLA (fenfluram",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 Not at all likely,2=2,3=3,4=4,5=5,6=6,7=7 Extremely likely",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all likely"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely likely"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E4b",
    "column": "E4br1",
    "description": "E4br1: Healthcare provider indicated he/she has no experience prescribing FINTEPLA (fenfluramine) - [pipe: E4bPipe]",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 I would be extremely against [pipe: S9 upper] being prescribed FINTEPLA (fenfluramine),2=2,3=3,4=4 I’m not sure if I’d want [pipe: S9 upper] to be prescribed FINTEPLA (fenfluramine),5=5,6=6,7=7 I would be extremely for [pipe: S9 upper] being prescribed FINTEPLA (fenfluramine)",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 I would be extremely against [pipe: S9 upper] being prescribed FINTEPLA (fenfluramine)"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4 I’m not sure if I’d want [pipe: S9 upper] to be prescribed FINTEPLA (fenfluramine)"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 I would be extremely for [pipe: S9 upper] being prescribed FINTEPLA (fenfluramine)"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E4b",
    "column": "E4br2",
    "description": "E4br2: Healthcare provider indicated he/she was not comfortable with the safety profile - [pipe: E4bPipe]",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 I would be extremely against [pipe: S9 upper] being prescribed FINTEPLA (fenfluramine),2=2,3=3,4=4 I’m not sure if I’d want [pipe: S9 upper] to be prescribed FINTEPLA (fenfluramine),5=5,6=6,7=7 I would be extremely for [pipe: S9 upper] being prescribed FINTEPLA (fenfluramine)",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 I would be extremely against [pipe: S9 upper] being prescribed FINTEPLA (fenfluramine)"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4 I’m not sure if I’d want [pipe: S9 upper] to be prescribed FINTEPLA (fenfluramine)"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 I would be extremely for [pipe: S9 upper] being prescribed FINTEPLA (fenfluramine)"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E5",
    "column": "E5r1",
    "description": "E5r1: Seizure reduction data - Which attributes of FINTEPLA (fenfluramine) are the most appealing?",
    "valueType": "Values: 1-5",
    "answerOptions": "1=1st Choice,2=2nd Choice,3=3rd Choice,4=4th Choice,5=5th Choice",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1st Choice"
      },
      {
        "value": 2,
        "label": "2nd Choice"
      },
      {
        "value": 3,
        "label": "3rd Choice"
      },
      {
        "value": 4,
        "label": "4th Choice"
      },
      {
        "value": 5,
        "label": "5th Choice"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E5",
    "column": "E5r2",
    "description": "E5r2: Long-lasting results - Which attributes of FINTEPLA (fenfluramine) are the most appealing?",
    "valueType": "Values: 1-5",
    "answerOptions": "1=1st Choice,2=2nd Choice,3=3rd Choice,4=4th Choice,5=5th Choice",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1st Choice"
      },
      {
        "value": 2,
        "label": "2nd Choice"
      },
      {
        "value": 3,
        "label": "3rd Choice"
      },
      {
        "value": 4,
        "label": "4th Choice"
      },
      {
        "value": 5,
        "label": "5th Choice"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E5",
    "column": "E5r3",
    "description": "E5r3: Time from initiation to results - Which attributes of FINTEPLA (fenfluramine) are the most appealing?",
    "valueType": "Values: 1-5",
    "answerOptions": "1=1st Choice,2=2nd Choice,3=3rd Choice,4=4th Choice,5=5th Choice",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1st Choice"
      },
      {
        "value": 2,
        "label": "2nd Choice"
      },
      {
        "value": 3,
        "label": "3rd Choice"
      },
      {
        "value": 4,
        "label": "4th Choice"
      },
      {
        "value": 5,
        "label": "5th Choice"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E5",
    "column": "E5r4",
    "description": "E5r4: Length of clinical study - Which attributes of FINTEPLA (fenfluramine) are the most appealing?",
    "valueType": "Values: 1-5",
    "answerOptions": "1=1st Choice,2=2nd Choice,3=3rd Choice,4=4th Choice,5=5th Choice",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1st Choice"
      },
      {
        "value": 2,
        "label": "2nd Choice"
      },
      {
        "value": 3,
        "label": "3rd Choice"
      },
      {
        "value": 4,
        "label": "4th Choice"
      },
      {
        "value": 5,
        "label": "5th Choice"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E5",
    "column": "E5r5",
    "description": "E5r5: Length of open-label extension - Which attributes of FINTEPLA (fenfluramine) are the most appealing?",
    "valueType": "Values: 1-5",
    "answerOptions": "1=1st Choice,2=2nd Choice,3=3rd Choice,4=4th Choice,5=5th Choice",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1st Choice"
      },
      {
        "value": 2,
        "label": "2nd Choice"
      },
      {
        "value": 3,
        "label": "3rd Choice"
      },
      {
        "value": 4,
        "label": "4th Choice"
      },
      {
        "value": 5,
        "label": "5th Choice"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E5",
    "column": "E5r6",
    "description": "E5r6: Not having to change/ make adjustments to current antiseizure treatments - Which attributes of FINTEPLA (fenfluramine) are the most appealing?",
    "valueType": "Values: 1-5",
    "answerOptions": "1=1st Choice,2=2nd Choice,3=3rd Choice,4=4th Choice,5=5th Choice",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1st Choice"
      },
      {
        "value": 2,
        "label": "2nd Choice"
      },
      {
        "value": 3,
        "label": "3rd Choice"
      },
      {
        "value": 4,
        "label": "4th Choice"
      },
      {
        "value": 5,
        "label": "5th Choice"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E5",
    "column": "E5r7",
    "description": "E5r7: Oral liquid treatment that is compatible with feeding tubes - Which attributes of FINTEPLA (fenfluramine) are the most appealing?",
    "valueType": "Values: 1-5",
    "answerOptions": "1=1st Choice,2=2nd Choice,3=3rd Choice,4=4th Choice,5=5th Choice",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1st Choice"
      },
      {
        "value": 2,
        "label": "2nd Choice"
      },
      {
        "value": 3,
        "label": "3rd Choice"
      },
      {
        "value": 4,
        "label": "4th Choice"
      },
      {
        "value": 5,
        "label": "5th Choice"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E5",
    "column": "E5r8",
    "description": "E5r8: Taken twice a day - Which attributes of FINTEPLA (fenfluramine) are the most appealing?",
    "valueType": "Values: 1-5",
    "answerOptions": "1=1st Choice,2=2nd Choice,3=3rd Choice,4=4th Choice,5=5th Choice",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1st Choice"
      },
      {
        "value": 2,
        "label": "2nd Choice"
      },
      {
        "value": 3,
        "label": "3rd Choice"
      },
      {
        "value": 4,
        "label": "4th Choice"
      },
      {
        "value": 5,
        "label": "5th Choice"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E5",
    "column": "E5r9",
    "description": "E5r9: No dietary restrictions, including being on the ketogenic diet - Which attributes of FINTEPLA (fenfluramine) are the most appealing?",
    "valueType": "Values: 1-5",
    "answerOptions": "1=1st Choice,2=2nd Choice,3=3rd Choice,4=4th Choice,5=5th Choice",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1st Choice"
      },
      {
        "value": 2,
        "label": "2nd Choice"
      },
      {
        "value": 3,
        "label": "3rd Choice"
      },
      {
        "value": 4,
        "label": "4th Choice"
      },
      {
        "value": 5,
        "label": "5th Choice"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E5",
    "column": "E5r10",
    "description": "E5r10: Few/Manageable side effects - Which attributes of FINTEPLA (fenfluramine) are the most appealing?",
    "valueType": "Values: 1-5",
    "answerOptions": "1=1st Choice,2=2nd Choice,3=3rd Choice,4=4th Choice,5=5th Choice",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1st Choice"
      },
      {
        "value": 2,
        "label": "2nd Choice"
      },
      {
        "value": 3,
        "label": "3rd Choice"
      },
      {
        "value": 4,
        "label": "4th Choice"
      },
      {
        "value": 5,
        "label": "5th Choice"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "noanswerE5_",
    "column": "noanswerE5_r11",
    "description": "noanswerE5_r11: Which attributes of FINTEPLA (fenfluramine) are the most appealing? $ {res.pop_link_1 if S3.r3 else res.pop_link_2} : None of these are appealing - No Answer",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Which attributes of FINTEPLA (fenfluramine) are the most appealing? $ {res.pop_link_1 if S3.r3 else res.pop_link_,1=Which attributes of FINTEPLA (fenfluramine) are the most appealing? $ {res.pop_link_1 if S3.r3 else res.pop_link_2} : No",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E6",
    "column": "E6r1",
    "description": "E6r1: Not satisfied with seizure reduction data - Which attributes of FINTEPLA (fenfluramine) are drawbacks?",
    "valueType": "Values: 1-5",
    "answerOptions": "1=1st Choice,2=2nd Choice,3=3rd Choice,4=4th Choice,5=5th Choice",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1st Choice"
      },
      {
        "value": 2,
        "label": "2nd Choice"
      },
      {
        "value": 3,
        "label": "3rd Choice"
      },
      {
        "value": 4,
        "label": "4th Choice"
      },
      {
        "value": 5,
        "label": "5th Choice"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E6",
    "column": "E6r2",
    "description": "E6r2: Not satisfied with long-term efficacy data - Which attributes of FINTEPLA (fenfluramine) are drawbacks?",
    "valueType": "Values: 1-5",
    "answerOptions": "1=1st Choice,2=2nd Choice,3=3rd Choice,4=4th Choice,5=5th Choice",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1st Choice"
      },
      {
        "value": 2,
        "label": "2nd Choice"
      },
      {
        "value": 3,
        "label": "3rd Choice"
      },
      {
        "value": 4,
        "label": "4th Choice"
      },
      {
        "value": 5,
        "label": "5th Choice"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E6",
    "column": "E6r3",
    "description": "E6r3: Clinical study is not long enough - Which attributes of FINTEPLA (fenfluramine) are drawbacks?",
    "valueType": "Values: 1-5",
    "answerOptions": "1=1st Choice,2=2nd Choice,3=3rd Choice,4=4th Choice,5=5th Choice",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1st Choice"
      },
      {
        "value": 2,
        "label": "2nd Choice"
      },
      {
        "value": 3,
        "label": "3rd Choice"
      },
      {
        "value": 4,
        "label": "4th Choice"
      },
      {
        "value": 5,
        "label": "5th Choice"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E6",
    "column": "E6r4",
    "description": "E6r4: Open-label extension is not long enough - Which attributes of FINTEPLA (fenfluramine) are drawbacks?",
    "valueType": "Values: 1-5",
    "answerOptions": "1=1st Choice,2=2nd Choice,3=3rd Choice,4=4th Choice,5=5th Choice",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1st Choice"
      },
      {
        "value": 2,
        "label": "2nd Choice"
      },
      {
        "value": 3,
        "label": "3rd Choice"
      },
      {
        "value": 4,
        "label": "4th Choice"
      },
      {
        "value": 5,
        "label": "5th Choice"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E6",
    "column": "E6r5",
    "description": "E6r5: Do not want an oral liquid treatment - Which attributes of FINTEPLA (fenfluramine) are drawbacks?",
    "valueType": "Values: 1-5",
    "answerOptions": "1=1st Choice,2=2nd Choice,3=3rd Choice,4=4th Choice,5=5th Choice",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1st Choice"
      },
      {
        "value": 2,
        "label": "2nd Choice"
      },
      {
        "value": 3,
        "label": "3rd Choice"
      },
      {
        "value": 4,
        "label": "4th Choice"
      },
      {
        "value": 5,
        "label": "5th Choice"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E6",
    "column": "E6r6",
    "description": "E6r6: Many side effects that seem difficult to manage - Which attributes of FINTEPLA (fenfluramine) are drawbacks?",
    "valueType": "Values: 1-5",
    "answerOptions": "1=1st Choice,2=2nd Choice,3=3rd Choice,4=4th Choice,5=5th Choice",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1st Choice"
      },
      {
        "value": 2,
        "label": "2nd Choice"
      },
      {
        "value": 3,
        "label": "3rd Choice"
      },
      {
        "value": 4,
        "label": "4th Choice"
      },
      {
        "value": 5,
        "label": "5th Choice"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E6",
    "column": "E6r7",
    "description": "E6r7: ECHO monitoring needed every 6 months - Which attributes of FINTEPLA (fenfluramine) are drawbacks?",
    "valueType": "Values: 1-5",
    "answerOptions": "1=1st Choice,2=2nd Choice,3=3rd Choice,4=4th Choice,5=5th Choice",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1st Choice"
      },
      {
        "value": 2,
        "label": "2nd Choice"
      },
      {
        "value": 3,
        "label": "3rd Choice"
      },
      {
        "value": 4,
        "label": "4th Choice"
      },
      {
        "value": 5,
        "label": "5th Choice"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E6",
    "column": "E6r8",
    "description": "E6r8: Only being available through the FINTEPLA REMS program - Which attributes of FINTEPLA (fenfluramine) are drawbacks?",
    "valueType": "Values: 1-5",
    "answerOptions": "1=1st Choice,2=2nd Choice,3=3rd Choice,4=4th Choice,5=5th Choice",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1st Choice"
      },
      {
        "value": 2,
        "label": "2nd Choice"
      },
      {
        "value": 3,
        "label": "3rd Choice"
      },
      {
        "value": 4,
        "label": "4th Choice"
      },
      {
        "value": 5,
        "label": "5th Choice"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E6",
    "column": "E6r9",
    "description": "E6r9: Potential development of heart valve problems and/or high blood pressure in the arteries of their lungs - Which attributes of FINTEPLA (fenfluramine) are drawbacks?",
    "valueType": "Values: 1-5",
    "answerOptions": "1=1st Choice,2=2nd Choice,3=3rd Choice,4=4th Choice,5=5th Choice",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1st Choice"
      },
      {
        "value": 2,
        "label": "2nd Choice"
      },
      {
        "value": 3,
        "label": "3rd Choice"
      },
      {
        "value": 4,
        "label": "4th Choice"
      },
      {
        "value": 5,
        "label": "5th Choice"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E6",
    "column": "E6r10",
    "description": "E6r10: I expect it will be expensive - Which attributes of FINTEPLA (fenfluramine) are drawbacks?",
    "valueType": "Values: 1-5",
    "answerOptions": "1=1st Choice,2=2nd Choice,3=3rd Choice,4=4th Choice,5=5th Choice",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1st Choice"
      },
      {
        "value": 2,
        "label": "2nd Choice"
      },
      {
        "value": 3,
        "label": "3rd Choice"
      },
      {
        "value": 4,
        "label": "4th Choice"
      },
      {
        "value": 5,
        "label": "5th Choice"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "noanswerE6_",
    "column": "noanswerE6_r11",
    "description": "noanswerE6_r11: Which attributes of FINTEPLA (fenfluramine) are drawbacks? $ {res.pop_link_1 if S3.r3 else res.pop_link_2} : I don’t see any drawbacks - No Answer",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Which attributes of FINTEPLA (fenfluramine) are drawbacks? $ {res.pop_link_1 if S3.r3 else res.pop_link_2} : I do,1=Which attributes of FINTEPLA (fenfluramine) are drawbacks? $ {res.pop_link_1 if S3.r3 else res.pop_link_2} : I don’t s",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E5a",
    "column": "E5ar1",
    "description": "E5ar1: Seizure reduction data - Which attributes of FINTEPLA (fenfluramine) are the most appealing? Please rank up to 5 attributes below, where 1 is most appealing, 2 is the second most appealing, etc.",
    "valueType": "Values: 1-5",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E5a",
    "column": "E5ar2",
    "description": "E5ar2: Long-lasting results - Which attributes of FINTEPLA (fenfluramine) are the most appealing? Please rank up to 5 attributes below, where 1 is most appealing, 2 is the second most appealing, etc.",
    "valueType": "Values: 1-5",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E5a",
    "column": "E5ar3",
    "description": "E5ar3: Time from initiation to results - Which attributes of FINTEPLA (fenfluramine) are the most appealing? Please rank up to 5 attributes below, where 1 is most appealing, 2 is the second most appealing, etc.",
    "valueType": "Values: 1-5",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E5a",
    "column": "E5ar4",
    "description": "E5ar4: Length of clinical study - Which attributes of FINTEPLA (fenfluramine) are the most appealing? Please rank up to 5 attributes below, where 1 is most appealing, 2 is the second most appealing, etc.",
    "valueType": "Values: 1-5",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E5a",
    "column": "E5ar5",
    "description": "E5ar5: Length of open-label extension - Which attributes of FINTEPLA (fenfluramine) are the most appealing? Please rank up to 5 attributes below, where 1 is most appealing, 2 is the second most appealing, etc.",
    "valueType": "Values: 2-5",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 2,
    "rangeMax": 5,
    "allowedValues": [
      2,
      3,
      4,
      5
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E5a",
    "column": "E5ar6",
    "description": "E5ar6: Not having to change/ make adjustments to current antiseizure treatments - Which attributes of FINTEPLA (fenfluramine) are the most appealing? Please rank up to 5 attributes below, where 1 is most appealing, 2 is the second most appealing, etc.",
    "valueType": "Values: 1-5",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E5a",
    "column": "E5ar7",
    "description": "E5ar7: Oral liquid treatment that is compatible with feeding tubes - Which attributes of FINTEPLA (fenfluramine) are the most appealing? Please rank up to 5 attributes below, where 1 is most appealing, 2 is the second most appealing, etc.",
    "valueType": "Values: 1-5",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E5a",
    "column": "E5ar8",
    "description": "E5ar8: Taken twice a day - Which attributes of FINTEPLA (fenfluramine) are the most appealing? Please rank up to 5 attributes below, where 1 is most appealing, 2 is the second most appealing, etc.",
    "valueType": "Values: 1-5",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E5a",
    "column": "E5ar9",
    "description": "E5ar9: No dietary restrictions, including being on the ketogenic diet - Which attributes of FINTEPLA (fenfluramine) are the most appealing? Please rank up to 5 attributes below, where 1 is most appealing, 2 is the second most appealing, etc.",
    "valueType": "Values: 1-5",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E5a",
    "column": "E5ar10",
    "description": "E5ar10: Few/Manageable side effects - Which attributes of FINTEPLA (fenfluramine) are the most appealing? Please rank up to 5 attributes below, where 1 is most appealing, 2 is the second most appealing, etc.",
    "valueType": "Values: 1-5",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "noanswerE5a_",
    "column": "noanswerE5a_r11",
    "description": "noanswerE5a_r11: Which attributes of FINTEPLA (fenfluramine) are the most appealing? Please rank up to 5 attributes below, where 1 is most appealing, 2 is the second most appealing, etc. $ {res.pop_link_1 if S3.r3 else res.pop_link_2} : None of these are",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Which attributes of FINTEPLA (fenfluramine) are the most appealing? Please rank up to 5 attributes below, where 1,1=Which attributes of FINTEPLA (fenfluramine) are the most appealing? Please rank up to 5 attributes below, where 1 is mos",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E6a",
    "column": "E6ar1",
    "description": "E6ar1: Not satisfied with seizure reduction data - Which attributes of FINTEPLA (fenfluramine) are drawbacks? Please rank up to 5 attributes below, where 1 is the top drawback, 2 is the second drawback, etc.",
    "valueType": "Values: 1-5",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E6a",
    "column": "E6ar2",
    "description": "E6ar2: Not satisfied with long-term efficacy data - Which attributes of FINTEPLA (fenfluramine) are drawbacks? Please rank up to 5 attributes below, where 1 is the top drawback, 2 is the second drawback, etc.",
    "valueType": "Values: 1-5",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E6a",
    "column": "E6ar3",
    "description": "E6ar3: Clinical study is not long enough - Which attributes of FINTEPLA (fenfluramine) are drawbacks? Please rank up to 5 attributes below, where 1 is the top drawback, 2 is the second drawback, etc.",
    "valueType": "Values: 1-5",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E6a",
    "column": "E6ar4",
    "description": "E6ar4: Open-label extension is not long enough - Which attributes of FINTEPLA (fenfluramine) are drawbacks? Please rank up to 5 attributes below, where 1 is the top drawback, 2 is the second drawback, etc.",
    "valueType": "Values: 1-5",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E6a",
    "column": "E6ar5",
    "description": "E6ar5: Do not want an oral liquid treatment - Which attributes of FINTEPLA (fenfluramine) are drawbacks? Please rank up to 5 attributes below, where 1 is the top drawback, 2 is the second drawback, etc.",
    "valueType": "Values: 1-5",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E6a",
    "column": "E6ar6",
    "description": "E6ar6: Many side effects that seem difficult to manage - Which attributes of FINTEPLA (fenfluramine) are drawbacks? Please rank up to 5 attributes below, where 1 is the top drawback, 2 is the second drawback, etc.",
    "valueType": "Values: 1-5",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E6a",
    "column": "E6ar7",
    "description": "E6ar7: ECHO monitoring needed every 6 months - Which attributes of FINTEPLA (fenfluramine) are drawbacks? Please rank up to 5 attributes below, where 1 is the top drawback, 2 is the second drawback, etc.",
    "valueType": "Values: 1-5",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E6a",
    "column": "E6ar8",
    "description": "E6ar8: Only being available through the FINTEPLA REMS program - Which attributes of FINTEPLA (fenfluramine) are drawbacks? Please rank up to 5 attributes below, where 1 is the top drawback, 2 is the second drawback, etc.",
    "valueType": "Values: 1-5",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E6a",
    "column": "E6ar9",
    "description": "E6ar9: Potential development of heart valve problems and/or high blood pressure in the arteries of their lungs - Which attributes of FINTEPLA (fenfluramine) are drawbacks? Please rank up to 5 attributes below, where 1 is the top drawback, 2 is the second",
    "valueType": "Values: 1-5",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E6a",
    "column": "E6ar10",
    "description": "E6ar10: I expect it will be expensive - Which attributes of FINTEPLA (fenfluramine) are drawbacks? Please rank up to 5 attributes below, where 1 is the top drawback, 2 is the second drawback, etc.",
    "valueType": "Values: 1-5",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "noanswerE6a_",
    "column": "noanswerE6a_r11",
    "description": "noanswerE6a_r11: Which attributes of FINTEPLA (fenfluramine) are drawbacks? Please rank up to 5 attributes below, where 1 is the top drawback, 2 is the second drawback, etc. $ {res.pop_link_1 if S3.r3 else res.pop_link_2} : I don’t see any drawbacks - N",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Which attributes of FINTEPLA (fenfluramine) are drawbacks? Please rank up to 5 attributes below, where 1 is the t,1=Which attributes of FINTEPLA (fenfluramine) are drawbacks? Please rank up to 5 attributes below, where 1 is the top draw",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "parent",
    "parentQuestion": "NA",
    "column": "E6b",
    "description": "E6b: If the ECHO monitoring could be done at [pipe: S9 upper]’s home, how, if at all, would your perceptions of FINTEPLA (fenfluramine) change? Please review the following details about the in-home ECHO option: At UCB, we strive to make the FINTEPLA Ris",
    "valueType": "Values: 1-7",
    "answerOptions": "1=1 No Impact on My Perceptions,2=2,3=3,4=4 Somewhat Improve My Perceptions,5=5,6=6,7=7 Extremely Improve My Perceptions",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 No Impact on My Perceptions"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4 Somewhat Improve My Perceptions"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely Improve My Perceptions"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E7",
    "column": "E7r1",
    "description": "E7r1: Free 3-month trial to Headspace - Which of the following offerings from Fintepla have you heard of?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Free 3-month trial to Headspace,1=Free 3-month trial to Headspace",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E7",
    "column": "E7r2",
    "description": "E7r2: Talk to Flo, Fintepla Clinical Nurse Educator (help answer your questions about [pipe: hS3], about Fintepla, clinical trials, Risk Evaluation and Mitigations Strategy (REMS) program, financial support for access to Fintepla treatment and echocardiog",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Talk to Flo, Fintepla Clinical Nurse Educator (help answer your questions about [pipe: hS3], about Fintepla, clin,1=Talk to Flo, Fintepla Clinical Nurse Educator (help answer your questions about [pipe: hS3], about Fintepla, clinical tr",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E7",
    "column": "E7r3",
    "description": "E7r3: Talk to a Care Coordinator (determining eligibility for financial support, working with insurance, treatment delivery coordination, getting your prescription and refills on time, scheduling echocardiogram appointments) - Which of the following offer",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Talk to a Care Coordinator (determining eligibility for financial support, working with insurance, treatment deli,1=Talk to a Care Coordinator (determining eligibility for financial support, working with insurance, treatment delivery co",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E7",
    "column": "E7r4",
    "description": "E7r4: Copay Assistance Program - Which of the following offerings from Fintepla have you heard of?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Copay Assistance Program,1=Copay Assistance Program",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E7",
    "column": "E7r6",
    "description": "E7r6: Chatbot virtual assistance (FAYE) within FINTEPLA.com - Which of the following offerings from Fintepla have you heard of?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Chatbot virtual assistance (FAYE) within FINTEPLA.com,1=Chatbot virtual assistance (FAYE) within FINTEPLA.com",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E7",
    "column": "E7r7",
    "description": "E7r7: At-home echo monitoring - Which of the following offerings from Fintepla have you heard of?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: At-home echo monitoring,1=At-home echo monitoring",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E7",
    "column": "E7r5",
    "description": "E7r5: None of these - Which of the following offerings from Fintepla have you heard of?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: None of these,1=None of these",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E7a_1",
    "column": "E7a_1r1",
    "description": "E7a_1r1: [pipe: S9 upper]'s healthcare provider's office - Where did you hear/find out about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: [pipe: S9 upper]'s healthcare provider's office,1=[pipe: S9 upper]'s healthcare provider's office",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E7a_1",
    "column": "E7a_1r2",
    "description": "E7a_1r2: Welcome kit/brochure - Where did you hear/find out about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Welcome kit/brochure,1=Welcome kit/brochure",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E7a_1",
    "column": "E7a_1r3",
    "description": "E7a_1r3: Onward - Where did you hear/find out about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Onward,1=Onward",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E7a_1",
    "column": "E7a_1r4",
    "description": "E7a_1r4: Online research - Where did you hear/find out about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Online research,1=Online research",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E7a_1",
    "column": "E7a_1r5",
    "description": "E7a_1r5: Social Media - Where did you hear/find out about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Social Media,1=Social Media",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E7a_1",
    "column": "E7a_1r6",
    "description": "E7a_1r6: Other caregivers - Where did you hear/find out about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Other caregivers,1=Other caregivers",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E7a_1",
    "column": "E7a_1r99",
    "description": "E7a_1r99: Other (please specify) - Where did you hear/find out about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Other (please specify),1=Other (please specify)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E7a_1",
    "column": "E7a_1r99oe",
    "description": "E7a_1r99oe: Where did you hear/find out about ? - Other (please specify)",
    "valueType": "Open Text",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "text_open"
  },
  {
    "level": "sub",
    "parentQuestion": "E7a_2",
    "column": "E7a_2r1",
    "description": "E7a_2r1: [pipe: S9 upper]'s healthcare provider's office - Where did you hear/find out about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: [pipe: S9 upper]'s healthcare provider's office,1=[pipe: S9 upper]'s healthcare provider's office",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E7a_2",
    "column": "E7a_2r2",
    "description": "E7a_2r2: Welcome kit/brochure - Where did you hear/find out about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Welcome kit/brochure,1=Welcome kit/brochure",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E7a_2",
    "column": "E7a_2r3",
    "description": "E7a_2r3: Onward - Where did you hear/find out about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Onward,1=Onward",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E7a_2",
    "column": "E7a_2r4",
    "description": "E7a_2r4: Online research - Where did you hear/find out about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Online research,1=Online research",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E7a_2",
    "column": "E7a_2r5",
    "description": "E7a_2r5: Social Media - Where did you hear/find out about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Social Media,1=Social Media",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E7a_2",
    "column": "E7a_2r6",
    "description": "E7a_2r6: Other caregivers - Where did you hear/find out about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Other caregivers,1=Other caregivers",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E7a_2",
    "column": "E7a_2r99",
    "description": "E7a_2r99: Other (please specify) - Where did you hear/find out about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Other (please specify),1=Other (please specify)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E7a_2",
    "column": "E7a_2r99oe",
    "description": "E7a_2r99oe: Where did you hear/find out about ? - Other (please specify)",
    "valueType": "Open Text",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "text_open"
  },
  {
    "level": "sub",
    "parentQuestion": "E7a_3",
    "column": "E7a_3r1",
    "description": "E7a_3r1: [pipe: S9 upper]'s healthcare provider's office - Where did you hear/find out about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: [pipe: S9 upper]'s healthcare provider's office,1=[pipe: S9 upper]'s healthcare provider's office",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E7a_3",
    "column": "E7a_3r2",
    "description": "E7a_3r2: Welcome kit/brochure - Where did you hear/find out about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Welcome kit/brochure,1=Welcome kit/brochure",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E7a_3",
    "column": "E7a_3r3",
    "description": "E7a_3r3: Onward - Where did you hear/find out about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Onward,1=Onward",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E7a_3",
    "column": "E7a_3r4",
    "description": "E7a_3r4: Online research - Where did you hear/find out about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Online research,1=Online research",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E7a_3",
    "column": "E7a_3r5",
    "description": "E7a_3r5: Social Media - Where did you hear/find out about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Social Media,1=Social Media",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E7a_3",
    "column": "E7a_3r6",
    "description": "E7a_3r6: Other caregivers - Where did you hear/find out about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Other caregivers,1=Other caregivers",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E7a_3",
    "column": "E7a_3r99",
    "description": "E7a_3r99: Other (please specify) - Where did you hear/find out about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Other (please specify),1=Other (please specify)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E7a_3",
    "column": "E7a_3r99oe",
    "description": "E7a_3r99oe: Where did you hear/find out about ? - Other (please specify)",
    "valueType": "Open Text",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "text_open"
  },
  {
    "level": "sub",
    "parentQuestion": "E7a_4",
    "column": "E7a_4r1",
    "description": "E7a_4r1: [pipe: S9 upper]'s healthcare provider's office - Where did you hear/find out about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: [pipe: S9 upper]'s healthcare provider's office,1=[pipe: S9 upper]'s healthcare provider's office",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E7a_4",
    "column": "E7a_4r2",
    "description": "E7a_4r2: Welcome kit/brochure - Where did you hear/find out about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Welcome kit/brochure,1=Welcome kit/brochure",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E7a_4",
    "column": "E7a_4r3",
    "description": "E7a_4r3: Onward - Where did you hear/find out about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Onward,1=Onward",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E7a_4",
    "column": "E7a_4r4",
    "description": "E7a_4r4: Online research - Where did you hear/find out about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Online research,1=Online research",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E7a_4",
    "column": "E7a_4r5",
    "description": "E7a_4r5: Social Media - Where did you hear/find out about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Social Media,1=Social Media",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E7a_4",
    "column": "E7a_4r6",
    "description": "E7a_4r6: Other caregivers - Where did you hear/find out about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Other caregivers,1=Other caregivers",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E7a_4",
    "column": "E7a_4r99",
    "description": "E7a_4r99: Other (please specify) - Where did you hear/find out about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Other (please specify),1=Other (please specify)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E7a_4",
    "column": "E7a_4r99oe",
    "description": "E7a_4r99oe: Where did you hear/find out about ? - Other (please specify)",
    "valueType": "Open Text",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "text_open"
  },
  {
    "level": "sub",
    "parentQuestion": "E7a_6",
    "column": "E7a_6r1",
    "description": "E7a_6r1: [pipe: S9 upper]'s healthcare provider's office - Where did you hear/find out about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: [pipe: S9 upper]'s healthcare provider's office,1=[pipe: S9 upper]'s healthcare provider's office",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E7a_6",
    "column": "E7a_6r2",
    "description": "E7a_6r2: Welcome kit/brochure - Where did you hear/find out about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Welcome kit/brochure,1=Welcome kit/brochure",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E7a_6",
    "column": "E7a_6r3",
    "description": "E7a_6r3: Onward - Where did you hear/find out about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Onward,1=Onward",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E7a_6",
    "column": "E7a_6r4",
    "description": "E7a_6r4: Online research - Where did you hear/find out about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Online research,1=Online research",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E7a_6",
    "column": "E7a_6r5",
    "description": "E7a_6r5: Social Media - Where did you hear/find out about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Social Media,1=Social Media",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E7a_6",
    "column": "E7a_6r6",
    "description": "E7a_6r6: Other caregivers - Where did you hear/find out about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Other caregivers,1=Other caregivers",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E7a_6",
    "column": "E7a_6r99",
    "description": "E7a_6r99: Other (please specify) - Where did you hear/find out about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Other (please specify),1=Other (please specify)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E7a_6",
    "column": "E7a_6r99oe",
    "description": "E7a_6r99oe: Where did you hear/find out about ? - Other (please specify)",
    "valueType": "Open Text",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "text_open"
  },
  {
    "level": "sub",
    "parentQuestion": "E7a_7",
    "column": "E7a_7r1",
    "description": "E7a_7r1: [pipe: S9 upper]'s healthcare provider's office - Where did you hear/find out about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: [pipe: S9 upper]'s healthcare provider's office,1=[pipe: S9 upper]'s healthcare provider's office",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E7a_7",
    "column": "E7a_7r2",
    "description": "E7a_7r2: Welcome kit/brochure - Where did you hear/find out about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Welcome kit/brochure,1=Welcome kit/brochure",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E7a_7",
    "column": "E7a_7r3",
    "description": "E7a_7r3: Onward - Where did you hear/find out about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Onward,1=Onward",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E7a_7",
    "column": "E7a_7r4",
    "description": "E7a_7r4: Online research - Where did you hear/find out about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Online research,1=Online research",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E7a_7",
    "column": "E7a_7r5",
    "description": "E7a_7r5: Social Media - Where did you hear/find out about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Social Media,1=Social Media",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E7a_7",
    "column": "E7a_7r6",
    "description": "E7a_7r6: Other caregivers - Where did you hear/find out about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Other caregivers,1=Other caregivers",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E7a_7",
    "column": "E7a_7r99",
    "description": "E7a_7r99: Other (please specify) - Where did you hear/find out about ?",
    "valueType": "Values: 0-1",
    "answerOptions": "0=NO TO: Other (please specify),1=Other (please specify)",
    "context": "",
    "normalizedType": "binary_flag",
    "rangeMin": 0,
    "rangeMax": 1,
    "allowedValues": [
      0,
      1
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E7a_7",
    "column": "E7a_7r99oe",
    "description": "E7a_7r99oe: Where did you hear/find out about ? - Other (please specify)",
    "valueType": "Open Text",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "text_open"
  },
  {
    "level": "sub",
    "parentQuestion": "E8",
    "column": "E8r1",
    "description": "E8r1: Free 3-month trial to Headspace - How satisfied [pipe: Text_1] with each of the following offerings from Fintepla?",
    "valueType": "Values: 1-8",
    "answerOptions": "1=1 Not at all satisfied,2=2,3=3,4=4,5=5,6=6,7=7 Extremely Satisfied,8=Have Never Used",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 8,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all satisfied"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely Satisfied"
      },
      {
        "value": 8,
        "label": "Have Never Used"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E8",
    "column": "E8r2",
    "description": "E8r2: Talk to Flo, Fintepla Clinical Nurse Educator (help answer your questions about [pipe: hS3], about Fintepla, clinical trials, Risk Evaluation and Mitigations Strategy (REMS) program, financial support for access to Fintepla treatment and echocardiog",
    "valueType": "Values: 1-8",
    "answerOptions": "1=1 Not at all satisfied,2=2,3=3,4=4,5=5,6=6,7=7 Extremely Satisfied,8=Have Never Used",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 8,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all satisfied"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely Satisfied"
      },
      {
        "value": 8,
        "label": "Have Never Used"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E8",
    "column": "E8r3",
    "description": "E8r3: Talk to a Care Coordinator (determining eligibility for financial support, working with insurance, treatment delivery coordination, getting your prescription and refills on time, scheduling echocardiogram appointments, ) - How satisfied [pipe: Text_",
    "valueType": "Values: 1-8",
    "answerOptions": "1=1 Not at all satisfied,2=2,3=3,4=4,5=5,6=6,7=7 Extremely Satisfied,8=Have Never Used",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 8,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all satisfied"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely Satisfied"
      },
      {
        "value": 8,
        "label": "Have Never Used"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E8",
    "column": "E8r4",
    "description": "E8r4: Copay Assistance Program - How satisfied [pipe: Text_1] with each of the following offerings from Fintepla?",
    "valueType": "Values: 1-8",
    "answerOptions": "1=1 Not at all satisfied,2=2,3=3,4=4,5=5,6=6,7=7 Extremely Satisfied,8=Have Never Used",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 8,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all satisfied"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely Satisfied"
      },
      {
        "value": 8,
        "label": "Have Never Used"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E8",
    "column": "E8r6",
    "description": "E8r6: Chatbot virtual assistance (FAYE) within FINTEPLA.com - How satisfied [pipe: Text_1] with each of the following offerings from Fintepla?",
    "valueType": "Values: 1-8",
    "answerOptions": "1=1 Not at all satisfied,2=2,3=3,4=4,5=5,6=6,7=7 Extremely Satisfied,8=Have Never Used",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 8,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all satisfied"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely Satisfied"
      },
      {
        "value": 8,
        "label": "Have Never Used"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E8",
    "column": "E8r7",
    "description": "E8r7: At-home echo monitoring - How satisfied [pipe: Text_1] with each of the following offerings from Fintepla?",
    "valueType": "Values: 1-8",
    "answerOptions": "1=1 Not at all satisfied,2=2,3=3,4=4,5=5,6=6,7=7 Extremely Satisfied,8=Have Never Used",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 8,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Not at all satisfied"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely Satisfied"
      },
      {
        "value": 8,
        "label": "Have Never Used"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E9",
    "column": "E9r1",
    "description": "E9r1: Free 3-month trial to Headspace - What are your overall impressions of each of the following offerings from Fintepla?",
    "valueType": "Values: 1-8",
    "answerOptions": "1=1 Extremely Unfavorable,2=2,3=3,4=4,5=5,6=6,7=7 Extremely Favorable,8=Have No Impressions",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 8,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Extremely Unfavorable"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely Favorable"
      },
      {
        "value": 8,
        "label": "Have No Impressions"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E9",
    "column": "E9r2",
    "description": "E9r2: Talk to Flo, Fintepla Clinical Nurse Educator (help answer your questions about [pipe: hS3], about Fintepla, clinical trials, Risk Evaluation and Mitigations Strategy (REMS) program, financial support for access to Fintepla treatment and echocardiog",
    "valueType": "Values: 1-8",
    "answerOptions": "1=1 Extremely Unfavorable,2=2,3=3,4=4,5=5,6=6,7=7 Extremely Favorable,8=Have No Impressions",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 8,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Extremely Unfavorable"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely Favorable"
      },
      {
        "value": 8,
        "label": "Have No Impressions"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E9",
    "column": "E9r3",
    "description": "E9r3: Talk to a Care Coordinator (determining eligibility for financial support, working with insurance, treatment delivery coordination, getting your prescription and refills on time, scheduling echocardiogram appointments, ) - What are your overall impr",
    "valueType": "Values: 1-8",
    "answerOptions": "1=1 Extremely Unfavorable,2=2,3=3,4=4,5=5,6=6,7=7 Extremely Favorable,8=Have No Impressions",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 8,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Extremely Unfavorable"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely Favorable"
      },
      {
        "value": 8,
        "label": "Have No Impressions"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E9",
    "column": "E9r4",
    "description": "E9r4: Copay Assistance Program - What are your overall impressions of each of the following offerings from Fintepla?",
    "valueType": "Values: 1-8",
    "answerOptions": "1=1 Extremely Unfavorable,2=2,3=3,4=4,5=5,6=6,7=7 Extremely Favorable,8=Have No Impressions",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 8,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Extremely Unfavorable"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely Favorable"
      },
      {
        "value": 8,
        "label": "Have No Impressions"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E9",
    "column": "E9r6",
    "description": "E9r6: Chatbot virtual assistance (FAYE) within FINTEPLA.com - What are your overall impressions of each of the following offerings from Fintepla?",
    "valueType": "Values: 1-8",
    "answerOptions": "1=1 Extremely Unfavorable,2=2,3=3,4=4,5=5,6=6,7=7 Extremely Favorable,8=Have No Impressions",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 8,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Extremely Unfavorable"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely Favorable"
      },
      {
        "value": 8,
        "label": "Have No Impressions"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E9",
    "column": "E9r7",
    "description": "E9r7: At-home echo monitoring - What are your overall impressions of each of the following offerings from Fintepla?",
    "valueType": "Values: 1-8",
    "answerOptions": "1=1 Extremely Unfavorable,2=2,3=3,4=4,5=5,6=6,7=7 Extremely Favorable,8=Have No Impressions",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 8,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "1 Extremely Unfavorable"
      },
      {
        "value": 2,
        "label": "2"
      },
      {
        "value": 3,
        "label": "3"
      },
      {
        "value": 4,
        "label": "4"
      },
      {
        "value": 5,
        "label": "5"
      },
      {
        "value": 6,
        "label": "6"
      },
      {
        "value": 7,
        "label": "7 Extremely Favorable"
      },
      {
        "value": 8,
        "label": "Have No Impressions"
      }
    ]
  },
  {
    "level": "parent",
    "parentQuestion": "NA",
    "column": "E10",
    "description": "E10: Have you ever attended [pipe: E10Pipe]?",
    "valueType": "Values: 1-99",
    "answerOptions": "1=Attended in 2024,2=Did not attend in 2024, but attended in a previous year,99=Have never attended",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 99,
    "allowedValues": [
      1,
      2,
      99
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "Attended in 2024"
      },
      {
        "value": 2,
        "label": "Did not attend in 2024"
      },
      {
        "value": 99,
        "label": "Have never attended"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E10a",
    "column": "E10ar1",
    "description": "E10ar1: Fintepla (fenfluramine) from UCB - During your time at the [pipe: E10aPipe], how would you describe your engagement with each of the following antiseizure treatments?",
    "valueType": "Values: 1-3",
    "answerOptions": "1=Did not see at the conference,2=Saw at the conference, but did not interact,3=Saw and interacted with at the conference",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 3,
    "allowedValues": [
      1,
      2,
      3
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "Did not see at the conference"
      },
      {
        "value": 2,
        "label": "Saw at the conference"
      },
      {
        "value": 3,
        "label": "Saw and interacted with at the conference"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E10a",
    "column": "E10ar2",
    "description": "E10ar2: Diacomit (stiripentol) from Biocodex - During your time at the [pipe: E10aPipe], how would you describe your engagement with each of the following antiseizure treatments?",
    "valueType": "Values: 1-3",
    "answerOptions": "1=Did not see at the conference,2=Saw at the conference, but did not interact,3=Saw and interacted with at the conference",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 3,
    "allowedValues": [
      1,
      2,
      3
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "Did not see at the conference"
      },
      {
        "value": 2,
        "label": "Saw at the conference"
      },
      {
        "value": 3,
        "label": "Saw and interacted with at the conference"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E10a",
    "column": "E10ar3",
    "description": "E10ar3: Epidiolex (cannabidiol) from Jazz Pharmaceuticals - During your time at the [pipe: E10aPipe], how would you describe your engagement with each of the following antiseizure treatments?",
    "valueType": "Values: 1-3",
    "answerOptions": "1=Did not see at the conference,2=Saw at the conference, but did not interact,3=Saw and interacted with at the conference",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 3,
    "allowedValues": [
      1,
      2,
      3
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "Did not see at the conference"
      },
      {
        "value": 2,
        "label": "Saw at the conference"
      },
      {
        "value": 3,
        "label": "Saw and interacted with at the conference"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E10a",
    "column": "E10ar4",
    "description": "E10ar4: Other antiseizure treatment(s): - During your time at the [pipe: E10aPipe], how would you describe your engagement with each of the following antiseizure treatments?",
    "valueType": "Values: 1-3",
    "answerOptions": "1=Did not see at the conference,2=Saw at the conference, but did not interact,3=Saw and interacted with at the conference",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 3,
    "allowedValues": [
      1,
      2,
      3
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "Did not see at the conference"
      },
      {
        "value": 2,
        "label": "Saw at the conference"
      },
      {
        "value": 3,
        "label": "Saw and interacted with at the conference"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "E10a",
    "column": "E10ar4oe",
    "description": "E10ar4oe: During your time at the [pipe: E10aPipe], how would you describe your engagement with each of the following antiseizure treatments? - Other antiseizure treatment(s):",
    "valueType": "Open Text",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "text_open"
  },
  {
    "level": "parent",
    "parentQuestion": "NA",
    "column": "F1",
    "description": "F1: How old was [pipe: S9 upper] at the time of their [pipe: hS3] diagnosis?",
    "valueType": "Values: 0-26",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 0,
    "rangeMax": 26,
    "allowedValues": [
      0,
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8,
      9,
      10,
      11,
      12,
      13,
      14,
      15,
      16,
      17,
      18,
      19,
      20,
      21,
      22,
      23,
      24,
      25,
      26
    ]
  },
  {
    "level": "parent",
    "parentQuestion": "NA",
    "column": "HF1",
    "description": "HF1: Calculate S10 - F1 to derive time since diagnosis",
    "valueType": "Values: 1-5",
    "answerOptions": "1=Within past year,2=1-2 years ago,3=3-5 years ago,4=6-10 years ago,5=Over 10 years ago",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 5,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "Within past year"
      },
      {
        "value": 2,
        "label": "1-2 years ago"
      },
      {
        "value": 3,
        "label": "3-5 years ago"
      },
      {
        "value": 4,
        "label": "6-10 years ago"
      },
      {
        "value": 5,
        "label": "Over 10 years ago"
      }
    ]
  },
  {
    "level": "parent",
    "parentQuestion": "NA",
    "column": "HF2",
    "description": "HF2: Derive age of loved one when diagnosed from F1.",
    "valueType": "Values: 1-3",
    "answerOptions": "1=Child (Ages 0-12),2=Teenager (13-17),3=Adult (18+)",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 3,
    "allowedValues": [
      1,
      2,
      3
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "Child (Ages 0-12)"
      },
      {
        "value": 2,
        "label": "Teenager (13-17)"
      },
      {
        "value": 3,
        "label": "Adult (18+)"
      }
    ]
  },
  {
    "level": "parent",
    "parentQuestion": "NA",
    "column": "F2",
    "description": "F2: Which of the following best describes where [pipe: S9 upper] lives?",
    "valueType": "Values: 1-3",
    "answerOptions": "1=Lives at home,2=Lives at a long-term care facility/group home,3=Somewhere else (Specify)",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 3,
    "allowedValues": [
      1,
      2,
      3
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "Lives at home"
      },
      {
        "value": 2,
        "label": "Lives at a long-term care facility/group home"
      },
      {
        "value": 3,
        "label": "Somewhere else (Specify)"
      }
    ]
  },
  {
    "level": "sub",
    "parentQuestion": "F2",
    "column": "F2r3oe",
    "description": "F2r3oe: Which of the following best describes where [pipe: S9 upper] lives? - Somewhere else (Specify)",
    "valueType": "Open Text",
    "answerOptions": "NA",
    "context": "F2: F2: Which of the following best describes where [pipe: S9 upper] lives?",
    "normalizedType": "text_open"
  },
  {
    "level": "parent",
    "parentQuestion": "NA",
    "column": "F5",
    "description": "F5: What is [pipe: S9 upper]'s primary form of insurance coverage?",
    "valueType": "Values: 1-7",
    "answerOptions": "1=HMO/PPO or other commercial insurance,2=Medicaid,3=Medicare,4=VA or military benefits,5=Don't currently have coverage / pay cash,6=Don't Know,7=Other type of coverage",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 7,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "HMO/PPO or other commercial insurance"
      },
      {
        "value": 2,
        "label": "Medicaid"
      },
      {
        "value": 3,
        "label": "Medicare"
      },
      {
        "value": 4,
        "label": "VA or military benefits"
      },
      {
        "value": 5,
        "label": "Don't currently have coverage / pay cash"
      },
      {
        "value": 6,
        "label": "Don't Know"
      },
      {
        "value": 7,
        "label": "Other type of coverage"
      }
    ]
  },
  {
    "level": "parent",
    "parentQuestion": "NA",
    "column": "F7",
    "description": "F7: In what state does [pipe: S9 upper] currently reside in?",
    "valueType": "Values: 1-51",
    "answerOptions": "1=Alaska,2=Alabama,3=Arkansas,4=Arizona,5=California,6=Colorado,7=Connecticut,8=District of Columbia,9=Delaware,10=Florida,11=Georgia,12=Hawaii,13=Iowa,14=Idaho,15=Illinois,16=Indiana,17=Kansas,18=Kentucky,19=Louisiana,20=Massachusetts,21=Maryland,22=Maine,23=Michigan,24=Minnesota,25=Missouri,26=Mississippi,27=Montana,28=North Carolina,29=North Dakota,30=Nebraska,31=New Hampshire,32=New Jersey,33=New Mexico,34=Nevada,35=New York,36=Ohio,37=Oklahoma,38=Oregon,39=Pennsylvania,40=Rhode Island,41=South Carolina,42=South Dakota,43=Tennessee,44=Texas,45=Utah,46=Virginia,47=Vermont,48=Washington,49=Wisconsin,50=West Virginia,51=Wyoming",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 51,
    "allowedValues": [
      1,
      2,
      3,
      4,
      5,
      6,
      7,
      8,
      9,
      10,
      11,
      12,
      13,
      14,
      15,
      16,
      17,
      18,
      19,
      20,
      21,
      22,
      23,
      24,
      25,
      26,
      27,
      28,
      29,
      30,
      31,
      32,
      33,
      34,
      35,
      36,
      37,
      38,
      39,
      40,
      41,
      42,
      43,
      44,
      45,
      46,
      47,
      48,
      49,
      50,
      51
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "Alaska"
      },
      {
        "value": 2,
        "label": "Alabama"
      },
      {
        "value": 3,
        "label": "Arkansas"
      },
      {
        "value": 4,
        "label": "Arizona"
      },
      {
        "value": 5,
        "label": "California"
      },
      {
        "value": 6,
        "label": "Colorado"
      },
      {
        "value": 7,
        "label": "Connecticut"
      },
      {
        "value": 8,
        "label": "District of Columbia"
      },
      {
        "value": 9,
        "label": "Delaware"
      },
      {
        "value": 10,
        "label": "Florida"
      },
      {
        "value": 11,
        "label": "Georgia"
      },
      {
        "value": 12,
        "label": "Hawaii"
      },
      {
        "value": 13,
        "label": "Iowa"
      },
      {
        "value": 14,
        "label": "Idaho"
      },
      {
        "value": 15,
        "label": "Illinois"
      },
      {
        "value": 16,
        "label": "Indiana"
      },
      {
        "value": 17,
        "label": "Kansas"
      },
      {
        "value": 18,
        "label": "Kentucky"
      },
      {
        "value": 19,
        "label": "Louisiana"
      },
      {
        "value": 20,
        "label": "Massachusetts"
      },
      {
        "value": 21,
        "label": "Maryland"
      },
      {
        "value": 22,
        "label": "Maine"
      },
      {
        "value": 23,
        "label": "Michigan"
      },
      {
        "value": 24,
        "label": "Minnesota"
      },
      {
        "value": 25,
        "label": "Missouri"
      },
      {
        "value": 26,
        "label": "Mississippi"
      },
      {
        "value": 27,
        "label": "Montana"
      },
      {
        "value": 28,
        "label": "North Carolina"
      },
      {
        "value": 29,
        "label": "North Dakota"
      },
      {
        "value": 30,
        "label": "Nebraska"
      },
      {
        "value": 31,
        "label": "New Hampshire"
      },
      {
        "value": 32,
        "label": "New Jersey"
      },
      {
        "value": 33,
        "label": "New Mexico"
      },
      {
        "value": 34,
        "label": "Nevada"
      },
      {
        "value": 35,
        "label": "New York"
      },
      {
        "value": 36,
        "label": "Ohio"
      },
      {
        "value": 37,
        "label": "Oklahoma"
      },
      {
        "value": 38,
        "label": "Oregon"
      },
      {
        "value": 39,
        "label": "Pennsylvania"
      },
      {
        "value": 40,
        "label": "Rhode Island"
      },
      {
        "value": 41,
        "label": "South Carolina"
      },
      {
        "value": 42,
        "label": "South Dakota"
      },
      {
        "value": 43,
        "label": "Tennessee"
      },
      {
        "value": 44,
        "label": "Texas"
      },
      {
        "value": 45,
        "label": "Utah"
      },
      {
        "value": 46,
        "label": "Virginia"
      },
      {
        "value": 47,
        "label": "Vermont"
      },
      {
        "value": 48,
        "label": "Washington"
      },
      {
        "value": 49,
        "label": "Wisconsin"
      },
      {
        "value": 50,
        "label": "West Virginia"
      },
      {
        "value": 51,
        "label": "Wyoming"
      }
    ]
  },
  {
    "level": "parent",
    "parentQuestion": "NA",
    "column": "REGION",
    "description": "REGION: REGION",
    "valueType": "Values: 1-4",
    "answerOptions": "1=Northeast,2=South,3=Midwest,4=West",
    "context": "",
    "normalizedType": "categorical_select",
    "rangeMin": 1,
    "rangeMax": 4,
    "allowedValues": [
      1,
      2,
      3,
      4
    ],
    "scaleLabels": [
      {
        "value": 1,
        "label": "Northeast"
      },
      {
        "value": 2,
        "label": "South"
      },
      {
        "value": 3,
        "label": "Midwest"
      },
      {
        "value": 4,
        "label": "West"
      }
    ]
  },
  {
    "level": "parent",
    "parentQuestion": "NA",
    "column": "qtime",
    "description": "qtime: Total Interview Time",
    "valueType": "Values: 641.61-11210.94",
    "answerOptions": "NA",
    "context": "",
    "normalizedType": "admin",
    "rangeMin": 641.61,
    "rangeMax": 11210.94
  }
]